"Current Phase","Phase III Date","Phase III Event Date","Phase II Date","Phase II Event Date","Phase I Date","Molecule","Route of Administration","Lead Company Name","Ticker","Drug Name","Disease Group","Indication Name","Target","Phase I Event Date"
"Preclinical",,,,,,"Peptide",,"Titan Pharmaceuticals Inc.","TTNP","JT-09","Allergy","Pruritus","Opioid receptors",
"Preclinical",,,,,,"Peptide",,"Bioniz Therapeutics, Inc.",,"BNZ-3","Autoimmune/immunology","Autoimmune Disorders","IL-21 (Interleukin-21),IL-4 (Interleukin-4),IL-9 (Interleukin-9)",
"Suspended",,,,,,"Peptide",,"Takeda Pharmaceutical Co. Ltd.","TAK","F-1324","Autoimmune/immunology","Autoimmune Disorders","Bcl6/B-cell lymphoma 6",
"Preclinical",,,,,,"Peptide",,"ReAlta Life Sciences, Inc.",,"PIC1-03","Autoimmune/immunology","Complement Deficiencies / Abnormalities","Complement Component 1q (C1q),Complement Pathway",
"Suspended",,,,,,"Peptide",,"OncoImmune, Inc.",,"Echinomycin","Autoimmune/immunology","Graft vs. Host Disease (GVHD) - Treatment","DNA",
"Preclinical",,,,,,"Peptide",,"Galmed Pharmaceuticals Ltd.","GLMD","Amilo-5MER","Autoimmune/immunology","Inflammatory Bowel Disease (IBD)","Apolipoprotein - B100 (Apo-B100),Transthyretin (TTR)",
"Preclinical",,,,,,"Peptide",,"Find Therapeutics",,"GPCR Allosteric Modulator Program (Find)","Autoimmune/immunology","Inflammatory Disorders",,
"I",,,,,"10/19/2017","Peptide",,"Amyndas Pharmaceuticals",,"AMY-101","Autoimmune/immunology","Paroxysmal Nocturnal Hemoglobinuria (PNH)","Complement Pathway","10/19/2017"
"Preclinical",,,,,,"Peptide",,"WntResearch AB","WNT.ST","Box-5","Autoimmune/immunology","Psoriasis","WNT Signaling Pathway",
"Preclinical",,,,,,"Peptide",,"CEL-SCI Corporation","CVM","CEL-4000","Autoimmune/immunology","Rheumatoid Arthritis (RA)","Immune System,T lymphocytes",
"Suspended",,,,,,"Peptide",,"Genovax S.r.l.",,"GX 101","Autoimmune/immunology","Systemic Lupus Erythematosus (SLE)","T lymphocytes",
"Preclinical",,,,,,"Peptide",,"Arrevus Inc. ",,"ARV-1502","Autoimmune/immunology","Wound Healing","DnaK,Protein synthesis",
"Suspended",,,,,,"Peptide",,"LEO Pharma A/S",,"Peptide Derived Program (Leo/Morphosys)","Dermatology","Dermatology",,
"II",,,,"06/09/2016",,"Peptide",,"Strongbridge Biopharma plc","SBBP","COR-005","Endocrine","Acromegaly","Somatostatin Receptors",
"Suspended",,,,,,"Peptide",,"Amryt Pharma plc","AMYT","AP102","Endocrine","Acromegaly","Somatostatin Receptors",
"Suspended",,,,,,"Peptide",,"Amryt Pharma plc","AMYT","AP102","Endocrine","Cushing's Syndrome","Somatostatin Receptors",
"Preclinical",,,,,,"Peptide",,"Follicum AB",,"Diabetes Peptide Program (Follicum)","Endocrine","Diabetes Mellitus, Type I",,
"Suspended",,,,,,"Peptide",,"Novartis AG","NVS","Biosimilar Insulin Aspart (Sandoz)","Endocrine","Diabetes Mellitus, Type I","Insulin Receptor",
"Suspended",,,,,,"Peptide",,"Novartis AG","NVS","Biosimilar Insulin Glargine (Sandoz)","Endocrine","Diabetes Mellitus, Type I","Insulin Receptor",
"Suspended",,,,,,"Peptide",,"Novartis AG","NVS","Biosimilar Insulin Lispro (Sandoz)","Endocrine","Diabetes Mellitus, Type I","Insulin Receptor",
"Suspended",,,,,,"Peptide",,"Sanofi","SNY","Pancreate","Endocrine","Diabetes Mellitus, Type I","Human proIslet Peptide (HIP) Receptor",
"Suspended",,,,,,"Peptide",,"Viatris Inc.","VTRS","Biosimilar Humalog (Mylan/Biocon)","Endocrine","Diabetes Mellitus, Type I","Insulin Receptor",
"Preclinical",,,,,,"Peptide",,"Carmot Therapeutics Inc.",,"CT-388","Endocrine","Diabetes Mellitus, Type II","GIP Receptor (GIPR)/Glucose-Dependent Insulinotropic Polypeptide Receptor,GLP-1 Receptor",
"Preclinical",,,,,,"Peptide",,"Thermalin Diabetes LLC",,"Fluorolog","Endocrine","Diabetes Mellitus, Type II","Insulin Receptor",
"Preclinical",,,,,,"Peptide",,"Zucara Therapeutics, Inc.",,"ZT-01","Endocrine","Diabetes Mellitus, Type II","Somatostatin Receptors",
"Suspended",,,,,,"Peptide",,"Nordic Bioscience A/S",,"UGP302","Endocrine","Diabetes Mellitus, Type II","Amylin Receptor",
"Suspended",,,,,"01/31/2012","Peptide",,"Bristol Myers Squibb Company","BMY","AC165198","Endocrine","Diabetes Mellitus, Type II","Unknown","01/31/2012"
"Suspended",,,,,,"Peptide",,"CohBar, Inc.","CWBR","CB4209","Endocrine","Diabetes Mellitus, Type II","Mitochondria",
"Suspended",,,,,,"Peptide",,"Eloxx Pharmaceuticals, Inc.","ELOX","SVN-003","Endocrine","Diabetes Mellitus, Type II","Insulin Receptor",
"Suspended",,,,"06/08/2017",,"Peptide",,"Eli Lilly and Company","LLY","DACRA-042","Endocrine","Diabetes Mellitus, Type II","Amylin Receptor,Calcitonin Receptor","08/19/2015"
"Suspended",,,,,,"Peptide",,"MorphoSys AG","MOR","PanCyte","Endocrine","Diabetes Mellitus, Type II",,
"Suspended",,,,,,"Peptide",,"Novartis AG","NVS","Biosimilar Insulin Aspart (Sandoz)","Endocrine","Diabetes Mellitus, Type II","Insulin Receptor",
"Suspended",,,,,,"Peptide",,"Novartis AG","NVS","Biosimilar Insulin Glargine (Sandoz)","Endocrine","Diabetes Mellitus, Type II","Insulin Receptor",
"Suspended",,,,,,"Peptide",,"Novartis AG","NVS","Biosimilar Insulin Lispro (Sandoz)","Endocrine","Diabetes Mellitus, Type II","Insulin Receptor",
"Suspended",,,,,,"Peptide",,"Roche Holding AG","RHHBY","RG7089","Endocrine","Diabetes Mellitus, Type II","Neuropeptide Y (NPY)/Peptide YY (PYY) Receptors","07/23/2009"
"Suspended",,,,,,"Peptide",,"Sanofi","SNY","Pancreate","Endocrine","Diabetes Mellitus, Type II","Human proIslet Peptide (HIP) Receptor",
"Suspended",,,,,,"Peptide",,"Viatris Inc.","VTRS","Biosimilar Humalog (Mylan/Biocon)","Endocrine","Diabetes Mellitus, Type II","Insulin Receptor",
"Suspended",,,,,,"Peptide",,"Assertio Therapeutics, Inc.","ASRT","Synthetic ACTH Depot","Endocrine","Endocrine Disorder","Corticotropin Releasing Factor (CRF) / Corticotropin Releasing Hormone (CRH)",
"I",,,,,"09/29/2020","Peptide",,"Zucara Therapeutics, Inc.",,"ZT-01","Endocrine","Hyperinsulinemia/Hypoglycemia","Somatostatin Receptors","09/29/2020"
"Preclinical",,,,,,"Peptide",,"AmideBio LLC",,"AB-G023","Endocrine","Hyperinsulinemia/Hypoglycemia","Glucagon Receptor",
"Suspended",,,,,,"Peptide",,"DiObex, Inc.",,"DIO-901","Endocrine","Hyperinsulinemia/Hypoglycemia","Glucagon Receptor","06/22/2007"
"I",,,,,"12/14/2020","Peptide",,"Amolyt Pharma",,"AZP-3601","Endocrine","Hypoparathyroidism","Parathyroid Hormone (PTH)","12/14/2020"
"Suspended",,,,,,"Peptide",,"CohBar, Inc.","CWBR","CB4209","Endocrine","Non-Alcoholic Steatohepatitis (NASH)","Mitochondria",
"Suspended",,,,,,"Peptide",,"Biosidus S.A.",,"Osteofortil","Endocrine","Osteoporosis / Osteopenia","Parathyroid Hormone Receptor (PTHR)",
"Suspended",,,,,,"Peptide",,"Hanmi Pharmaceutical Co., Ltd.",128940,"HM15910","Gastroenterology (Non Inflammatory Bowel Disease)","Short Bowel Syndrome (SBS)","GLP-2 Receptor",
"Preclinical",,,,,,"Peptide",,"ReAlta Life Sciences, Inc.",,"PIC1-02","Hematology","Autoimmune Hemolytic Anemia (AIHA)","Complement Component 1q (C1q),Complement Pathway",
"Preclinical",,,,,,"Peptide",,"Apitope Technology (Bristol) Ltd",,"ATX-F8","Hematology","Factor VIII Intolerance","Unknown",
"Suspended",,,,,,"Peptide",,"Chemokine Therapeutics Corp.",,"CTCE-0214","Hematology","Neutropenia / Leukopenia","Chemokine (C-X-C motif) Receptor 4 (CXCR4)","10/19/2004"
"Preclinical",,,,,,"Peptide",,"NovaBiotics Ltd",,"Novarifyn","Infectious Disease","Antibacterial - General","Cell Membrane",
"Preclinical",,,,,,"Peptide",,"Soligenix, Inc.","SNGX","SGX943","Infectious Disease","Antibacterial - General","Immune System",
"Suspended",,,,,,"Peptide",,"Arrevus Inc. ",,"ARV-1501","Infectious Disease","Antibacterial - General","DnaK,Protein synthesis",
"Suspended",,,,,,"Peptide",,"Arrevus Inc. ",,"ARV-1503x","Infectious Disease","Antibacterial - General","DnaK,Protein synthesis",
"Suspended",,,,,,"Peptide",,"Arrevus Inc. ",,"ARV-1601","Infectious Disease","Antibacterial - General","DnaK,Gram-Negative Bacteria,Protein synthesis",
"Suspended",,,,,,"Peptide",,"EligoChem Ltd.",,"Helical Antimicrobial Peptide Program","Infectious Disease","Antibacterial - General","Gram-Negative Bacteria",
"Suspended",,,,,,"Peptide",,"Promore Pharma AB","PROMO","Pergamum-Cadila compound","Infectious Disease","Antibacterial - General","Unknown",
"Preclinical",,,,,,"Peptide",,"Vaxil Bio Ltd.",,"CorVax","Infectious Disease","COVID-19 Prevention","Immune System,SARS-CoV-2",
"I",,,,,"12/17/2020","Peptide",,"Vasomune Therapeutics, Inc.",,"AV-001","Infectious Disease","COVID-19 Treatment","Angiopoietin Receptors (TIE-1 and TIE-2)","12/17/2020"
"IND",,,,,,"Peptide",,"Amyndas Pharmaceuticals",,"AMY-101","Infectious Disease","COVID-19 Treatment","Complement Pathway",
"IND",,,,,,"Peptide",,"ReAlta Life Sciences, Inc.",,"RLS-0071","Infectious Disease","COVID-19 Treatment","Complement Component 1q (C1q),Complement Pathway",
"Preclinical",,,,,,"Peptide",,"Ligandal, Inc",,"Ligandal COVID-19 Vaccine","Infectious Disease","COVID-19 Treatment",,
"Suspended",,,"05/04/2015","05/04/2015",,"Peptide",,"Fortress Biotech Inc.","FBIO","PepVax","Infectious Disease","Cytomegalovirus (CMV) Infection (Antiviral)","Human Cytomegalovirus (HCMV)","04/02/2015"
"Suspended",,,,,,"Peptide",,"Enzo Biochem, Inc.","ENZ","EHC18","Infectious Disease","Hepatitis C (HCV) (Antiviral)","Unknown","03/15/2001"
"Suspended",,,,,,"Peptide",,"Spero Therapeutics, Inc.","SPRO","Gram-negative Program (Spero/Cantab)","Infectious Disease","Infectious Disease","Unknown",
"Preclinical",,,,,,"Peptide",,"CEL-SCI Corporation","CVM","LEAPS-H1N1-DC","Infectious Disease","Influenza (including vaccines)","Immune System,Influenza Virus",
"Suspended",,,,,,"Peptide",,"Arrevus Inc. ",,"ARV-1502","Infectious Disease","Skin and Skin-Structure Infections (Antibacterial)","DnaK,Protein synthesis",
"Suspended",,,,,,"Peptide",,"Cantab Anti-infectives Ltd.",,"NVB333","Infectious Disease","Staphylococcal Vaccines and Other Staphylococcus-Specific Agents (Antibacterial)","Staphylococcus",
"Suspended",,,,,,"Peptide",,"Akashi Therapeutics, Inc.",,"AT-300","Metabolic","Duchenne Muscular Dystrophy (DMD)",,
"Preclinical",,,,,,"Peptide",,"Alexion Pharmaceuticals Inc.","ALXN","Peptide Therapeutic Program (Alexion/Zealand)","Metabolic","Metabolic - General","Complement Pathway",
"Preclinical",,,,,,"Peptide",,"Zealand Pharma A/S","ZEAL","Peptide Therapeutic Program (Zealand/Orbit)","Metabolic","Metabolic - General",,
"Suspended",,,,,,"Peptide",,"GP Pharm, S.A.",,"Triptorelin (GP Pharm)","Metabolic","Metabolic - General","Gonadotropin-Releasing Hormone (GnRH) Receptor",
"Suspended",,,,,,"Peptide",,"Zealand Pharma A/S","ZEAL","Peptide Therapeutic Program (Zealand/TPIMS)","Metabolic","Metabolic - General",,
"Suspended",,,,,"03/30/2004","Peptide",,"Bristol Myers Squibb Company","BMY","AC162352","Metabolic","Obesity","Neuropeptide Y (NPY)/Peptide YY (PYY) Receptors","03/30/2004"
"Suspended",,,,,,"Peptide",,"CohBar, Inc.","CWBR","CB4209","Metabolic","Obesity","Mitochondria",
"I/II",,,,"01/12/2015",,"Peptide",,"Johnson & Johnson","JNJ","ACI-35","Neurology","Alzheimer's Disease (AD)","Immune System,Tau proteins",
"Preclinical",,,,,,"Peptide",,"Cenna Biosciences, Inc.",,"P8","Neurology","Alzheimer's Disease (AD)","Amyloid Beta/Amyloid Plaques",
"Suspended",,,,,,"Peptide",,"Neurotez, Inc.",,"NT1","Neurology","Alzheimer's Disease (AD)","Cytoplasmic linker protein 170 (CLIP-170) ,Presenilin 1 (PS1)",
"Preclinical",,,,,,"Peptide",,"Angiochem, Inc.",,"ANG2002","Neurology","Chronic Pain","NT1 (Neurotensin receptor type 1),NT2 (Neurotensin receptor type 2)",
"Suspended",,,,"03/31/2018",,"Peptide",,"Assertio Therapeutics, Inc.","ASRT","Synthetic ACTH Depot","Neurology","Infantile Spasms (West Syndrome; Epilepsy)","Corticotropin Releasing Factor (CRF) / Corticotropin Releasing Hormone (CRH)",
"Suspended",,,,,,"Peptide",,"Travere Therapeutics, Inc.","TVTX","RE-034","Neurology","Infantile Spasms (West Syndrome; Epilepsy)","Melanocortin (MC) receptors",
"II",,,"09/11/2020","09/11/2020","07/31/2017","Peptide",,"Lumosa Therapeutics Co., Ltd.","6535.TWO","LT3001","Neurology","Ischemic Stroke","Tissue Plasminogen Activator (TPA)","07/28/2017"
"Suspended",,,,,,"Peptide",,"Constant Therapeutics, LLC",,"TXA302","Neurology","Ischemic Stroke","Angiotensin II Receptor Type 1 (AT1),Angiotensin II Receptor Type 2 (AT2)",
"Suspended",,,,,,"Peptide",,"AnGes, Inc.",4563,"AGMG0201","Neurology","Ischemic Stroke","Angiotensins (I-IV),Immune System",
"Preclinical",,,,,,"Peptide",,"Axoltis Pharma",,"NX218","Neurology","Neurology - Other","Unknown",
"Preclinical",,,,,,"Peptide",,"ReAlta Life Sciences, Inc.",,"RLS-0071","Neurology","Neurology - Other","Complement Component 1q (C1q),Complement Pathway",
"I",,,,,,"Peptide",,"Stragen Pharm SA",,"STR-324","Neurology","Pain Indications","Nociceptin/Orphanin FQ Peptide (NOP) Receptor","02/23/2018"
"Suspended",,,,,,"Peptide",,"BioLineRx Ltd.","BLRX","EDP 32","Neurology","Parkinson's Disease (PD)","Alpha-synuclein",
"I",,,,,,"Peptide",,"Takeda Pharmaceutical Co. Ltd.","TAK","TAK-951","Not Specified","Emesis",,"05/14/2019"
"Program Hold",,,,,,"Peptide",,"Pantarhei Bioscience B.V.",,"OTE-F","Obstetrics/Gynecology","Reproductive Disorder","Estrogen Receptor Beta (ER2 or ER beta),Oxytocin Receptor","03/06/2013"
"Suspended",,,,"01/14/2010",,"Peptide",,"Gedeon Richter Plc.","RICHT","PGL3001","Obstetrics/Gynecology","Reproductive Disorder","Unknown",
"Preclinical",,,,,,"Peptide",,"Sapience Therapeutics, Inc.",,"ST101 (Sapience)","Oncology","Acute Myelogenous Leukemia (AML)",,
"Suspended",,,,,,"Peptide",,"OncoImmune, Inc.",,"Echinomycin","Oncology","Acute Myelogenous Leukemia (AML)","DNA",
"Suspended",,,,,,"Peptide",,"CytRx Corporation","CYTR","INNO-305","Oncology","Acute Myelogenous Leukemia (AML)","Immune System,Wilms' Tumor Protein 1 (WT1)","10/27/2006"
"Investigator Initiated",,,"12/13/2016",,,"Peptide",,"IMV Inc.","IMV","DPX-E7","Oncology","Anal Cancer","Human Papillomavirus (HPV),Immune System",
"II",,,"01/26/2016","12/31/2015",,"Peptide",,"Cleveland BioLabs, Inc.","CBLI","CBLB612","Oncology","Bone Marrow Transplant and Stem Cell Transplant","Toll-Like Receptor 2 (TLR2)","11/05/2014"
"Preclinical",,,,,,"Peptide",,"Arch Biopartners Inc.","ACHFF","MetaMx","Oncology","Brain Cancer (Malignant Glioma; AA and glioblastoma (GBM))","Tumor Cells",
"IND",,,,,,"Peptide",,"Neon Therapeutics, Inc.",,"NEO-SV-01","Oncology","Breast Cancer","Immune System",
"Suspended",,,,,,"Peptide",,"Treos Bio Limited",,"PolyPEPI915","Oncology","Breast Cancer","Immune System,T lymphocytes",
"IND",,,,,,"Peptide",,"Clovis Oncology, Inc.","CLVS","FAP-2286","Oncology","Cancer","Fibroblast Activation Protein (FAP),Radiopharmaceutical",
"Preclinical",,,,,,"Peptide",,"Soricimed Biopharma Inc.",,"SBI-1301","Oncology","Cancer","TRPV6, transient receptor potential vanilloid receptor 6, VR-6",
"Preclinical",,,,,,"Peptide",,"Portage Biotech Inc.","PTGEF","NLG PD1 Aptamer","Oncology","Cancer","Programmed death-1 receptor (PD-1) / Programmed death ligands (PD-L1 and PD-L2)",
"Preclinical",,,,,,"Peptide",,"Roche Holding AG","RHHBY","Roche Bicycle Program","Oncology","Cancer","Unknown",
"Preclinical",,,,,,"Peptide",,"Theratechnologies Inc.","THTX","TH1901","Oncology","Cancer","Sortilin 1 (SORT1)",
"Suspended",,,,,,"Peptide",,"Vaxon Biotech",,"Vbx-016","Oncology","Cancer","Carcinoembryonic antigen (CEA),HER2/neu or ErbB-2,Immune System,Melanoma antigen-encoding gene (MAGE),Telomerase",
"Suspended",,,,,,"Peptide",,"Altimmune Inc. ","ALT","Oncosyn","Oncology","Cancer","Immune System,T-Cell Receptor (TCR)",
"Investigator Initiated",,,"12/13/2016",,,"Peptide",,"IMV Inc.","IMV","DPX-E7","Oncology","Cervical Cancer","Human Papillomavirus (HPV),Immune System",
"Preclinical",,,,,,"Peptide",,"Hamlet Pharma AB","HAMLET","Alpha1H","Oncology","Gastric Cancer","Tumor Cells",
"Suspended",,,,,,"Peptide",,"Roche Holding AG","RHHBY","IMA942","Oncology","Gastric Cancer","Immune System,Tumor Cells",
"Investigator Initiated",,,"12/13/2016",,,"Peptide",,"IMV Inc.","IMV","DPX-E7","Oncology","Head and Neck Cancer","Human Papillomavirus (HPV),Immune System",
"Suspended",,,,,,"Peptide",,"Ono Pharmaceutical Company, Ltd.","4528:JP","ONO-7268MX2","Oncology","Hepatocellular (Liver) Cancer (HCC) (Including Secondary Metastases)","Immune System",
"Preclinical",,,,,,"Peptide",,"CohBar, Inc.","CWBR","CXCR4 Inhibitor (CohBar)","Oncology","Melanoma","Chemokine (C-X-C motif) Receptor 4 (CXCR4)",
"IND",,,,,,"Peptide",,"Oncopeptides AB","ONKO:SS","OPD5","Oncology","Multiple Myeloma (MM)","Aminopeptidase",
"Suspended",,,,,,"Peptide",,"Andarix Pharmaceuticals",,"Tozaride","Oncology","Non-Small Cell Lung Cancer (NSCLC)","Radiopharmaceutical,Somatostatin Receptors","06/03/2007"
"Suspended",,,,,,"Peptide",,"Roche Holding AG","RHHBY","IMA930","Oncology","Non-Small Cell Lung Cancer (NSCLC)","Immune System,Tumor Cells",
"Preclinical",,,,,,"Peptide",,"Theratechnologies Inc.","THTX","TH-1902","Oncology","Ovarian Cancer","Microtubules (Tubulin),Sortilin 1 (SORT1)",
"Preclinical",,,,,,"Peptide",,"Theratechnologies Inc.","THTX","TH-1904","Oncology","Ovarian Cancer","Sortilin 1 (SORT1),Topoisomerase II (DNA gyrase)",
"Suspended",,,,,,"Peptide",,"Treos Bio Limited",,"PolyPEPI1211","Oncology","Ovarian Cancer","Immune System,T lymphocytes",
"Suspended",,,,,"01/17/2019","Peptide",,"IMV Inc.","IMV","DPX-NEO Program","Oncology","Ovarian Cancer","Tumor Cells","01/17/2019"
"Preclinical",,,,,,"Peptide",,"Andarix Pharmaceuticals",,"Tozaride","Oncology","Pancreatic Cancer","Radiopharmaceutical,Somatostatin Receptors",
"Suspended",,,,,,"Peptide",,"Aileron Therapeutics, Inc","ALRN","ATSP-9172","Oncology","Prostate Cancer","Hypoxia Inducible Factor-1 alpha (HIF-1a)",
"Suspended",,,,,,"Peptide",,"Inspyr Therapeutics, Inc.","NSPX","G-115","Oncology","Prostate Cancer","Prostate-Specific Antigen (PSA),Sarcoplasmic reticulum Ca2+-ATPase (SERCA)",
"I",,,,,,"Peptide",,"Debiopharm S.A.",,"Debio 1124","Oncology","Small Cell Lung Cancer (SCLC)","Cholecystokinin 2 (CCK2 or CCKB) / Gastrin receptor,Radiopharmaceutical","08/26/2020"
"I/II",,,,"01/31/2004",,"Peptide",,"Andarix Pharmaceuticals",,"Tozaride","Oncology","Small Cell Lung Cancer (SCLC)","Radiopharmaceutical,Somatostatin Receptors",
"I",,,,,"11/28/2017","Peptide",,"Vigeo Therapeutics, Inc.",,"VT1021","Oncology","Solid Tumors",,"12/06/2017"
"I",,,,,,"Peptide",,"Vaxon Biotech",,"Vx-006","Oncology","Solid Tumors","HER2/neu or ErbB-2,Immune System,Melanoma antigen-encoding gene (MAGE),Telomerase","11/12/2014"
"I/II",,,"07/01/2020","07/01/2020",,"Peptide",,"Sapience Therapeutics, Inc.",,"ST101 (Sapience)","Oncology","Solid Tumors",,
"I/II",,,,"11/13/2019","11/13/2019","Peptide",,"Bicycle Therapeutics, plc","BCYC","BT5528","Oncology","Solid Tumors","Antibody-drug Conjugate (ADC),Ephrin Receptor EphA2 ",
"Preclinical",,,,,,"Peptide",,"Sapience Therapeutics, Inc.",,"Beta-Catenin Antagonist","Oncology","Solid Tumors",,
"Preclinical",,,,,,"Peptide",,"Altimmune Inc. ","ALT","ALT-702","Oncology","Solid Tumors","Immune System,Toll-like receptor 7 (TLR7),Toll-like receptor 8 (TLR8)",
"Preclinical",,,,,,"Peptide",,"Scancell","SCLP","Modi-2","Oncology","Solid Tumors","Cluster of Differentiation 4 (CD4),Immune System,Vimentin",
"Preclinical",,,,,,"Peptide",,"Theratechnologies Inc.","THTX","TH-1902","Oncology","Solid Tumors","Microtubules (Tubulin),Sortilin 1 (SORT1)",
"Suspended",,,,,"08/16/2018","Peptide",,"Biosceptre International Limited",,"BIL06v","Oncology","Solid Tumors","Immune System,Purinergic receptor P2X ligand-gated ion channel 7 (P2RX7)",
"Suspended",,,,,,"Peptide",,"Mediolanum Farmaceutici SpA",,"GX 301","Oncology","Solid Tumors","Telomerase",
"Suspended",,,,,,"Peptide",,"Aeterna Zentaris Inc.","AEZS","AEZS-125","Oncology","Solid Tumors","Gonadotropin-Releasing Hormone (GnRH) Receptor",
"Preclinical",,,,,,"Peptide",,"Debiopharm S.A.",,"Debio 1124","Oncology","Thyroid Cancer - Imaging","Cholecystokinin 2 (CCK2 or CCKB) / Gastrin receptor,Radiopharmaceutical",
"I/II",,,,"12/16/2019","12/16/2019","Peptide",,"Allysta Pharmaceuticals",,"ALY688","Ophthalmology","Dry Eye (Ophthalmology)","Adiponectin receptors",
"Suspended",,,,,"05/15/2017","Peptide",,"Takeda Pharmaceutical Co. Ltd.","TAK","SHP639","Ophthalmology","Glaucoma / Ocular Hypertension (Ophthalmology)",,"05/15/2017"
"Suspended",,,,,,"Peptide",,"Santen Pharmaceutical Co., Ltd.",4536,"PDPS Program (Santen/PeptiDream)","Ophthalmology","Other Ophthalmological Indications (Ophthalmology)","Unknown",
"Suspended",,,,,,"Peptide",,"BioDiem Ltd",,"BDM-E","Ophthalmology","Retinitis Pigmentosa (RP) (Ophthalmology)","Unknown",
"Suspended",,,,,,"Peptide",,"Thrasos Theraputics, Inc.",,"THR-8590","Renal","Renal Disease / Renal Failure",,
"Suspended",,,,,,"Peptide",,"Spotlight Innovation Inc.","STLT","Cardiotoxin","Renal","Renal Disease / Renal Failure","Potassium channels",
"Suspended",,,,,,"Peptide",,"Travere Therapeutics, Inc.","TVTX","RE-034","Renal","Renal Disease / Renal Failure","Melanocortin (MC) receptors",
"Suspended",,,,,,"Peptide",,"Windtree Therapeutics, Inc.","WINT","DSC-104","Respiratory","Asthma","Alveolar Surface","03/09/2004"
"Preclinical",,,,,,"Peptide",,"CohBar, Inc.","CWBR","MBT2 Analog (CohBar)","Respiratory","Idiopathic Pulmonary Fibrosis (IPF)","Mitochondria",
"Suspended",,,,,,"Peptide",,"Compugen Ltd.","CGEN","CGEN-25009","Respiratory","Idiopathic Pulmonary Fibrosis (IPF)","Relaxin Family Peptide Receptors 1-4 (RXFP1-4)",
"Preclinical",,,,,,"Peptide",,"Eli Lilly and Company","LLY","DACRA-056","Rheumatology (Non Autoimmune)","Osteoarthritis and Osteoarthritis Pain","Amylin Receptor,Calcitonin Gene-Related Peptide (CGRP) / Receptor",
"Development Outside U.S.",,,,,,"Peptide",,"Hamlet Pharma AB","HAMLET","Alpha1H","Oncology","Bladder Cancer","Tumor Cells",
"Development Outside U.S.",,,,,,"Peptide",,"Strongbridge Biopharma plc","SBBP","COR-005","Endocrine","Cushing's Syndrome","Somatostatin Receptors",
"Development Outside U.S.",,,,,,"Peptide",,"Strongbridge Biopharma plc","SBBP","COR-005","Ophthalmology","Diabetic Retinopathy (Ophthalmology)","Somatostatin Receptors",
"Development Outside U.S.",,,,,,"Peptide",,"Amolyt Pharma",,"AZP-3404","Endocrine","Endocrine Disorder","Insulin-Like Growth Factor Family ",
"Development Outside U.S.",,,,,,"Peptide",,"OncoTherapy Science, Inc.","4564:JP","OTSGC-A24","Oncology","Gastric Cancer","T lymphocytes",
"Development Outside U.S.",,,,,"04/12/2018","Peptide",,"AnGes, Inc.",4563,"AGMG0201","Cardiovascular","Hypertension (Systemic)","Angiotensins (I-IV),Immune System",
"Development Outside U.S.",,,,,"10/26/2016","Peptide",,"Apitope Technology (Bristol) Ltd",,"ATX-GD-459","Endocrine","Hyperthyroidism / Graves' Disease","Thyroid stimulating hormone receptor (TSHR)",
"Development Outside U.S.",,,,,,"Peptide",,"WntResearch AB","WNT.ST","Box-5","Oncology","Melanoma","WNT Signaling Pathway",
"Development Outside U.S.",,,,,,"Peptide",,"JCR Pharmaceuticals Co., Ltd.",4552,"JR-171","Metabolic","Mucopolysaccharidosis I (MPS I; Hurler Syndrome)","Unsulfated alpha-L-iduronic acid",
"Development Outside U.S.",,,,,,"Peptide",,"FunPep Co. Ltd.",,"FPP003","Autoimmune/immunology","Psoriasis",,
"Development Outside U.S.",,,,,,"Peptide",,"Strongbridge Biopharma plc","SBBP","COR-005","Oncology","Solid Tumors","Somatostatin Receptors",
"Suspended",,,"04/17/2013","04/17/2013",,"Peptide","Inhaled","APEPTICO GmbH",,"AP301","Autoimmune/immunology","Lung Transplant Rejection","Tumor Necrosis Factor-alpha (TNF-alpha)",
"II",,,,"10/12/2006",,"Peptide","Inhaled","NeuroRx, Inc.",,"Aviptadil","Autoimmune/immunology","Sarcoidosis","Vasoactive Intestinal Peptide (VIP) Receptor",
"Suspended",,,,"09/14/2006",,"Peptide","Inhaled","NeuroRx, Inc.",,"Aviptadil","Cardiovascular","Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension (PH)","Vasoactive Intestinal Peptide (VIP) Receptor","12/22/2003"
"Suspended",,,,"04/05/2005",,"Peptide","Inhaled","Biogen, Inc.","BIIB","Aviptadil (PAH)","Cardiovascular","Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension (PH)","Vasoactive Intestinal Peptide (VIP) Receptor","07/28/2004"
"I/II",,,"03/28/2013","11/30/2013",,"Peptide","Inhaled","Aerami Therapeutics",,"AER-501","Endocrine","Diabetes Mellitus, Type I","Insulin Receptor",
"Suspended",,,,"09/20/2005",,"Peptide","Inhaled","AbbVie Inc.","ABBV","ABT Inhaled Insulin","Endocrine","Diabetes Mellitus, Type I","Insulin Receptor","08/24/2003"
"Suspended",,,,,,"Peptide","Inhaled","Allergan plc","AGN","MAP0001","Endocrine","Diabetes Mellitus, Type I","Insulin Receptor","03/20/2008"
"Suspended","08/10/2004","07/19/2005","11/27/2000","08/10/2004",,"Peptide","Inhaled","Eli Lilly and Company","LLY","AIR Insulin","Endocrine","Diabetes Mellitus, Type I","Insulin Receptor","11/27/2000"
"Withdrawn from Market","11/10/1998","05/02/2002",,"06/16/1998",,"Peptide","Inhaled","Nektar Therapeutics","NKTR","Exubera","Endocrine","Diabetes Mellitus, Type I","Insulin Receptor",
"II",,,"09/24/2013","11/30/2013",,"Peptide","Inhaled","Aerami Therapeutics",,"AER-501","Endocrine","Diabetes Mellitus, Type II","Insulin Receptor",
"Suspended",,,,"08/26/2004",,"Peptide","Inhaled","AbbVie Inc.","ABBV","ABT Inhaled Insulin","Endocrine","Diabetes Mellitus, Type II","Insulin Receptor",
"Suspended",,,,,,"Peptide","Inhaled","Allergan plc","AGN","MAP0001","Endocrine","Diabetes Mellitus, Type II","Insulin Receptor","03/20/2008"
"Suspended","07/19/2005","07/19/2005",,,,"Peptide","Inhaled","Eli Lilly and Company","LLY","AIR Insulin","Endocrine","Diabetes Mellitus, Type II","Insulin Receptor",
"Suspended",,,,,,"Peptide","Inhaled","MannKind Corporation","MNKD","MKC-253","Endocrine","Diabetes Mellitus, Type II","GLP-1 Receptor","05/11/2007"
"Withdrawn from Market","11/10/1998","11/10/1998",,"06/16/1998",,"Peptide","Inhaled","Nektar Therapeutics","NKTR","Exubera","Endocrine","Diabetes Mellitus, Type II","Insulin Receptor",
"Suspended",,,,,,"Peptide","Inhaled","Azelon Pharmaceuticals",,"Ostabolin-C (inhalable)","Endocrine","Osteoporosis / Osteopenia","Parathyroid Hormone Receptor (PTHR)","09/21/2006"
"Suspended",,,,,"06/07/2007","Peptide","Inhaled","Alkermes plc","ALKS","AIR PTH","Endocrine","Osteoporosis / Osteopenia","Parathyroid Hormone Receptor (PTHR)","06/07/2007"
"II/III",,"11/13/2020","04/07/2020","04/07/2020",,"Peptide","Inhaled","NeuroRx, Inc.",,"Aviptadil","Infectious Disease","COVID-19 Treatment","Vasoactive Intestinal Peptide (VIP) Receptor",
"IND",,,,,,"Peptide","Inhaled","Synairgen plc","SNG","SNG001","Infectious Disease","COVID-19 Treatment","Interferon Receptor",
"Preclinical",,,,,,"Peptide","Inhaled","Windtree Therapeutics, Inc.","WINT","Aerosurf","Infectious Disease","Influenza (excluding vaccines)","Alveolar Surface",
"Suspended",,,,,,"Peptide","Inhaled","Synairgen plc","SNG","SNG001","Infectious Disease","Influenza (including vaccines)","Interferon Receptor",
"Preclinical",,,,,,"Peptide","Inhaled","Santhera Pharmaceuticals","SANN","POL6014","Metabolic","Metabolic - General","Human Neutrophil elastase (hNE)",
"II",,,"01/23/2018","01/23/2018",,"Peptide","Inhaled","BioMarck Pharmaceuticals, Ltd.",,"BIO-11006","Oncology","Non-Small Cell Lung Cancer (NSCLC)","MARCKS (Myristoylated alanine-rich C-kinase substrate)",
"II",,,,"06/16/2005",,"Peptide","Inhaled","NeuroRx, Inc.",,"Aviptadil","Respiratory","Acute Respiratory Failure, Acute Lung Injury (ALI), Acute Respiratory Distress Syndrome (ARDS)","Vasoactive Intestinal Peptide (VIP) Receptor","07/28/2004"
"II",,,"10/03/2017","10/03/2017",,"Peptide","Inhaled","BioMarck Pharmaceuticals, Ltd.",,"BIO-11006","Respiratory","Acute Respiratory Failure, Acute Lung Injury (ALI), Acute Respiratory Distress Syndrome (ARDS)","MARCKS (Myristoylated alanine-rich C-kinase substrate)",
"Suspended",,,"06/29/2012","06/29/2012","04/07/2011","Peptide","Inhaled","APEPTICO GmbH",,"AP301","Respiratory","Acute Respiratory Failure, Acute Lung Injury (ALI), Acute Respiratory Distress Syndrome (ARDS)","Tumor Necrosis Factor-alpha (TNF-alpha)","04/07/2011"
"Preclinical",,,,,,"Peptide","Inhaled","Antlia Bioscience, Inc.",,"LANA-AS","Respiratory","Asthma","Unknown",
"Suspended",,,,,,"Peptide","Inhaled","Longevity Biotech, Inc.",,"5A ApoA-I Mimetic Peptide Program","Respiratory","Asthma"," ATP-Binding Cassette Transporter G1 (ABCG1),Reactive Oxygen Species/Free Radicals",
"Suspended",,,"04/01/2010","04/01/2010",,"Peptide","Inhaled","Synairgen plc","SNG","SNG001","Respiratory","Asthma","Interferon Receptor","06/12/2007"
"Preclinical",,,,,"06/06/2016","Peptide","Inhaled","Santhera Pharmaceuticals","SANN","POL6014","Respiratory","Bronchiectasis","Human Neutrophil elastase (hNE)","06/06/2016"
"Program Hold",,,"02/07/2018","07/30/2015",,"Peptide","Inhaled","Synairgen plc","SNG","SNG001","Respiratory","Chronic Obstructive Pulmonary Disease (COPD)","Interferon Receptor","06/12/2007"
"Suspended",,,,"06/26/2008",,"Peptide","Inhaled","BioMarck Pharmaceuticals, Ltd.",,"BIO-11006","Respiratory","Chronic Obstructive Pulmonary Disease (COPD)","MARCKS (Myristoylated alanine-rich C-kinase substrate)",
"I",,,,,"09/01/2015","Peptide","Inhaled","Santhera Pharmaceuticals","SANN","POL6014","Respiratory","Cystic Fibrosis (CF)","Human Neutrophil elastase (hNE)","09/01/2015"
"Program Hold",,,"09/03/2008","09/03/2008",,"Peptide","Inhaled","Windtree Therapeutics, Inc.","WINT","Aerosurf","Respiratory","Cystic Fibrosis (CF)","Alveolar Surface",
"Suspended",,,"08/31/2017","08/31/2017",,"Peptide","Inhaled","Spyryx Biosciences, Inc.",,"SPX-101","Respiratory","Cystic Fibrosis (CF)","Sodium Channels","08/18/2016"
"Suspended",,,,,,"Peptide","Inhaled","RegeneRx Biopharmaceuticals, Inc.","RGRX","RGN-457","Respiratory","Cystic Fibrosis (CF)","Actin Filaments,ATP Synthase,Integrin-linked kinase (ILK)",
"f",,,,"04/01/2007",,"Peptide","Inhaled","NeuroRx, Inc.",,"Aviptadil","Respiratory","Idiopathic Pulmonary Fibrosis (IPF)","Vasoactive Intestinal Peptide (VIP) Receptor",
"Suspended",,,,,,"Peptide","Inhaled","Moerae Matrix, Inc.",,"MMI-0100","Respiratory","Idiopathic Pulmonary Fibrosis (IPF)","Mitogen-Activated Protein Kinase-Activated Protein Kinase 2 (MK2)","08/05/2014"
"Suspended",,,,,"01/12/2016","Peptide","Inhaled","GlaxoSmithKline plc","GSK","GSK3008348","Respiratory","Idiopathic Pulmonary Fibrosis (IPF)","Integrin Alpha-V Family","01/12/2016"
"Preclinical",,,,,,"Peptide","Inhaled","Santhera Pharmaceuticals","SANN","POL6014","Respiratory","Respiratory Disease","Human Neutrophil elastase (hNE)",
"IIb",,,,"08/08/2008",,"Peptide","Inhaled","Windtree Therapeutics, Inc.","WINT","Aerosurf","Respiratory","Respiratory Distress Syndrome (RDS)","Alveolar Surface","05/01/2006"
"Preclinical",,,,,,"Peptide","Inhaled","Acorda Therapeutics, Inc.","ACOR","CVT-717","Respiratory","Respiratory Distress Syndrome (RDS)","Alveolar Surface",
"Development Outside U.S.",,,,,,"Peptide","Inhaled","APEPTICO GmbH",,"AP301","Infectious Disease","COVID-19 Treatment","Tumor Necrosis Factor-alpha (TNF-alpha)",
"Development Outside U.S.",,,,,,"Peptide","Inhaled","Polyphor AG","POLN","Inhaled Murepavadin","Infectious Disease","Pseudomonas-Specific Agents (Antibacterial)","Cell Membrane,Pseudomonas aeruginosa",
"Approved (Generic Competition)",,"11/01/2002",,,,"Peptide","Inhaled","Sawai Pharmaceutical Co., Ltd.",4555,"Fortical","Endocrine","Osteoporosis / Osteopenia","Calcitonin Receptor",
"Approved","06/29/2005","06/29/2005",,"11/10/2004",,"Peptide","Inhaled","MannKind Corporation","MNKD","Afrezza","Endocrine","Diabetes Mellitus, Type I","Insulin Receptor",
"Approved","06/29/2005","06/29/2005",,"11/10/2004",,"Peptide","Inhaled","MannKind Corporation","MNKD","Afrezza","Endocrine","Diabetes Mellitus, Type II","Insulin Receptor",
"II",,,"01/23/2014","08/16/2013",,"Peptide","Intraarticular","OrthoTrophix, Inc.",,"TPX-100","Rheumatology (Non Autoimmune)","Osteoarthritis and Osteoarthritis Pain","Integrin Alpha 2 beta 1/VLA-2",
"Suspended",,,"02/10/2009","02/10/2009","02/29/2008","Peptide","Intradermal","Capstone Therapeutics Corp.","CAPS","AZX100","Autoimmune/immunology","Wound Healing","Actin Filaments","02/29/2008"
"II",,,"04/25/2016","07/05/2017",,"Peptide","Intradermal","Sumitomo Dainippon Pharma Co., Ltd.",4506,"DSP-7888","Oncology","Brain Cancer (Malignant Glioma; AA and glioblastoma (GBM))","Immune System,Wilms' Tumor Protein 1 (WT1)",
"II",,,,"05/29/2020",,"Peptide","Intradermal","Greenwich LifeSciences","GLSI","GP2","Oncology","Breast Cancer","HER2/neu or ErbB-2",
"IIb",,,"02/01/2007","02/01/2007","03/22/2005","Peptide","Intradermal","Generex Biotechnology Corporation","GNBT","AE37","Oncology","Breast Cancer","HER2/neu or ErbB-2,Immune System","03/22/2005"
"IIb","11/23/2011","06/19/2009",,"01/22/2008",,"Peptide","Intradermal","SELLAS Life Sciences Group, Inc.","SLS","NeuVax","Oncology","Breast Cancer","Granulocyte Macrophage Colony-Stimulating Factor Receptor (GM-CSFR)/CD116,HER2/neu or ErbB-2,Immune System",
"Suspended",,,,"04/19/2016",,"Peptide","Intradermal","SELLAS Life Sciences Group, Inc.","SLS","GALE-301/302","Oncology","Breast Cancer","Folate Binding Protein,Immune System","09/30/2013"
"Suspended",,,,,"10/15/2010","Peptide","Intradermal","Lytix Biopharma AS",,"LTX-315/GV1001","Oncology","Cancer","Cell Membrane,Immune System,Telomerase","06/09/2010"
"Suspended",,,,"04/22/2008",,"Peptide","Intradermal","Immatics N.V.","IMTX","IMA910","Oncology","Colorectal Cancer (CRC)","Immune System,Tumor Cells",
"Suspended",,,,,,"Peptide","Intradermal","SELLAS Life Sciences Group, Inc.","SLS","NeuVax","Oncology","Gastric Cancer","Granulocyte Macrophage Colony-Stimulating Factor Receptor (GM-CSFR)/CD116,HER2/neu or ErbB-2,Immune System",
"I",,,,,"05/11/2016","Peptide","Intradermal","BrightPath Biotherapeutics Co., Ltd",,"GRN-1201","Oncology","Melanoma","HLA-A,Immune System","05/11/2016"
"Suspended",,,,,,"Peptide","Intradermal","Sumitomo Dainippon Pharma Co., Ltd.",4506,"WT4869","Oncology","Multiple Myeloma (MM)","Immune System,Wilms' Tumor Protein 1 (WT1)",
"I",,,,,"07/21/2015","Peptide","Intradermal","Sumitomo Dainippon Pharma Co., Ltd.",4506,"DSP-7888","Oncology","Myelodysplastic Syndrome (MDS)","Immune System,Wilms' Tumor Protein 1 (WT1)","07/21/2015"
"Suspended",,,,,,"Peptide","Intradermal","Sumitomo Dainippon Pharma Co., Ltd.",4506,"WT4869","Oncology","Myelodysplastic Syndrome (MDS)","Immune System,Wilms' Tumor Protein 1 (WT1)",
"II",,,"06/13/2018","01/30/2018",,"Peptide","Intradermal","BrightPath Biotherapeutics Co., Ltd",,"GRN-1201","Oncology","Non-Small Cell Lung Cancer (NSCLC)","HLA-A,Immune System",
"Suspended",,,,,"08/07/2008","Peptide","Intradermal","Generex Biotechnology Corporation","GNBT","AE37","Oncology","Ovarian Cancer","HER2/neu or ErbB-2,Immune System","08/07/2008"
"Suspended",,,,,,"Peptide","Intradermal","SELLAS Life Sciences Group, Inc.","SLS","GALE-301/302","Oncology","Ovarian Cancer","Folate Binding Protein,Immune System","09/30/2013"
"Suspended",,,,,,"Peptide","Intradermal","SELLAS Life Sciences Group, Inc.","SLS","NeuVax","Oncology","Ovarian Cancer","Granulocyte Macrophage Colony-Stimulating Factor Receptor (GM-CSFR)/CD116,HER2/neu or ErbB-2,Immune System",
"I",,,,,,"Peptide","Intradermal","Generex Biotechnology Corporation","GNBT","AE37","Oncology","Prostate Cancer","HER2/neu or ErbB-2,Immune System","08/08/2006"
"Suspended",,,,,,"Peptide","Intradermal","SELLAS Life Sciences Group, Inc.","SLS","NeuVax","Oncology","Prostate Cancer","Granulocyte Macrophage Colony-Stimulating Factor Receptor (GM-CSFR)/CD116,HER2/neu or ErbB-2,Immune System","08/21/2012"
"Suspended","12/22/2010","12/22/2010",,"09/25/2007",,"Peptide","Intradermal","Immatics N.V.","IMTX","IMA901","Oncology","Renal Cell Cancer (RCC)","Immune System","11/29/2005"
"I/II",,,,"02/26/2015","02/26/2015","Peptide","Intradermal","ISA Pharmaceuticals B.V.",,"ISA201","Oncology","Solid Tumors","Human Papillomavirus (HPV),Immune System,Toll-Like Receptor (TLR) Family,Toll-Like Receptor 2 (TLR2)",
"I/II",,,"07/30/2019","07/30/2019","12/24/2017","Peptide","Intradermal","Sumitomo Dainippon Pharma Co., Ltd.",4506,"DSP-7888","Oncology","Solid Tumors","Immune System,Wilms' Tumor Protein 1 (WT1)","12/24/2017"
"Suspended",,,,,,"Peptide","Intradermal","Sumitomo Dainippon Pharma Co., Ltd.",4506,"WT4869","Oncology","Solid Tumors","Immune System,Wilms' Tumor Protein 1 (WT1)",
"Development Outside U.S.",,,,,,"Peptide","Intradermal","PassPort Technologies, Inc.",,"Alzheimer's Peptide Program (PassPort/Hokkaido)","Neurology","Alzheimer's Disease (AD)","Unknown",
"Development Outside U.S.",,,,,"11/17/2016","Peptide","Intradermal","Targovax ASA","TRVX","TG02 (Targovax)","Oncology","Colorectal Cancer (CRC)","Immune System,Ras","11/17/2016"
"Development Outside U.S.",,,,,,"Peptide","Intradermal","CYTLIMIC, Inc.",,"CYT001","Oncology","Hepatocellular (Liver) Cancer (HCC) (Including Secondary Metastases)","Immune System",
"Development Outside U.S.",,,,,,"Peptide","Intradermal","Targovax ASA","TRVX","TG02 (Targovax)","Oncology","Non-Small Cell Lung Cancer (NSCLC)","Immune System,Ras",
"Development Outside U.S.",,,,"01/30/2013","01/30/2013","Peptide","Intradermal","Targovax ASA","TRVX","TG01","Oncology","Pancreatic Cancer","Immune System,Ras",
"IIb",,,,"12/31/2003",,"Peptide","Intradermal, Intranasal","Bionor Holding AS",,"Vacc-4x","Infectious Disease","HIV / AIDS","HIV p24 protein,Immune System",
"Preclinical",,,,,,"Peptide","Intramuscular (IM)","ImCyse S.A.",,"NMO Imotope Program (Imcyse)","Autoimmune/immunology","Neuromyelitis Optica (Devic's Syndrome, NMO)","HLA-DR,Immune System,T lymphocytes,T-Cell Receptor (TCR)",
"Preclinical",,,,,,"Peptide","Intramuscular (IM)","ImCyse S.A.",,"RA Imotope Program (ImCyse/Pfizer)","Autoimmune/immunology","Rheumatoid Arthritis (RA)","HLA-DR,Immune System,T lymphocytes,T-Cell Receptor (TCR)",
"Suspended",,,"03/31/2005","03/31/2005",,"Peptide","Intramuscular (IM)","Urigen Pharmaceuticals, Inc.",,"VLTS 934","Cardiovascular","Peripheral Arterial Disease (PAD)","Cell Membrane",
"Suspended",,"10/26/2006",,,,"Peptide","Intramuscular (IM)","Ambrilia Biopharma, Inc.","AMB","C2L","Endocrine","Acromegaly","Somatostatin Receptors",
"Suspended",,,,"02/02/2009",,"Peptide","Intramuscular (IM)","Cancer Advances, Inc.",,"Polyclonal Antibody Stimulator","Gastroenterology (Non Inflammatory Bowel Disease)","Gastroesophageal Reflux Disease (GERD)","gastrin1-17 (G17),Immune System",
"II",,,"12/08/2015","12/08/2015","08/24/2009","Peptide","Intramuscular (IM)","United Biomedical, Inc. ",,"UB-311","Neurology","Alzheimer's Disease (AD)","Amyloid Beta/Amyloid Plaques","08/24/2009"
"III","09/04/2019","09/04/2019","12/17/2014","12/17/2014",,"Peptide","Intramuscular (IM)","Viatris Inc.","VTRS","Glatiramer Acetate (GA) Depot","Neurology","Multiple Sclerosis (MS)","Myelin,T lymphocytes",
"Suspended",,"06/19/2002",,,,"Peptide","Intramuscular (IM)","GlaxoSmithKline plc","GSK","Plenaxis","Obstetrics/Gynecology","Endometriosis","Gonadotropin-Releasing Hormone (GnRH) Receptor",
"I",,,,,"11/28/2016","Peptide","Intramuscular (IM)","OncoPep, Inc.",,"PVX-410","Oncology","Breast Cancer","CS1/SLAMF7,Immune System","11/28/2016"
"Suspended",,,,"02/02/2009",,"Peptide","Intramuscular (IM)","Cancer Advances, Inc.",,"Polyclonal Antibody Stimulator","Oncology","Colorectal Cancer (CRC)","gastrin1-17 (G17),Immune System",
"Suspended",,"02/02/2009",,"07/08/2003",,"Peptide","Intramuscular (IM)","Cancer Advances, Inc.",,"Polyclonal Antibody Stimulator","Oncology","Gastric Cancer","gastrin1-17 (G17),Immune System",
"I/II",,,,"01/29/2013",,"Peptide","Intramuscular (IM)","OncoPep, Inc.",,"PVX-410","Oncology","Multiple Myeloma (MM)","CS1/SLAMF7,Immune System",
"III",,"08/14/2000",,,,"Peptide","Intramuscular (IM)","Cancer Advances, Inc.",,"Polyclonal Antibody Stimulator","Oncology","Pancreatic Cancer","gastrin1-17 (G17),Immune System",
"III",,"05/29/2008",,,,"Peptide","Intramuscular (IM)","GP Pharm, S.A.",,"Lutrate","Oncology","Prostate Cancer",,
"Withdrawn from Market",,"12/03/2001",,,,"Peptide","Intramuscular (IM)","GlaxoSmithKline plc","GSK","Plenaxis","Oncology","Prostate Cancer","Gonadotropin-Releasing Hormone (GnRH) Receptor",
"Development Outside U.S.",,,,,,"Peptide","Intramuscular (IM)","Alliance Pharma plc","APH","Syntometrine","Obstetrics/Gynecology","Labor Induction","Alpha Adrenergic Receptors,Dopamine Receptor - Unspecified,Oxytocin Receptor,Serotonin 5-HT2 receptor",
"Development Outside U.S.",,,,,,"Peptide","Intramuscular (IM)","ImCyse S.A.",,"Autologous CD4+T Cells","Neurology","Multiple Sclerosis (MS)","HLA-DR,Immune System,T lymphocytes,T-Cell Receptor (TCR)",
"Approved",,,,,,"Peptide","Intramuscular (IM)","Novartis AG","NVS","Sandostatin LAR","Endocrine","Acromegaly","Somatostatin Receptors",
"Approved","05/30/2012","05/30/2012",,,,"Peptide","Intramuscular (IM)","Arbor Pharmaceuticals, LLC",,"Triptodur","Endocrine","Endocrine Disorder","Gonadotropin-Releasing Hormone (GnRH)",
"Approved",,,,,,"Peptide","Intramuscular (IM)","Fresenius SE & Co. KGaA","FSNUY","Glucagon Emergency Kit (Fresenius)","Endocrine","Hyperinsulinemia/Hypoglycemia","Glucagon Receptor",
"Approved",,,,,,"Peptide","Intramuscular (IM)","Novartis AG","NVS","Sandostatin LAR","Oncology","Neuroendocrine Tumors (NET)","Somatostatin Receptors",
"Approved",,,,,,"Peptide","Intramuscular (IM)","Recordati SpA","REC:IM","Cosmegen","Oncology","Solid Tumors","RNA synthesis",
"Approved","09/30/2013","09/30/2013","03/31/2012","03/31/2012",,"Peptide","Intramuscular (IM), Intranasal","Eli Lilly and Company","LLY","Baqsimi","Endocrine","Hyperinsulinemia/Hypoglycemia","Glucagon Receptor",
"Suspended",,,,"05/23/2012",,"Peptide","Intramuscular (IM), Subcutaneous (SQ), Oral (PO)","Mallinckrodt plc","MNK","H.P. Acthar Gel","Endocrine","Diabetic Nephropathy","Corticotropin Releasing Factor (CRF) / Corticotropin Releasing Hormone (CRH)",
"Suspended",,,"07/24/2013","07/24/2013",,"Peptide","Intramuscular (IM), Subcutaneous (SQ), Oral (PO)","Mallinckrodt plc","MNK","H.P. Acthar Gel","Neurology","Amyotrophic Lateral Sclerosis (ALS)","Corticotropin Releasing Factor (CRF) / Corticotropin Releasing Hormone (CRH)",
"III",,"05/17/2016",,,,"Peptide","Intramuscular (IM), Subcutaneous (SQ), Oral (PO)","Mallinckrodt plc","MNK","H.P. Acthar Gel","Renal","Focal Segmental Glomerulosclerosis (FSGS)","Corticotropin Releasing Factor (CRF) / Corticotropin Releasing Hormone (CRH)",
"Investigator Initiated",,,,,,"Peptide","Intramuscular (IM), Subcutaneous (SQ), Oral (PO)","Mallinckrodt plc","MNK","H.P. Acthar Gel","Renal","Immunoglobulin A (IgA) Nephropathy (Berger's Disease)","Corticotropin Releasing Factor (CRF) / Corticotropin Releasing Hormone (CRH)",
"Suspended",,,"10/22/2013","10/22/2013",,"Peptide","Intramuscular (IM), Subcutaneous (SQ), Oral (PO)","Mallinckrodt plc","MNK","H.P. Acthar Gel","Respiratory","Acute Respiratory Failure, Acute Lung Injury (ALI), Acute Respiratory Distress Syndrome (ARDS)","Corticotropin Releasing Factor (CRF) / Corticotropin Releasing Hormone (CRH)",
"Approved",,,,,,"Peptide","Intramuscular (IM), Subcutaneous (SQ), Oral (PO)","Mallinckrodt plc","MNK","H.P. Acthar Gel","Autoimmune/immunology","Dermatomyositis","Corticotropin Releasing Factor (CRF) / Corticotropin Releasing Hormone (CRH)",
"Approved",,"07/31/2001",,,,"Peptide","Intramuscular (IM), Subcutaneous (SQ), Oral (PO)","Mallinckrodt plc","MNK","H.P. Acthar Gel","Neurology","Infantile Spasms (West Syndrome; Epilepsy)","Corticotropin Releasing Factor (CRF) / Corticotropin Releasing Hormone (CRH)",
"Approved",,,,,,"Peptide","Intramuscular (IM), Subcutaneous (SQ), Oral (PO)","Mallinckrodt plc","MNK","H.P. Acthar Gel","Neurology","Multiple Sclerosis (MS)","Corticotropin Releasing Factor (CRF) / Corticotropin Releasing Hormone (CRH)",
"Approved",,,,,,"Peptide","Intramuscular (IM), Subcutaneous (SQ), Oral (PO)","Mallinckrodt plc","MNK","H.P. Acthar Gel","Ophthalmology","Ocular Pain and/or Inflammation (Ophthalmology)","Corticotropin Releasing Factor (CRF) / Corticotropin Releasing Hormone (CRH)",
"Approved",,,,,,"Peptide","Intramuscular (IM), Subcutaneous (SQ), Oral (PO)","Mallinckrodt plc","MNK","H.P. Acthar Gel","Autoimmune/immunology","Psoriatic Arthritis (PA)","Corticotropin Releasing Factor (CRF) / Corticotropin Releasing Hormone (CRH)",
"Approved",,,,,,"Peptide","Intramuscular (IM), Subcutaneous (SQ), Oral (PO)","Mallinckrodt plc","MNK","H.P. Acthar Gel","Renal","Renal Disease / Renal Failure","Corticotropin Releasing Factor (CRF) / Corticotropin Releasing Hormone (CRH)",
"Approved",,,,,,"Peptide","Intramuscular (IM), Subcutaneous (SQ), Oral (PO)","Mallinckrodt plc","MNK","H.P. Acthar Gel","Autoimmune/immunology","Rheumatoid Arthritis (RA)","Corticotropin Releasing Factor (CRF) / Corticotropin Releasing Hormone (CRH)",
"Approved",,,,,,"Peptide","Intramuscular (IM), Subcutaneous (SQ), Oral (PO)","Mallinckrodt plc","MNK","H.P. Acthar Gel","Autoimmune/immunology","Sarcoidosis","Corticotropin Releasing Factor (CRF) / Corticotropin Releasing Hormone (CRH)",
"Approved",,,,,,"Peptide","Intramuscular (IM), Subcutaneous (SQ), Oral (PO)","Mallinckrodt plc","MNK","H.P. Acthar Gel","Autoimmune/immunology","Systemic Lupus Erythematosus (SLE)","Corticotropin Releasing Factor (CRF) / Corticotropin Releasing Hormone (CRH)",
"Approved",,,,,,"Peptide","Intramuscular (IM), Subcutaneous (SQ), Oral (PO)","Mallinckrodt plc","MNK","H.P. Acthar Gel","Ophthalmology","Uveitis (Ophthalmology)","Corticotropin Releasing Factor (CRF) / Corticotropin Releasing Hormone (CRH)",
"I",,,,,"01/24/2017","Peptide","Intranasal","Dauntless Pharmaceuticals, Inc.",,"DP1038","Endocrine","Acromegaly","Somatostatin Receptors","01/24/2017"
"Suspended",,,,,"09/19/2006","Peptide","Intranasal","AstraZeneca PLC","AZN","Intranasal exenatide","Endocrine","Diabetes Mellitus, Type II","GLP-1 Receptor","09/19/2006"
"Suspended",,,,,"04/15/2014","Peptide","Intranasal","Critical Pharmaceuticals",,"CP046","Endocrine","Osteoporosis / Osteopenia","Parathyroid Hormone Receptor (PTHR)","04/15/2014"
"Suspended",,,,"12/04/2006","07/05/2005","Peptide","Intranasal","Adhera Therapeutics, Inc.","ATRX","Teriparatide Nasal Spray","Endocrine","Osteoporosis / Osteopenia","Parathyroid Hormone Receptor (PTHR)","07/05/2005"
"Preclinical",,,,"10/31/2018","10/23/2015","Peptide","Intranasal","Monash Institute of Pharmaceutical Science (MIPS)",,"Oxytocin Dry Powder Inhaler","Hematology","Acute Hemorrhage","Oxytocin Receptor","10/23/2015"
"Preclinical",,,,,,"Peptide","Intranasal","Sotira, LLC",,"Keptide Covid","Infectious Disease","COVID-19 Treatment","Angiotensin Converting Enzyme- Related Carbopeptidase2 (ACE2),SARS-CoV-2",
"Preclinical",,,,,,"Peptide","Intranasal","NovaBiotics Ltd",,"Luminaderm","Infectious Disease","Staphylococcal Vaccines and Other Staphylococcus-Specific Agents (Antibacterial)","Unknown",
"Suspended",,,"08/14/2006","08/14/2006","09/23/2003","Peptide","Intranasal","Adhera Therapeutics, Inc.","ATRX","PYY3-36","Metabolic","Obesity","Neuropeptide Y (NPY)/Peptide YY (PYY) Receptors","01/20/2004"
"Suspended",,,,"10/05/2015",,"Peptide","Intranasal","Impel NeuroPharma, Inc.",,"INP-102","Neurology","Alzheimer's Disease (AD)","Insulin Receptor",
"Suspended",,,,,,"Peptide","Intranasal","ProteoTech, Inc.",,"PeptiClere","Neurology","Alzheimer's Disease (AD)","Amyloid Beta/Amyloid Plaques",
"Suspended",,,"12/06/2006","12/06/2006","01/25/2005","Peptide","Intranasal","Endo International plc","ENDP","Davunetide","Neurology","Alzheimer's Disease (AD)","Microtubules (Tubulin)","01/25/2005"
"Suspended",,,"08/12/2014","08/16/2013",,"Peptide","Intranasal","Vyera Pharmaceuticals, LLC",,"Syntocinon Nasal Spray","Neurology","Autism Spectrum Disorders (Autism)","Oxytocin Receptor",
"Preclinical",,,,,,"Peptide","Intranasal","Tonix Pharmaceuticals Holding Corp.","TNXP","TNX-1900","Neurology","Migraine and Other Headaches","Oxytocin Receptor",
"Preclinical",,,,,,"Peptide","Intranasal","Nanomerics, Ltd.",,"NM127","Neurology","Moderate to Severe Pain","Opioid receptors",
"Program Hold",,,,,,"Peptide","Intranasal","Trigemina, Inc.",,"TI-002","Neurology","Pain Indications",,
"Suspended",,,,,,"Peptide","Intranasal","Endo International plc","ENDP","Davunetide","Neurology","Parkinson's Disease (PD)","Microtubules (Tubulin)",
"Suspended",,"01/04/2011",,,,"Peptide","Intranasal","Endo International plc","ENDP","Davunetide","Neurology","Progressive Supranuclear Palsy","Microtubules (Tubulin)","01/12/2009"
"Withdrawn from Market",,,,,,"Peptide","Intranasal","Vyera Pharmaceuticals, LLC",,"Syntocinon Nasal Spray","Obstetrics/Gynecology","Milk Letdown","Oxytocin Receptor",
"I",,,,,"01/24/2017","Peptide","Intranasal","Dauntless Pharmaceuticals, Inc.",,"DP1038","Oncology","Neuroendocrine Tumors (NET)","Somatostatin Receptors","01/24/2017"
"I",,,,,"08/05/2018","Peptide","Intranasal","Impel NeuroPharma, Inc.",,"INP-105","Psychiatry","Bipolar Disorder","Dopamine 1 (D1) Receptor,Dopamine 2 (D2) Receptor","08/05/2018"
"Suspended",,,,,,"Peptide","Intranasal","Impel NeuroPharma, Inc.",,"INP-105","Psychiatry","Major Depressive Disorder (MDD)","Dopamine 1 (D1) Receptor,Dopamine 2 (D2) Receptor",
"I",,,,,"08/05/2018","Peptide","Intranasal","Impel NeuroPharma, Inc.",,"INP-105","Psychiatry","Schizophrenia","Dopamine 1 (D1) Receptor,Dopamine 2 (D2) Receptor","08/05/2018"
"Suspended",,,,"12/08/2009",,"Peptide","Intranasal","Vyera Pharmaceuticals, LLC",,"Syntocinon Nasal Spray","Psychiatry","Schizophrenia","Oxytocin Receptor",
"Suspended",,,"03/27/2007","03/27/2007",,"Peptide","Intranasal","Endo International plc","ENDP","Davunetide","Psychiatry","Schizophrenia","Microtubules (Tubulin)",
"Development Outside U.S.",,,,,,"Peptide","Intranasal","OptiNose, Inc.","OPTN","OPN300","Neurology","Autism Spectrum Disorders (Autism)","Oxytocin Receptor",
"Development Outside U.S.",,,,,,"Peptide","Intranasal","Ovoca Bio plc","OVB","BP-101","Obstetrics/Gynecology","Female Sexual Arousal Disorder","Unknown",
"Approved (Generic Competition)",,,,,,"Peptide","Intranasal","Novartis AG","NVS","Miacalcin","Endocrine","Osteoporosis / Osteopenia","Calcitonin Receptor",
"Approved",,"07/10/2009",,"11/17/2008",,"Peptide","Intranasal","Avadel Pharmaceuticals plc","AVDL","Noctiva","Urology","Urinary Symptoms (e.g. Nocturia, Polyuria)","Vasopressin receptors","11/06/2008"
"II",,,"09/01/2020","09/01/2020","05/25/2018","Peptide","Intraocular/Subretinal/Subconjunctival","Oxurion NV","OXUR","THR-149","Ophthalmology","Diabetic Macular Edema (Ophthalmology)","Kinin-Kallikrein System ","05/25/2018"
"IIb",,,,"12/20/2011",,"Peptide","Intraocular/Subretinal/Subconjunctival","Allegro Ophthalmics, LLC.",,"Luminate","Ophthalmology","Diabetic Macular Edema (Ophthalmology)","Angiogenesis,Integrins","10/21/2011"
"Preclinical",,,,,,"Peptide","Intraocular/Subretinal/Subconjunctival","OcuNexus Therapeutics, Inc.",,"Peptagon","Ophthalmology","Diabetic Macular Edema (Ophthalmology)","Connexin / Connexon / Hemichannel",
"Preclinical",,,,,,"Peptide","Intraocular/Subretinal/Subconjunctival","OcuNexus Therapeutics, Inc.",,"Peptagon","Ophthalmology","Diabetic Retinopathy (Ophthalmology)","Connexin / Connexon / Hemichannel",
"Suspended",,,"05/04/2015","05/04/2015",,"Peptide","Intraocular/Subretinal/Subconjunctival","Allegro Ophthalmics, LLC.",,"Luminate","Ophthalmology","Diabetic Retinopathy (Ophthalmology)","Angiogenesis,Integrins",
"II",,,"08/09/2018","08/09/2018",,"Peptide","Intraocular/Subretinal/Subconjunctival","Allegro Ophthalmics, LLC.",,"Luminate","Ophthalmology","Dry Age-Related Macular Degeneration (Dry AMD)/Geographic Atrophy (Ophthalmology)","Angiogenesis,Integrins",
"Preclinical",,,,,,"Peptide","Intraocular/Subretinal/Subconjunctival","OcuNexus Therapeutics, Inc.",,"Peptagon","Ophthalmology","Dry Age-Related Macular Degeneration (Dry AMD)/Geographic Atrophy (Ophthalmology)","Connexin / Connexon / Hemichannel",
"Suspended",,,"07/09/2012","07/09/2012",,"Peptide","Intraocular/Subretinal/Subconjunctival","Novartis AG","NVS","APL-1","Ophthalmology","Dry Age-Related Macular Degeneration (Dry AMD)/Geographic Atrophy (Ophthalmology)","Complement Pathway",
"II",,,,"02/07/2017",,"Peptide","Intraocular/Subretinal/Subconjunctival","BRIM Biotechnology, Inc.",,"BRM421","Ophthalmology","Dry Eye (Ophthalmology)","PEDF (pigment epithelium-derived factor)",
"II",,,"02/19/2020","02/19/2020",,"Peptide","Intraocular/Subretinal/Subconjunctival","Palatin Technologies, Inc.","PTN","PL-9643","Ophthalmology","Dry Eye (Ophthalmology)","Melanocortin (MC) receptors",
"II",,,,"02/17/2020",,"Peptide","Intraocular/Subretinal/Subconjunctival","Recordati SpA","REC:IM","REC 0559","Ophthalmology","Ophthalmic Wound Healing (Ophthalmology)","Nerve growth factor (NGF)/receptor",
"I",,,,,"10/23/2019","Peptide","Intraocular/Subretinal/Subconjunctival","ONL Therapeutics ",,"ONL1204","Ophthalmology","Rhegmatogenous Retinal Detachment (RRD) (Ophthalmology)","Fas receptor (FasR)/CD95/Apo-1/TNFRSf6)","10/23/2019"
"II",,,,"06/02/2014",,"Peptide","Intraocular/Subretinal/Subconjunctival","Allegro Ophthalmics, LLC.",,"Luminate","Ophthalmology","Vitreomacular Adhesion (Ophthalmology)","Angiogenesis,Integrins",
"II",,,"12/31/2019","09/20/2018",,"Peptide","Intraocular/Subretinal/Subconjunctival","RIBOMIC, Inc.",4591,"RBM-007","Ophthalmology","Wet Age-Related Macular Degeneration (Wet AMD) (Ophthalmology)","Fibroblast Growth Factor Receptor-2",
"Preclinical",,,,,,"Peptide","Intraocular/Subretinal/Subconjunctival","OcuNexus Therapeutics, Inc.",,"Peptagon","Ophthalmology","Wet Age-Related Macular Degeneration (Wet AMD) (Ophthalmology)","Connexin / Connexon / Hemichannel",
"Suspended",,,"07/06/2011","07/06/2011","03/20/2007","Peptide","Intraocular/Subretinal/Subconjunctival","Novartis AG","NVS","APL-1","Ophthalmology","Wet Age-Related Macular Degeneration (Wet AMD) (Ophthalmology)","Complement Pathway","03/20/2007"
"Development Outside U.S.",,,,,,"Peptide","Intraocular/Subretinal/Subconjunctival","RIBOMIC, Inc.",4591,"RBM-007","Endocrine","Achondroplasia","Fibroblast Growth Factor Receptor-2",
"Development Outside U.S.",,,"03/31/2012",,,"Peptide","Intraocular/Subretinal/Subconjunctival","Allegro Ophthalmics, LLC.",,"Luminate","Ophthalmology","Wet Age-Related Macular Degeneration (Wet AMD) (Ophthalmology)","Angiogenesis,Integrins",
"Approved",,"09/30/2014",,,,"Peptide","Intraocular/Subretinal/Subconjunctival","Sun Pharmaceutical Industries Ltd.",524715,"Cequa","Ophthalmology","Dry Eye (Ophthalmology)","Calcineurin phosphatase ",
"NDA","06/26/2018","05/09/2018",,,"11/25/2014","Peptide","Intraocular/Subretinal/Subconjunctival, Intravenous (IV), Subcutaneous (SQ)","Apellis Pharmaceuticals, Inc.","APLS","Pegcetacoplan","Autoimmune/immunology","Paroxysmal Nocturnal Hemoglobinuria (PNH)","Complement Pathway","04/20/2014"
"II",,,"08/31/2017","08/31/2017",,"Peptide","Intraocular/Subretinal/Subconjunctival, Intravenous (IV), Subcutaneous (SQ)","Apellis Pharmaceuticals, Inc.","APLS","Pegcetacoplan","Hematology","Autoimmune Hemolytic Anemia (AIHA)","Complement Pathway",
"Preclinical",,,,"10/27/2020",,"Peptide","Intraocular/Subretinal/Subconjunctival, Intravenous (IV), Subcutaneous (SQ)","Apellis Pharmaceuticals, Inc.","APLS","Pegcetacoplan","Hematology","Transplant-Associated Thrombotic Microangiopathy (TA-TMA)","Complement Pathway",
"II",,,"11/19/2020","11/19/2020",,"Peptide","Intraocular/Subretinal/Subconjunctival, Intravenous (IV), Subcutaneous (SQ)","Apellis Pharmaceuticals, Inc.","APLS","Pegcetacoplan","Neurology","Amyotrophic Lateral Sclerosis (ALS)","Complement Pathway",
"III","09/12/2018","09/12/2018","10/14/2015","10/14/2015",,"Peptide","Intraocular/Subretinal/Subconjunctival, Intravenous (IV), Subcutaneous (SQ)","Apellis Pharmaceuticals, Inc.","APLS","Pegcetacoplan","Ophthalmology","Dry Age-Related Macular Degeneration (Dry AMD)/Geographic Atrophy (Ophthalmology)","Complement Pathway",
"I/II",,,"03/13/2018","03/13/2018","02/10/2015","Peptide","Intraocular/Subretinal/Subconjunctival, Intravenous (IV), Subcutaneous (SQ)","Apellis Pharmaceuticals, Inc.","APLS","Pegcetacoplan","Ophthalmology","Wet Age-Related Macular Degeneration (Wet AMD) (Ophthalmology)","Complement Pathway","02/10/2015"
"II",,,"02/27/2018","02/27/2018",,"Peptide","Intraocular/Subretinal/Subconjunctival, Intravenous (IV), Subcutaneous (SQ)","Apellis Pharmaceuticals, Inc.","APLS","Pegcetacoplan","Renal","C3 Glomerulopathy (C3G), including Dense Deposit Disease (DDD) and C3 Glomerulonephritis (C3GN)","Complement Pathway",
"Investigator Initiated",,,,,,"Peptide","Intrathecal","TerSera Therapeutics LLC",,"Prialt","Neurology","Neuropathic Pain","Calcium Channel",
"Preclinical",,,,,,"Peptide","Intrathecal","Axoltis Pharma",,"NX210","Neurology","Spinal Cord Injury (SCI)",,
"Approved",,"01/13/1998",,,,"Peptide","Intrathecal","TerSera Therapeutics LLC",,"Prialt","Neurology","Chronic Pain","Calcium Channel",
"IND",,,,,,"Peptide","Intratracheal","Windtree Therapeutics, Inc.","WINT","Surfaxin","Infectious Disease","COVID-19 Treatment","Alveolar Surface",
"Program Hold",,,,"12/07/2004",,"Peptide","Intratracheal","Windtree Therapeutics, Inc.","WINT","Surfaxin","Respiratory","Acute Respiratory Failure, Acute Lung Injury (ALI), Acute Respiratory Distress Syndrome (ARDS)","Alveolar Surface",
"Suspended",,,,"01/06/2005",,"Peptide","Intratracheal","Windtree Therapeutics, Inc.","WINT","Surfaxin","Respiratory","Bronchopulmonary Dysplasia (BPD)","Alveolar Surface",
"Suspended",,,,"01/30/2013",,"Peptide","Intratracheal","Chiesi Farmaceutici S.p.A.",,"CHF 5633","Respiratory","Respiratory Distress Syndrome (RDS)","Alveolar Surface",
"Approved",,,,,,"Peptide","Intratracheal","Windtree Therapeutics, Inc.","WINT","Surfaxin","Respiratory","Respiratory Distress Syndrome (RDS)","Alveolar Surface",
"Suspended",,,,,,"Peptide","Intratumoral","Lytix Biopharma AS",,"Oncopore","Oncology","Breast Cancer","Cell Membrane",
"II",,,"03/01/2012","03/01/2012",,"Peptide","Intratumoral","Nymox Pharmaceutical Corporation","NYMX","NX-1207","Oncology","Prostate Cancer","Apoptosis (Cell Death),Mitochondria",
"Preclinical",,,,,,"Peptide","Intratumoral","Lytix Biopharma AS",,"Oncopore","Oncology","Skin Cancer - Basal Cell Carcinoma (BCC)","Cell Membrane",
"I/II",,,,"02/05/2020",,"Peptide","Intratumoral","Olatec Therapeutics LLC",,"CyPep-1 (Intratumoral)","Oncology","Solid Tumors","Tumor Cells",
"III","06/09/2008","06/09/2008",,"01/26/2004",,"Peptide","Intratumoral","Nymox Pharmaceutical Corporation","NYMX","NX-1207","Urology","Benign Prostatic Hyperplasia (BPH)","Apoptosis (Cell Death),Mitochondria",
"Development Outside U.S.",,,,,,"Peptide","Intratumoral","Lytix Biopharma AS",,"Oncopore","Oncology","Sarcoma","Cell Membrane",
"Development Outside U.S.",,,,,"02/01/2010","Peptide","Intratumoral","Lytix Biopharma AS",,"Oncopore","Oncology","Solid Tumors","Cell Membrane",
"III","11/13/2015","11/13/2015","06/16/2005","06/16/2005",,"Peptide","Intratympanic, Intraocular/Subretinal/Subconjunctival","Zilentin AG",,"Sonsuvi","ENT/Dental","Hearing Loss - General","c-Jun N-terminal kinase (JNK)",
"Suspended",,"09/10/2014",,,,"Peptide","Intratympanic, Intraocular/Subretinal/Subconjunctival","Zilentin AG",,"Sonsuvi","Ophthalmology","Ocular Pain and/or Inflammation (Ophthalmology)","c-Jun N-terminal kinase (JNK)",
"Suspended",,,,,,"Peptide","Intravenous (IV)","Araim Pharmaceuticals, Inc.",,"Cibinetide","Autoimmune/immunology","Inflammatory Bowel Disease (IBD)","CSF2RB (common  subunit, CD131),Erythropoietin Receptor (EPOR)",
"Suspended",,,,,,"Peptide","Intravenous (IV)","Soligenix, Inc.","SNGX","SGX942","Autoimmune/immunology","Inflammatory Disorders","Immune System",
"III","07/27/2017","07/27/2017","12/05/2013","12/05/2013",,"Peptide","Intravenous (IV)","Soligenix, Inc.","SNGX","SGX942","Autoimmune/immunology","Mucositis","Immune System","12/18/2012"
"Suspended",,,,"12/02/2010",,"Peptide","Intravenous (IV)","Araim Pharmaceuticals, Inc.",,"Cibinetide","Autoimmune/immunology","Rheumatoid Arthritis (RA)","CSF2RB (common  subunit, CD131),Erythropoietin Receptor (EPOR)",
"II",,,"10/01/2011","09/13/2011",,"Peptide","Intravenous (IV)","Araim Pharmaceuticals, Inc.",,"Cibinetide","Autoimmune/immunology","Sarcoidosis","CSF2RB (common  subunit, CD131),Erythropoietin Receptor (EPOR)",
"Suspended",,,,,,"Peptide","Intravenous (IV)","Araim Pharmaceuticals, Inc.",,"Cibinetide","Autoimmune/immunology","Systemic Lupus Erythematosus (SLE)","CSF2RB (common  subunit, CD131),Erythropoietin Receptor (EPOR)",
"Suspended",,,,,,"Peptide","Intravenous (IV)","Astellas Pharma, Inc.","4503:JP","ASP2409","Autoimmune/immunology","Transplant Rejection",,"02/01/2012"
"Suspended",,,,,,"Peptide","Intravenous (IV)","Esperion Therapeutics, Inc.","ESPR","4WF","Cardiovascular","Acute Coronary Syndrome (ACS)","Reverse Cholesterol Transport (RCT)",
"Suspended",,,,"02/10/2011",,"Peptide","Intravenous (IV)","RegeneRx Biopharmaceuticals, Inc.","RGRX","RGN-352","Cardiovascular","Acute Coronary Syndrome (ACS)","Actin Filaments,ATP Synthase,Integrin-linked kinase (ILK)","07/31/2007"
"Suspended",,,"07/01/2010","07/01/2010",,"Peptide","Intravenous (IV)","Renova Therapeutics",,"RT-400","Cardiovascular","Acute Decompensated Heart Failure","Corticotropin Releasing Factor -Receptor2 (CRF-R2)",
"Suspended","08/10/2012","08/10/2012","03/16/2006","03/16/2006",,"Peptide","Intravenous (IV)","Cardiorentis AG",,"Ularitide","Cardiovascular","Acute Decompensated Heart Failure","Natriuretic Peptide Receptors",
"Suspended",,,"10/28/2009","04/28/2005","02/10/2005","Peptide","Intravenous (IV)","Neurocrine Biosciences, Inc.","NBIX","Urocortin 2","Cardiovascular","Acute Decompensated Heart Failure","Corticotropin Releasing Factor -Receptor2 (CRF-R2)","02/10/2005"
"Suspended","10/01/2009","10/01/2009","11/01/2005","11/01/2005",,"Peptide","Intravenous (IV)","Novartis AG","NVS","Reasanz","Cardiovascular","Acute Decompensated Heart Failure","Relaxin Family Peptide Receptors 1-4 (RXFP1-4)",
"Suspended",,,,,,"Peptide","Intravenous (IV)","Artery Therapeutics, Inc.",,"ATI-5261","Cardiovascular","Atherosclerosis","Apolipoprotein A-I",
"Suspended",,"12/28/2004",,,,"Peptide","Intravenous (IV)","The Medicines Company","MDCO","Angiomax","Cardiovascular","Cardiac Valve Surgery","Thrombin (Coagulation Factor IIa)",
"Preclinical",,,,,,"Peptide","Intravenous (IV)","Araim Pharmaceuticals, Inc.",,"Cibinetide","Cardiovascular","Cardiovascular Disease","CSF2RB (common  subunit, CD131),Erythropoietin Receptor (EPOR)",
"Suspended",,,,,"06/01/2003","Peptide","Intravenous (IV)","Pfizer Inc.","PFE","ETC-642","Cardiovascular","Cardiovascular Disease","Reverse Cholesterol Transport (RCT)","06/30/2003"
"Suspended",,,"11/20/2011","11/20/2011",,"Peptide","Intravenous (IV)","Johnson & Johnson","JNJ","JNJ-54452840","Cardiovascular","Congestive Heart Failure (CHF) and Cardiomyopathies","Beta Adrenergic Receptors","11/25/2009"
"Suspended",,,"05/15/2014","11/12/2013",,"Peptide","Intravenous (IV)","Novartis AG","NVS","Reasanz","Cardiovascular","Congestive Heart Failure (CHF) and Cardiomyopathies","Relaxin Family Peptide Receptors 1-4 (RXFP1-4)",
"Suspended",,"02/11/2003",,,,"Peptide","Intravenous (IV)","The Medicines Company","MDCO","Angiomax","Cardiovascular","Coronary Artery Bypass Graft (CABG)","Thrombin (Coagulation Factor IIa)",
"Suspended",,,,,,"Peptide","Intravenous (IV)","Artery Therapeutics, Inc.",,"CS-6253","Cardiovascular","Dyslipidemia / Hypercholesterolemia"," ATP-Binding Cassette Transporter G1 (ABCG1)",
"Suspended",,,,"12/16/2014",,"Peptide","Intravenous (IV)","Capstone Therapeutics Corp.","CAPS","AEM-28","Cardiovascular","Dyslipidemia / Hypercholesterolemia","Lipoproteins","04/08/2014"
"Suspended",,,"06/30/2005","07/27/2005","03/04/2005","Peptide","Intravenous (IV)","Pfizer Inc.","PFE","Rotigaptide","Cardiovascular","Dysrhythmia (Arrhythmia)","Gap Junction","03/04/2005"
"Suspended",,,"03/04/2010","03/04/2010",,"Peptide","Intravenous (IV)","Araim Pharmaceuticals, Inc.",,"Cibinetide","Cardiovascular","Peripheral Arterial Disease (PAD)","CSF2RB (common  subunit, CD131),Erythropoietin Receptor (EPOR)",
"Suspended",,"08/07/2003",,,,"Peptide","Intravenous (IV)","The Medicines Company","MDCO","Angiomax","Cardiovascular","Peripheral Arterial Disease (PAD)","Thrombin (Coagulation Factor IIa)",
"I",,,,,"09/12/2017","Peptide","Intravenous (IV)","Bioniz Therapeutics, Inc.",,"BNZ-1","Dermatology","Alopecia Areata","IL-15 (Interleukin-15)/IL-15 Receptor,IL-2 (Interleukin-2),IL-9 (Interleukin-9)","09/12/2017"
"Suspended",,,,,,"Peptide","Intravenous (IV)","Araim Pharmaceuticals, Inc.",,"Cibinetide","Endocrine","Diabetes Mellitus, Type I","CSF2RB (common  subunit, CD131),Erythropoietin Receptor (EPOR)",
"Suspended",,,,,"12/02/2014","Peptide","Intravenous (IV)","Merck & Co., Inc.","MRK","MK-2640","Endocrine","Diabetes Mellitus, Type I","Insulin Receptor","08/18/2016"
"III","06/01/2004","11/10/2004",,,,"Peptide","Intravenous (IV)","Mallinckrodt plc","MNK","Terlipressin","Endocrine","Hepatorenal Syndrome (HRS)","Vasopressin receptors",
"Suspended",,,,,"07/02/2013","Peptide","Intravenous (IV)","La Jolla Pharmaceutical Company","LJPC","Giapreza","Endocrine","Hepatorenal Syndrome (HRS)","Angiotensin II Receptor Type 1 (AT1),Angiotensin II Receptor Type 2 (AT2)","07/02/2013"
"Withdrawn from Market",,,,,,"Peptide","Intravenous (IV)","Sanofi","SNY","Parathar","Endocrine","Hypoparathyroidism","Parathyroid Hormone Receptor (PTHR)",
"II",,,"07/12/2017","07/12/2017",,"Peptide","Intravenous (IV)","BioVie, Inc.","BIVI","BIV201","Gastroenterology (Non Inflammatory Bowel Disease)","Liver Failure / Cirrhosis","Vasopressin receptors",
"Suspended",,,"05/05/2008","05/05/2008",,"Peptide","Intravenous (IV)","Helsinn Healthcare SA",,"Ipamorelin","Gastroenterology (Non Inflammatory Bowel Disease)","Postoperative Ileus","Ghrelin Receptor","09/19/2006"
"Preclinical",,,,,,"Peptide","Intravenous (IV)","Soligenix, Inc.","SNGX","SGX942","Infectious Disease","Antibacterial - General","Immune System",
"Suspended",,,,,"02/17/2009","Peptide","Intravenous (IV)","Merck & Co., Inc.","MRK","CB-182,804","Infectious Disease","Antibacterial - General","Cell Membrane","02/17/2009"
"Suspended",,,,,,"Peptide","Intravenous (IV)","Takeda Pharmaceutical Co. Ltd.","TAK","Mifamurtide","Infectious Disease","Anti-Parasitic and Anti-Protozoal","Immune System",
"Preclinical",,,,,,"Peptide","Intravenous (IV)","OncoTherapy Science, Inc.","4564:JP","COVID-19 Peptide Vaccine (OncoTherapy)","Infectious Disease","COVID-19 Prevention","SARS-CoV-2",
"II",,,"09/22/2020","07/23/2020",,"Peptide","Intravenous (IV)","INOTREM S.A.",,"Nangibotide","Infectious Disease","COVID-19 Treatment","Immune System,Triggering Receptor Expressed on Myeloid Cells-1 (TREM-1)",
"II",,,"10/07/2020","10/07/2020",,"Peptide","Intravenous (IV)","Arch Biopartners Inc.","ACHFF","Metablok","Infectious Disease","COVID-19 Treatment","Dipeptidase 1 (DPEP-1)",
"Preclinical",,,,,,"Peptide","Intravenous (IV)","Soricimed Biopharma Inc.",,"SOR-C13","Infectious Disease","COVID-19 Treatment","TRPV6, transient receptor potential vanilloid receptor 6, VR-6",
"Preclinical",,,,,,"Peptide","Intravenous (IV)","Orgenesis, Inc.","ORGS","Onconase","Infectious Disease","COVID-19 Treatment","RNA",
"Suspended",,,,,,"Peptide","Intravenous (IV)","Orgenesis, Inc.","ORGS","Onconase","Infectious Disease","Cytomegalovirus (CMV) Infection (Antiviral)","RNA",
"Suspended",,,,,,"Peptide","Intravenous (IV)","Orgenesis, Inc.","ORGS","Onconase","Infectious Disease","Ebola","RNA",
"Suspended","10/24/2018","10/24/2018","08/19/2013","08/19/2013",,"Peptide","Intravenous (IV)","Polyphor AG","POLN","Murepavadin","Infectious Disease","Hospital Acquired (Nosocomial) Pneumonia (HAP) (Antibacterial)","Cell wall synthesis,Pseudomonas aeruginosa",
"II",,,,"02/25/2016",,"Peptide","Intravenous (IV)","Orgenesis, Inc.","ORGS","Onconase","Infectious Disease","Human Papillomavirus (HPV) Treatment (Antiviral)","RNA",
"Suspended","10/24/2018","10/24/2018","08/19/2013","08/19/2013",,"Peptide","Intravenous (IV)","Polyphor AG","POLN","Murepavadin","Infectious Disease","Pseudomonas-Specific Agents (Antibacterial)","Cell wall synthesis,Pseudomonas aeruginosa","03/04/2013"
"IIb",,,"11/14/2019","11/14/2019",,"Peptide","Intravenous (IV)","INOTREM S.A.",,"Nangibotide","Infectious Disease","Sepsis and Septic Shock","Immune System,Triggering Receptor Expressed on Myeloid Cells-1 (TREM-1)",
"Suspended","07/27/2015","07/27/2015",,"11/25/2009",,"Peptide","Intravenous (IV)","Ferring Pharmaceuticals",,"Selepressin","Infectious Disease","Sepsis and Septic Shock","Vasopressin receptors",
"NDA","10/05/2015","10/05/2015","12/13/2011","12/13/2011","09/14/2010","Peptide","Intravenous (IV)","Atox Bio",,"Reltecimod","Infectious Disease","Skin and Skin-Structure Infections (Antibacterial)","Cluster of Differentiation 28 (CD28) /ICOS and B7RP-1 Pathway,Immune System","09/14/2010"
"Suspended",,,,,,"Peptide","Intravenous (IV)","Soligenix, Inc.","SNGX","SGX942","Infectious Disease","Skin and Skin-Structure Infections (Antibacterial)","Immune System","12/18/2012"
"I",,,,,"10/01/2018","Peptide","Intravenous (IV)","Attralus, Inc.",,"AT-01","Metabolic","Amyloidosis",,"10/01/2018"
"Suspended",,,,,,"Peptide","Intravenous (IV)","9 Meters Biopharma, Inc. ","NMTR","INN-329","Metabolic","Spinal Muscular Atrophy","Secretin receptor","11/08/2012"
"Suspended",,,,,,"Peptide","Intravenous (IV)","ArmaGen, Inc.",,"AGT-3100","Neurology","Alzheimer's Disease - Imaging","Amyloid Beta/Amyloid Plaques,Radiopharmaceutical",
"Suspended",,,,,,"Peptide","Intravenous (IV)","Genervon Biopharmaceuticals, LLC",,"GM605","Neurology","Alzheimer's Disease (AD)","Insulin Receptor,Melanocortin (MC) receptors,Neuropeptide Y (NPY)/Peptide YY (PYY) Receptors,Nociceptin/Orphanin FQ Peptide (NOP) Receptor,Notch Receptors,Somatostatin Receptors","01/04/2013"
"II",,,"05/29/2013","05/29/2013",,"Peptide","Intravenous (IV)","Genervon Biopharmaceuticals, LLC",,"GM604","Neurology","Amyotrophic Lateral Sclerosis (ALS)",,
"Suspended","02/14/2002","02/14/2002",,,,"Peptide","Intravenous (IV)","9 Meters Biopharma, Inc. ","NMTR","INN-329","Neurology","Autism Spectrum Disorders (Autism)","Secretin receptor",
"Suspended",,,,"06/02/2006",,"Peptide","Intravenous (IV)","Endo International plc","ENDP","AL-208","Neurology","Cognitive Dysfunction","Microtubules (Tubulin)","08/22/2005"
"Preclinical",,,,,,"Peptide","Intravenous (IV)","RegeneRx Biopharmaceuticals, Inc.","RGRX","RGN-352","Neurology","Diabetic Peripheral Neuropathy (DPN)","Actin Filaments,ATP Synthase,Integrin-linked kinase (ILK)",
"Suspended",,,,,,"Peptide","Intravenous (IV)","9 Meters Biopharma, Inc. ","NMTR","INN-329","Neurology","Friedreich's Ataxia","Secretin receptor","11/08/2012"
"III","03/26/2015","03/26/2015","08/04/2008","08/04/2008",,"Peptide","Intravenous (IV)","NoNO Inc.",,"NA-1","Neurology","Ischemic Stroke","PSD-95 (postsynaptic density protein 95)/SAP-90 (synapse-associated protein 90)",
"Suspended",,,"04/14/2011","04/14/2011",,"Peptide","Intravenous (IV)","Genervon Biopharmaceuticals, LLC",,"GM602","Neurology","Ischemic Stroke","Unknown",
"Suspended",,,,"12/02/2010",,"Peptide","Intravenous (IV)","D-Pharm Ltd.","DPRM","THR-18","Neurology","Ischemic Stroke","Plasminogen Activator Inhibitor-1 (PAI-1, PLANH1)","02/04/2010"
"Suspended",,"10/09/2013",,,,"Peptide","Intravenous (IV)","The Medicines Company","MDCO","Angiomax","Neurology","Ischemic Stroke","Thrombin (Coagulation Factor IIa)",
"Suspended",,,,,,"Peptide","Intravenous (IV)","Artielle ImmunoTherapeutics, Inc.",,"RTL1000","Neurology","Multiple Sclerosis (MS)","T-Cell Receptor (TCR)","03/14/2007"
"Suspended","12/12/2003","12/08/2004",,"09/05/2001",,"Peptide","Intravenous (IV)","Medwell Capital Corp.","MWC:CN","Dirucotide","Neurology","Multiple Sclerosis (MS)","Immune System,Myelin Basic Protein (MBP)",
"Suspended",,,,,,"Peptide","Intravenous (IV)","RegeneRx Biopharmaceuticals, Inc.","RGRX","RGN-352","Neurology","Multiple Sclerosis (MS)","Actin Filaments,ATP Synthase,Integrin-linked kinase (ILK)",
"Preclinical",,,,,,"Peptide","Intravenous (IV)","Vect-Horus S.A.S.",,"VH-N439","Neurology","Neurology - Other","NT1 (Neurotensin receptor type 1)",
"Suspended",,,,"06/25/2010",,"Peptide","Intravenous (IV)","Araim Pharmaceuticals, Inc.",,"Cibinetide","Neurology","Neuropathic Pain","CSF2RB (common  subunit, CD131),Erythropoietin Receptor (EPOR)",
"Suspended",,,,,,"Peptide","Intravenous (IV)","Allergan plc","AGN","Rapastinel","Neurology","Neuropathic Pain","NMDA Receptor - Glycine Site","09/27/2011"
"Suspended",,,,"01/04/2013",,"Peptide","Intravenous (IV)","Genervon Biopharmaceuticals, LLC",,"GM608","Neurology","Parkinson's Disease (PD)","Unknown",
"Suspended",,,,,,"Peptide","Intravenous (IV)","RegeneRx Biopharmaceuticals, Inc.","RGRX","RGN-352","Neurology","Traumatic Brain Injury (TBI)","Actin Filaments,ATP Synthase,Integrin-linked kinase (ILK)",
"Suspended",,,,,,"Peptide","Intravenous (IV)","Soligenix, Inc.","SNGX","SGX942","Not Specified","Acute Radiation Syndrome (ARS)","Immune System",
"I/II",,,,"06/18/2020","06/18/2020","Peptide","Intravenous (IV)","Alume Biosciences, Inc.",,"ALM-488","Not Specified","Surgical and Procedure Complications","Unknown",
"Suspended",,,,"03/27/2012",,"Peptide","Intravenous (IV)","Novartis AG","NVS","Reasanz","Obstetrics/Gynecology","Eclampsia/Pre-Eclampsia","Relaxin Family Peptide Receptors 1-4 (RXFP1-4)","12/22/2009"
"Suspended",,,,"04/23/2008",,"Peptide","Intravenous (IV)","Novartis AG","NVS","Reasanz","Obstetrics/Gynecology","Labor Induction","Relaxin Family Peptide Receptors 1-4 (RXFP1-4)",
"I",,,"07/08/2018","07/08/2018",,"Peptide","Intravenous (IV)","Immune System Key Ltd.",,"Nerofe","Oncology","Acute Myelogenous Leukemia (AML)","Angiogenesis,Apoptosis (Cell Death),Immune System","07/29/2020"
"Investigator Initiated",,,,,,"Peptide","Intravenous (IV)","Tiziana Life Sciences plc","TLSA","Dactinomycin","Oncology","Acute Myelogenous Leukemia (AML)","RNA synthesis",
"Preclinical",,,,,,"Peptide","Intravenous (IV)","Rasna Therapeutics, Inc. ","RASP","RASP-101","Oncology","Acute Myelogenous Leukemia (AML)","RNA synthesis",
"Suspended",,,"09/15/2014","09/15/2014",,"Peptide","Intravenous (IV)","Genus Oncology, LLC",,"GO-203-2c","Oncology","Acute Myelogenous Leukemia (AML)","Mucin 1 (MUC-1)",
"Suspended",,,,,"09/20/2016","Peptide","Intravenous (IV)","Aileron Therapeutics, Inc","ALRN","ALRN-6924","Oncology","Acute Myelogenous Leukemia (AML)","Mdm2,Mdmx/Mdm4","09/20/2016"
"Preclinical",,,,,,"Peptide","Intravenous (IV)","Bioniz Therapeutics, Inc.",,"BNZ-1","Oncology","Adult T-cell Leukemia/Lymphoma (ATL)","IL-15 (Interleukin-15)/IL-15 Receptor,IL-2 (Interleukin-2),IL-9 (Interleukin-9)",
"Suspended",,,,"01/22/2013",,"Peptide","Intravenous (IV)","Spectrum Pharmaceuticals Inc.","SPPI","SPI-1620","Oncology","Biliary Tract Cancer","Endothelin Receptor Type B (EDNRB)","02/08/2008"
"Suspended",,,"11/03/2010","11/03/2010",,"Peptide","Intravenous (IV)","Aeterna Zentaris Inc.","AEZS","Zoptrex","Oncology","Bladder Cancer","DNA,DNA synthesis,Gonadotropin-Releasing Hormone (GnRH) Receptor,Topoisomerase I (Topo-I)",
"Suspended",,,,,,"Peptide","Intravenous (IV)","University of Texas MD Anderson Cancer Center",,"BMTP-11","Oncology","Bone Cancer","IL-11R (interleukin-11 receptor)",
"Suspended",,,,"04/13/2010",,"Peptide","Intravenous (IV)","Polyphor AG","POLN","POL6326","Oncology","Bone Marrow Transplant and Stem Cell Transplant","Chemokine (C-X-C motif) Receptor 4 (CXCR4)",
"III","11/28/2018","11/28/2018",,,"09/25/2014","Peptide","Intravenous (IV)","Blaze Bioscience, Inc. ",,"BLZ-100","Oncology","Brain Cancer - Imaging",,"09/25/2014"
"II",,,"12/06/2007","12/06/2007",,"Peptide","Intravenous (IV)","Angiochem, Inc.",,"ANG1005","Oncology","Brain Cancer (Malignant Glioma; AA and glioblastoma (GBM))","Cluster of Differentiation 91 (CD91) / Low density lipoprotein receptor-related protein 1 (LRP1),Microtubules (Tubulin)",
"III","12/01/2011","12/01/2011","06/01/1996","06/01/1996",,"Peptide","Intravenous (IV)","Burzynski Research Institute, Inc.","BZYR","Antineoplastons","Oncology","Brain Cancer (Malignant Glioma; AA and glioblastoma (GBM))","Tumor Cells",
"Suspended",,"02/20/2008",,"11/22/2004",,"Peptide","Intravenous (IV)","EspeRare Foundation",,"EspoiR-003","Oncology","Brain Cancer (Malignant Glioma; AA and glioblastoma (GBM))","Integrin Alpha-V Family",
"Suspended",,"12/02/2008",,"04/01/2002",,"Peptide","Intravenous (IV)","TransMolecular, Inc.",,"TM-601","Oncology","Brain Cancer (Malignant Glioma; AA and glioblastoma (GBM))","MMP-2 (Metalloproteinase-2) Receptor ,Radiopharmaceutical",
"Suspended",,,"02/19/2014","02/19/2014",,"Peptide","Intravenous (IV)","Inspyr Therapeutics, Inc.","NSPX","Mipsagargin","Oncology","Brain Cancer (Malignant Glioma; AA and glioblastoma (GBM))","Prostate-specific Membrane Antigen (PSMA),Sarcoplasmic reticulum Ca2+-ATPase (SERCA)",
"II",,,"12/06/2007","12/06/2007",,"Peptide","Intravenous (IV)","Angiochem, Inc.",,"ANG1005","Oncology","Brain Cancer (Secondary; Metastases)","Cluster of Differentiation 91 (CD91) / Low density lipoprotein receptor-related protein 1 (LRP1),Microtubules (Tubulin)",
"I/II",,,"09/06/2018","09/06/2018",,"Peptide","Intravenous (IV)","Immune System Key Ltd.",,"Nerofe","Oncology","Breast Cancer","Angiogenesis,Apoptosis (Cell Death),Immune System","12/01/2013"
"III",,"03/15/2019",,,"11/29/2013","Peptide","Intravenous (IV)","Polyphor AG","POLN","POL6326","Oncology","Breast Cancer","Chemokine (C-X-C motif) Receptor 4 (CXCR4)","11/29/2013"
"Suspended",,,,"10/25/2011",,"Peptide","Intravenous (IV)","Aeterna Zentaris Inc.","AEZS","Zoptrex","Oncology","Breast Cancer","DNA,DNA synthesis,Gonadotropin-Releasing Hormone (GnRH) Receptor,Topoisomerase I (Topo-I)","06/05/2006"
"Suspended","06/22/2009","06/22/2009",,,,"Peptide","Intravenous (IV)","Merck KGaA","MKKGY","Tecemotide","Oncology","Breast Cancer","Immune System,Mucin 1 (MUC-1)",
"II/III","08/02/2018","08/02/2018","06/30/2017","06/30/2017","04/16/2015","Peptide","Intravenous (IV)","Avelas Biosciences, Inc.",,"AVB-620","Oncology","Breast Cancer - Imaging","Protease","03/17/2015"
"Suspended",,,,,,"Peptide","Intravenous (IV)","ISA Pharmaceuticals B.V.",,"ISA203","Oncology","Cancer","Immune System",
"Suspended",,,,"09/16/2013",,"Peptide","Intravenous (IV)","ISA Pharmaceuticals B.V.",,"ISA102","Oncology","Colorectal Cancer (CRC)","Immune System,p53",
"Suspended",,,,"08/01/1998",,"Peptide","Intravenous (IV)","Burzynski Research Institute, Inc.","BZYR","Antineoplastons","Oncology","Colorectal Cancer (CRC)","Tumor Cells",
"Suspended",,,"01/06/2012","01/06/2012",,"Peptide","Intravenous (IV)","Merck KGaA","MKKGY","Tecemotide","Oncology","Colorectal Cancer (CRC)","Immune System,Mucin 1 (MUC-1)",
"I/II",,,,"09/13/2017","02/07/2017","Peptide","Intravenous (IV)","Bioniz Therapeutics, Inc.",,"BNZ-1","Oncology","Cutaneous T-Cell Lymphoma (CTCL) - NHL","IL-15 (Interleukin-15)/IL-15 Receptor,IL-2 (Interleukin-2),IL-9 (Interleukin-9)","02/07/2017"
"Suspended",,,,,,"Peptide","Intravenous (IV)","PharmaMar, S.A.","PHM","Irvalec","Oncology","Esophageal Cancer","ErbB3/HER3",
"Suspended",,,,,,"Peptide","Intravenous (IV)","Inspyr Therapeutics, Inc.","NSPX","Mipsagargin","Oncology","Gastric Cancer","Prostate-specific Membrane Antigen (PSMA),Sarcoplasmic reticulum Ca2+-ATPase (SERCA)",
"Suspended",,,,,,"Peptide","Intravenous (IV)","PharmaMar, S.A.","PHM","Irvalec","Oncology","Gastric Cancer","ErbB3/HER3",
"Suspended",,,"11/03/2008","11/03/2008",,"Peptide","Intravenous (IV)","EspeRare Foundation",,"EspoiR-003","Oncology","Head and Neck Cancer","Integrin Alpha-V Family",
"Suspended",,,,"05/02/2006",,"Peptide","Intravenous (IV)","Pertinax Therapeutics",,"PTX-9908","Oncology","Hepatocellular (Liver) Cancer (HCC) (Including Secondary Metastases)","Chemokine (C-X-C motif) Receptor 4 (CXCR4)","12/11/2003"
"Suspended",,,,,,"Peptide","Intravenous (IV)","Horizon Therapeutics plc","HZNP","HepTide Program","Oncology","Hepatocellular (Liver) Cancer (HCC) (Including Secondary Metastases)","Cluster of Differentiation 91 (CD91) / Low density lipoprotein receptor-related protein 1 (LRP1)",
"Suspended",,,"02/21/2013","11/19/2012",,"Peptide","Intravenous (IV)","Inspyr Therapeutics, Inc.","NSPX","Mipsagargin","Oncology","Hepatocellular (Liver) Cancer (HCC) (Including Secondary Metastases)","Prostate-specific Membrane Antigen (PSMA),Sarcoplasmic reticulum Ca2+-ATPase (SERCA)","01/25/2010"
"Suspended",,,,,,"Peptide","Intravenous (IV)","Takeda Pharmaceutical Co. Ltd.","TAK","Mifamurtide","Oncology","Hepatocellular (Liver) Cancer (HCC) (Including Secondary Metastases)","Immune System",
"Suspended",,,,,,"Peptide","Intravenous (IV)","Mallinckrodt plc","MNK","Terlipressin","Oncology","Malignant Ascites","Vasopressin receptors",
"Program Hold",,,,"06/05/2004",,"Peptide","Intravenous (IV)","ExperGen Drug Development GmbH",,"TLN-232","Oncology","Melanoma","M2PK (pyruvate kinase)",
"Suspended",,,,,,"Peptide","Intravenous (IV)","SolaranRx, Inc",,"SRX-1117","Oncology","Melanoma","Melanocortin (MC) receptors,Radiopharmaceutical",
"Suspended",,,,"06/02/2008",,"Peptide","Intravenous (IV)","TransMolecular, Inc.",,"TM-601","Oncology","Melanoma","MMP-2 (Metalloproteinase-2) Receptor ,Radiopharmaceutical",
"II",,,,"06/03/2008",,"Peptide","Intravenous (IV)","CanBas Co., Ltd.",4575,"CBP501","Oncology","Mesothelioma","Cell Cycle Checkpoint Kinase 1 (Chk1)","01/06/2006"
"Suspended","05/15/1997","04/26/1999",,"05/15/1997",,"Peptide","Intravenous (IV)","Orgenesis, Inc.","ORGS","Onconase","Oncology","Mesothelioma","RNA",
"Suspended",,,,"03/23/2010",,"Peptide","Intravenous (IV)","Merck KGaA","MKKGY","Tecemotide","Oncology","Multiple Myeloma (MM)","Immune System,Mucin 1 (MUC-1)",
"Suspended",,,,,"09/20/2016","Peptide","Intravenous (IV)","Aileron Therapeutics, Inc","ALRN","ALRN-6924","Oncology","Myelodysplastic Syndrome (MDS)","Mdm2,Mdmx/Mdm4","09/20/2016"
"I",,,,"02/19/2017",,"Peptide","Intravenous (IV)","Ipsen SA","IPSEY","SOMTher","Oncology","Neuroendocrine Tumors (NET)","Radiopharmaceutical,Somatostatin Receptors","07/30/2020"
"I/II",,,"04/24/2018","04/24/2018","11/24/2016","Peptide","Intravenous (IV)","Tarveda Therapeutics, Inc.",,"PEN-221","Oncology","Neuroendocrine Tumors (NET)","Somatostatin Receptors,Tumor Cells","11/24/2016"
"Suspended",,,,"01/24/2007",,"Peptide","Intravenous (IV)","Progenics Pharmaceuticals, Inc.","PGNX","Onalta","Oncology","Neuroendocrine Tumors (NET)","Radiopharmaceutical,Somatostatin Receptors",
"Suspended",,,,,,"Peptide","Intravenous (IV)","Esperance Pharmaceuticals, Inc.",,"EP-100","Oncology","Non-Hodgkin's Lymphoma (NHL)","Luteinizing Hormone Receptor (LHR) ",
"II",,,"07/07/2009","07/07/2009",,"Peptide","Intravenous (IV)","CanBas Co., Ltd.",4575,"CBP501","Oncology","Non-Small Cell Lung Cancer (NSCLC)","Cell Cycle Checkpoint Kinase 1 (Chk1)","01/06/2006"
"Suspended",,,"02/11/2009","02/11/2009",,"Peptide","Intravenous (IV)","EspeRare Foundation",,"EspoiR-003","Oncology","Non-Small Cell Lung Cancer (NSCLC)","Integrin Alpha-V Family",
"Suspended",,,,"05/02/2005",,"Peptide","Intravenous (IV)","Yakult Honsha Co. Ltd. ","2267:JP","Soblidotin","Oncology","Non-Small Cell Lung Cancer (NSCLC)","Microtubules (Tubulin)","10/31/2001"
"Suspended","01/02/2007","01/02/2007","11/13/2002","11/13/2002",,"Peptide","Intravenous (IV)","Merck KGaA","MKKGY","Tecemotide","Oncology","Non-Small Cell Lung Cancer (NSCLC)","Immune System,Mucin 1 (MUC-1)",
"Suspended",,,,"02/08/2005","02/08/2005","Peptide","Intravenous (IV)","Orgenesis, Inc.","ORGS","Onconase","Oncology","Non-Small Cell Lung Cancer (NSCLC)","RNA",
"Suspended",,,,"12/18/2008",,"Peptide","Intravenous (IV)","PharmaMar, S.A.","PHM","Irvalec","Oncology","Non-Small Cell Lung Cancer (NSCLC)","ErbB3/HER3",
"Suspended",,,,"12/03/2012","02/08/2008","Peptide","Intravenous (IV)","Spectrum Pharmaceuticals Inc.","SPPI","SPI-1620","Oncology","Non-Small Cell Lung Cancer (NSCLC)","Endothelin Receptor Type B (EDNRB)","02/08/2008"
"I",,,,,"08/06/2019","Peptide","Intravenous (IV)","Soricimed Biopharma Inc.",,"SOR-C13","Oncology","Ovarian Cancer","TRPV6, transient receptor potential vanilloid receptor 6, VR-6","08/06/2019"
"I/II",,,"09/06/2018","09/06/2018",,"Peptide","Intravenous (IV)","Immune System Key Ltd.",,"Nerofe","Oncology","Ovarian Cancer","Angiogenesis,Apoptosis (Cell Death),Immune System","12/01/2013"
"Suspended",,,"02/16/2012","02/16/2012",,"Peptide","Intravenous (IV)","Esperance Pharmaceuticals, Inc.",,"EP-100","Oncology","Ovarian Cancer","Luteinizing Hormone Receptor (LHR) ","06/01/2011"
"Suspended",,,,"10/01/2009",,"Peptide","Intravenous (IV)","ISA Pharmaceuticals B.V.",,"ISA102","Oncology","Ovarian Cancer","Immune System,p53",
"Suspended",,,,,,"Peptide","Intravenous (IV)","CanBas Co., Ltd.",4575,"CBP501","Oncology","Ovarian Cancer","Cell Cycle Checkpoint Kinase 1 (Chk1)","10/29/2007"
"Suspended",,,,"12/06/2007",,"Peptide","Intravenous (IV)","Aeterna Zentaris Inc.","AEZS","Zoptrex","Oncology","Ovarian Cancer","DNA,DNA synthesis,Gonadotropin-Releasing Hormone (GnRH) Receptor,Topoisomerase I (Topo-I)","06/05/2006"
"I",,,,,"08/13/2018","Peptide","Intravenous (IV)","Cend Therapeutics",,"CEND-1","Oncology","Pancreatic Cancer","Integrin Alpha-V Family,Neuropilin 1 (NRP1)","08/13/2018"
"I",,,,,"08/06/2019","Peptide","Intravenous (IV)","Soricimed Biopharma Inc.",,"SOR-C13","Oncology","Pancreatic Cancer","TRPV6, transient receptor potential vanilloid receptor 6, VR-6","08/06/2019"
"IND",,,,,,"Peptide","Intravenous (IV)","Immune Therapeutics, Inc.","IMUN","MENK","Oncology","Pancreatic Cancer","Opioid receptors",
"Program Hold",,,,,,"Peptide","Intravenous (IV)","ExperGen Drug Development GmbH",,"TLN-232","Oncology","Pancreatic Cancer","M2PK (pyruvate kinase)","03/14/2006"
"Suspended","12/06/1995","12/06/1995",,,,"Peptide","Intravenous (IV)","Orgenesis, Inc.","ORGS","Onconase","Oncology","Pancreatic Cancer","RNA",
"Suspended","03/26/2008","03/26/2008",,,,"Peptide","Intravenous (IV)","9 Meters Biopharma, Inc. ","NMTR","INN-329","Oncology","Pancreatic Cancer - Imaging","Secretin receptor",
"Suspended",,,"08/31/2016","08/31/2016",,"Peptide","Intravenous (IV)","Aileron Therapeutics, Inc","ALRN","ALRN-6924","Oncology","Peripheral T-Cell Lymphoma (PTCL) - NHL","Mdm2,Mdmx/Mdm4",
"Suspended",,,,,,"Peptide","Intravenous (IV)","University of Texas MD Anderson Cancer Center",,"BMTP-11","Oncology","Prostate Cancer","IL-11R (interleukin-11 receptor)","03/30/2009"
"Suspended",,,,"12/22/2003",,"Peptide","Intravenous (IV)","Kotinos Pharmaceuticals, Inc.",,"PCK3145","Oncology","Prostate Cancer","Follicle-stimulating hormone (FSH)",
"Suspended",,,"11/12/2010","11/12/2010",,"Peptide","Intravenous (IV)","Aeterna Zentaris Inc.","AEZS","Zoptrex","Oncology","Prostate Cancer","DNA,DNA synthesis,Gonadotropin-Releasing Hormone (GnRH) Receptor,Topoisomerase I (Topo-I)","08/05/2010"
"Suspended",,,,,"01/13/2015","Peptide","Intravenous (IV)","Aptevo Therapeutics Inc.","APVO","APVO414","Oncology","Prostate Cancer","Cluster of Differentiation 3 (CD3),Prostate-specific Membrane Antigen (PSMA),T-Cell Receptor (TCR)","01/13/2015"
"Suspended",,,"10/19/2001","10/19/2001",,"Peptide","Intravenous (IV)","Merck KGaA","MKKGY","Tecemotide","Oncology","Prostate Cancer","Immune System,Mucin 1 (MUC-1)",
"Suspended",,,"11/27/2012","11/27/2012",,"Peptide","Intravenous (IV)","Inspyr Therapeutics, Inc.","NSPX","Mipsagargin","Oncology","Prostate Cancer","Prostate-specific Membrane Antigen (PSMA),Sarcoplasmic reticulum Ca2+-ATPase (SERCA)","09/11/2009"
"Program Hold",,,,"04/04/2007",,"Peptide","Intravenous (IV)","ExperGen Drug Development GmbH",,"TLN-232","Oncology","Renal Cell Cancer (RCC)","M2PK (pyruvate kinase)","03/14/2006"
"Suspended",,,"07/05/2016","07/05/2016",,"Peptide","Intravenous (IV)","Inspyr Therapeutics, Inc.","NSPX","Mipsagargin","Oncology","Renal Cell Cancer (RCC)","Prostate-specific Membrane Antigen (PSMA),Sarcoplasmic reticulum Ca2+-ATPase (SERCA)","06/24/2014"
"Suspended",,,,"08/01/2001",,"Peptide","Intravenous (IV)","Orgenesis, Inc.","ORGS","Onconase","Oncology","Renal Cell Cancer (RCC)","RNA",
"Suspended",,,,,"09/22/2015","Peptide","Intravenous (IV)","Blaze Bioscience, Inc. ",,"BLZ-100","Oncology","Sarcoma - Imaging",,"09/22/2015"
"Suspended",,,,,"12/19/2013","Peptide","Intravenous (IV)","Blaze Bioscience, Inc. ",,"BLZ-100","Oncology","Skin Cancer - Imaging",,"12/19/2013"
"I/II",,,"04/24/2018","04/24/2018","11/24/2016","Peptide","Intravenous (IV)","Tarveda Therapeutics, Inc.",,"PEN-221","Oncology","Small Cell Lung Cancer (SCLC)","Somatostatin Receptors,Tumor Cells","11/24/2016"
"I/II",,,,"11/20/2017","11/20/2017","Peptide","Intravenous (IV)","Novartis AG","NVS","Lutathera","Oncology","Small Cell Lung Cancer (SCLC)","Radiopharmaceutical,Somatostatin Receptors",
"I",,,,,,"Peptide","Intravenous (IV)","PIN Pharma, Inc.",,"PIN-2","Oncology","Solid Tumors","Cluster of Differentiation 80 (CD80),Cluster of Differentiation 86 (CD86),Immune System,T lymphocytes","11/15/2017"
"I",,,,,"07/26/2012","Peptide","Intravenous (IV)","Soricimed Biopharma Inc.",,"SOR-C13","Oncology","Solid Tumors","TRPV6, transient receptor potential vanilloid receptor 6, VR-6","07/26/2012"
"II",,,"01/16/2019","01/16/2019","02/12/2015","Peptide","Intravenous (IV)","Aileron Therapeutics, Inc","ALRN","ALRN-6924","Oncology","Solid Tumors","Mdm2,Mdmx/Mdm4","02/12/2015"
"Suspended",,,,,,"Peptide","Intravenous (IV)","CytImmune Sciences Inc.",,"CYT-6091","Oncology","Solid Tumors","Tumor Necrosis Factor-alpha (TNF-alpha)","07/26/2006"
"Suspended",,,,,"02/15/2011","Peptide","Intravenous (IV)","Genus Oncology, LLC",,"GO-203-2c","Oncology","Solid Tumors","Mucin 1 (MUC-1)","02/15/2011"
"Suspended",,,,,,"Peptide","Intravenous (IV)","Eisai Co., Ltd.","4523:JP","E7974","Oncology","Solid Tumors","Microtubules (Tubulin)","07/15/2005"
"Suspended",,,,"12/31/2008",,"Peptide","Intravenous (IV)","PharmaMar, S.A.","PHM","Irvalec","Oncology","Solid Tumors","ErbB3/HER3","10/04/2005"
"I",,,,,"07/14/2015","Peptide","Intravenous (IV)","Blaze Bioscience, Inc. ",,"BLZ-100","Oncology","Solid Tumors - Imaging",,"07/14/2015"
"Suspended","05/30/2013","12/28/2012","12/06/2007","12/06/2007",,"Peptide","Intravenous (IV)","Aeterna Zentaris Inc.","AEZS","Zoptrex","Oncology","Uterine (Endometrial) Cancer","DNA,DNA synthesis,Gonadotropin-Releasing Hormone (GnRH) Receptor,Topoisomerase I (Topo-I)","06/05/2006"
"Investigator Initiated",,,,,"05/10/2016","Peptide","Intravenous (IV)","Araim Pharmaceuticals, Inc.",,"Cibinetide","Ophthalmology","Diabetic Macular Edema (Ophthalmology)","CSF2RB (common  subunit, CD131),Erythropoietin Receptor (EPOR)",
"Program Hold",,,,"04/25/2012",,"Peptide","Intravenous (IV)","Allergan plc","AGN","Rapastinel","Psychiatry","Bipolar Disorder","NMDA Receptor - Glycine Site",
"Suspended","11/01/2016","10/28/2016","05/09/2011","05/09/2011",,"Peptide","Intravenous (IV)","Allergan plc","AGN","Rapastinel","Psychiatry","Major Depressive Disorder (MDD)","NMDA Receptor - Glycine Site","12/16/2009"
"Suspended",,,,,,"Peptide","Intravenous (IV)","Allergan plc","AGN","Rapastinel","Psychiatry","Obsessive-Compulsive Disorder (OCD)","NMDA Receptor - Glycine Site",
"Suspended",,,,,,"Peptide","Intravenous (IV)","9 Meters Biopharma, Inc. ","NMTR","INN-329","Psychiatry","Obsessive-Compulsive Disorder (OCD)","Secretin receptor","05/25/2005"
"Suspended",,,,"12/10/2003",,"Peptide","Intravenous (IV)","9 Meters Biopharma, Inc. ","NMTR","INN-329","Psychiatry","Schizophrenia","Secretin receptor",
"Suspended",,,,,,"Peptide","Intravenous (IV)","Allergan plc","AGN","Rapastinel","Psychiatry","Substance Use Disorder","NMDA Receptor - Glycine Site",
"Suspended",,,,,,"Peptide","Intravenous (IV)","EspeRare Foundation",,"EspoiR-003","Renal","Focal Segmental Glomerulosclerosis (FSGS)","Integrin Alpha-V Family",
"Suspended",,,,"12/04/2017",,"Peptide","Intravenous (IV)","Atox Bio",,"Reltecimod","Renal","Renal Disease / Renal Failure","Cluster of Differentiation 28 (CD28) /ICOS and B7RP-1 Pathway,Immune System",
"Suspended",,,,"06/25/2008",,"Peptide","Intravenous (IV)","AbbVie Inc.","ABBV","ABT-719","Renal","Renal Disease / Renal Failure","Melanocortin (MC) receptors",
"Suspended",,,,,,"Peptide","Intravenous (IV)","Relief Therapeutics Holding AG","RLFTF","DK0141","Respiratory","Acute Respiratory Failure, Acute Lung Injury (ALI), Acute Respiratory Distress Syndrome (ARDS)",,
"Development Outside U.S.",,,,,,"Peptide","Intravenous (IV)","Araclon Biotech S.L.",,"ABvac40","Neurology","Alzheimer's Disease (AD)","Amyloid Beta/Amyloid Plaques,Immune System",
"Development Outside U.S.",,,,,,"Peptide","Intravenous (IV)","Invectys",,"UCPVax","Oncology","Brain Cancer (Malignant Glioma; AA and glioblastoma (GBM))","Immune System,Telomerase",
"Development Outside U.S.",,,,,,"Peptide","Intravenous (IV)","Invectys",,"UCPVax","Oncology","Cancer","Immune System,Telomerase",
"Development Outside U.S.",,,,,,"Peptide","Intravenous (IV)","WntResearch AB","WNT.ST","Foxy-5","Oncology","Colorectal Cancer (CRC)","WNT Signaling Pathway",
"Development Outside U.S.",,,,,,"Peptide","Intravenous (IV)","INOTREM S.A.",,"Nangibotide","Cardiovascular","Congestive Heart Failure (CHF) and Cardiomyopathies","Immune System,Triggering Receptor Expressed on Myeloid Cells-1 (TREM-1)",
"Development Outside U.S.",,,,,"07/10/2017","Peptide","Intravenous (IV)","Beijing Northland Biotechnology Co., Ltd",,"NL-005","Cardiovascular","Congestive Heart Failure (CHF) and Cardiomyopathies","Actin Filaments,ATP Synthase,Integrin-linked kinase (ILK)",
"Development Outside U.S.",,,,,,"Peptide","Intravenous (IV)","La Jolla Pharmaceutical Company","LJPC","Giapreza","Infectious Disease","COVID-19 Treatment","Angiotensin II Receptor Type 1 (AT1),Angiotensin II Receptor Type 2 (AT2)",
"Development Outside U.S.",,,,,,"Peptide","Intravenous (IV)","Beijing Northland Biotechnology Co., Ltd",,"NL-005","Ophthalmology","Dry Eye (Ophthalmology)","Actin Filaments,ATP Synthase,Integrin-linked kinase (ILK)",
"Development Outside U.S.",,,,,,"Peptide","Intravenous (IV)","Shionogi & Co. Ltd.",4507,"S-488210","Oncology","Head and Neck Cancer","Unknown",
"Development Outside U.S.",,,,,,"Peptide","Intravenous (IV)","Invectys",,"UCPVax","Oncology","Non-Small Cell Lung Cancer (NSCLC)","Immune System,Telomerase",
"Development Outside U.S.",,,,,,"Peptide","Intravenous (IV)","Arch Biopartners Inc.","ACHFF","Metablok","Renal","Renal Disease / Renal Failure","Dipeptidase 1 (DPEP-1)",
"Development Outside U.S.",,,,,,"Peptide","Intravenous (IV)","Ferring Pharmaceuticals",,"Tractocile ","Obstetrics/Gynecology","Reproductive Disorder","Oxytocin Receptor",
"Development Outside U.S.",,,,,,"Peptide","Intravenous (IV)","amcure GmbH",,"AMC303","Oncology","Solid Tumors","Cluster of Differentiation 44 (CD44)",
"Development Outside U.S.",,,,,,"Peptide","Intravenous (IV)","OncoTherapy Science, Inc.","4564:JP","S-588210","Oncology","Solid Tumors",,
"Approved in other than U.S./E.U.",,,,"10/01/2005",,"Peptide","Intravenous (IV)","Daiichi Sankyo Co., Ltd.",4568,"Carperitide","Cardiovascular","Acute Decompensated Heart Failure","Natriuretic Peptide Receptors",
"Approved in other than U.S./E.U.","02/18/2015",,,,,"Peptide","Intravenous (IV)","Frontier Biotechnologies Inc",,"Aikening","Infectious Disease","HIV / AIDS","gp41",
"Approved in Europe",,"04/01/1995",,,,"Peptide","Intravenous (IV)","Takeda Pharmaceutical Co. Ltd.","TAK","Mifamurtide","Oncology","Bone Cancer","Immune System",
"Approved in Europe",,,,,,"Peptide","Intravenous (IV)","Ferring Pharmaceuticals",,"Tractocile ","Obstetrics/Gynecology","Preterm Labor","Oxytocin Receptor",
"Approved (Generic Competition)",,"11/18/1998",,,,"Peptide","Intravenous (IV)","The Medicines Company","MDCO","Angiomax","Cardiovascular","Acute Coronary Syndrome (ACS)","Thrombin (Coagulation Factor IIa)",
"Approved (Generic Competition)",,,,,,"Peptide","Intravenous (IV)","Astellas Pharma, Inc.","4503:JP","Mycamine","Infectious Disease","Fungal Infections - Non-Systemic","Beta (1,3)-D-Glucan",
"Approved (Generic Competition)",,,,,,"Peptide","Intravenous (IV)","Astellas Pharma, Inc.","4503:JP","Mycamine","Infectious Disease","Fungal Infections - Systemic","Beta (1,3)-D-Glucan",
"Approved (Generic Competition)",,"11/18/1998",,,,"Peptide","Intravenous (IV)","The Medicines Company","MDCO","Angiomax","Cardiovascular","Percutaneous Coronary Interventions (PCIs) for Stable Angina","Thrombin (Coagulation Factor IIa)",
"Approved",,"11/07/1996",,"01/12/1994",,"Peptide","Intravenous (IV)","Johnson & Johnson","JNJ","Natrecor","Cardiovascular","Acute Decompensated Heart Failure","Natriuretic Peptide Receptors",
"Approved",,"12/20/2000",,,,"Peptide","Intravenous (IV)","CSL Limited","CSL","Zemaira","Metabolic","Alpha-1 Antitrypsin Deficiency (A1AD or AATD)","Alpha-1-antitrypsin (A1AT),Protease",
"Approved",,,,,,"Peptide","Intravenous (IV)","Bayer AG","BAYN","NeoTect","Oncology","Cancer - Imaging",,
"Approved",,,,,,"Peptide","Intravenous (IV)","Baxter International Inc.","BAX","Myxredlin","Endocrine","Diabetes Mellitus, Type I","Insulin Receptor",
"Approved",,,,,,"Peptide","Intravenous (IV)","Baxter International Inc.","BAX","Myxredlin","Endocrine","Diabetes Mellitus, Type II","Insulin Receptor",
"Approved","07/01/2008","09/13/2005",,,,"Peptide","Intravenous (IV)","CSL Limited","CSL","Kcentra","Hematology","Hemostasis","Coagulation Factor IX,Coagulation Factor VII,Coagulation Factor X,Protein C,Protein S,Thrombin (Coagulation Factor IIa)",
"Approved",,,,,,"Peptide","Intravenous (IV)","Bristol Myers Squibb Company","BMY","Refludan","Cardiovascular","Heparin-Induced Thrombocytopenia (HIT)","Thrombin (Coagulation Factor IIa)",
"Approved","02/05/2013","02/05/2013","03/14/2011","03/14/2011",,"Peptide","Intravenous (IV)","Amgen, Inc.","AMGN","Parsabiv","Endocrine","Hyperparathyroidism (Secondary)","Protein Kinase C (PKC)","07/20/2010"
"Approved",,,,,,"Peptide","Intravenous (IV)","Endo International plc","ENDP","Vasostrict","Cardiovascular","Hypotension/Shock",,
"Approved",,"01/13/2015",,,,"Peptide","Intravenous (IV)","La Jolla Pharmaceutical Company","LJPC","Giapreza","Cardiovascular","Hypotension/Shock","Angiotensin II Receptor Type 1 (AT1),Angiotensin II Receptor Type 2 (AT2)","07/23/2012"
"Approved",,,,,,"Peptide","Intravenous (IV)","ANI Pharmaceuticals, Inc.","ANIP","Cortrophin-Zinc","Neurology","Multiple Sclerosis (MS)","Corticotropin Releasing Factor (CRF) / Corticotropin Releasing Hormone (CRH)",
"Approved",,,,,,"Peptide","Intravenous (IV)","ANI Pharmaceuticals, Inc.","ANIP","Purified Cortrophin Gel","Neurology","Multiple Sclerosis (MS)","Corticotropin Releasing Factor (CRF) / Corticotropin Releasing Hormone (CRH)",
"Approved","09/30/2012","09/30/2012","01/31/2008","01/31/2008",,"Peptide","Intravenous (IV)","Novartis AG","NVS","Lutathera","Oncology","Neuroendocrine Tumors (NET)","Radiopharmaceutical,Somatostatin Receptors",
"Development Outside U.S.",,,,,,"Peptide","Intravenous (IV), Intradermal","BioNTech SE","BNTX","GAPVAC","Oncology","Brain Cancer (Malignant Glioma; AA and glioblastoma (GBM))","Immune System",
"Suspended",,,"01/16/2018","01/16/2018","08/25/2016","Peptide","Intravenous (IV), Intramuscular (IM)","Marathon Pharmaceuticals LLC ",,"Synacthen Depot","Metabolic","Duchenne Muscular Dystrophy (DMD)","Melanocortin (MC) receptors","08/25/2016"
"Approved in Europe",,,,,,"Peptide","Intravenous (IV), Intramuscular (IM)","Marathon Pharmaceuticals LLC ",,"Synacthen Depot","Allergy","Atopic Dermatitis (Eczema)","Melanocortin (MC) receptors",
"Approved in Europe",,,,,,"Peptide","Intravenous (IV), Intramuscular (IM)","Marathon Pharmaceuticals LLC ",,"Synacthen Depot","Not Specified","Drug Toxicity","Melanocortin (MC) receptors",
"Approved in Europe",,,,,,"Peptide","Intravenous (IV), Intramuscular (IM)","Marathon Pharmaceuticals LLC ",,"Synacthen Depot","Endocrine","Endocrine Disorder","Melanocortin (MC) receptors",
"Approved in Europe",,,,,,"Peptide","Intravenous (IV), Intramuscular (IM)","Mallinckrodt plc","MNK","Synacthen (IR)","Endocrine","Endocrine Disorder","Melanocortin (MC) receptors",
"Approved in Europe",,,,,,"Peptide","Intravenous (IV), Intramuscular (IM)","Marathon Pharmaceuticals LLC ",,"Synacthen Depot","Neurology","Infantile Spasms (West Syndrome; Epilepsy)","Melanocortin (MC) receptors",
"Approved in Europe",,,,,,"Peptide","Intravenous (IV), Intramuscular (IM)","Marathon Pharmaceuticals LLC ",,"Synacthen Depot","Autoimmune/immunology","Inflammatory Disorders","Melanocortin (MC) receptors",
"Approved in Europe",,,,,,"Peptide","Intravenous (IV), Intramuscular (IM)","Marathon Pharmaceuticals LLC ",,"Synacthen Depot","Neurology","Multiple Sclerosis (MS)","Melanocortin (MC) receptors",
"Approved in Europe",,,,,,"Peptide","Intravenous (IV), Intramuscular (IM)","Marathon Pharmaceuticals LLC ",,"Synacthen Depot","Autoimmune/immunology","Pemphigus Vulgaris","Melanocortin (MC) receptors",
"Approved in Europe",,,,,,"Peptide","Intravenous (IV), Intramuscular (IM)","Marathon Pharmaceuticals LLC ",,"Synacthen Depot","Autoimmune/immunology","Psoriasis","Melanocortin (MC) receptors",
"Approved in Europe",,,,,,"Peptide","Intravenous (IV), Intramuscular (IM)","Marathon Pharmaceuticals LLC ",,"Synacthen Depot","Autoimmune/immunology","Ulcerative Colitis (UC)","Melanocortin (MC) receptors",
"NDA","06/29/2016","06/29/2016","08/06/2014","08/06/2014",,"Peptide","Intravenous (IV), Oral (PO)","Cara Therapeutics, Inc.","CARA","Korsuva","Allergy","Pruritus","Opioid receptors","04/29/2013"
"Suspended",,,,,,"Peptide","Intravenous (IV), Oral (PO)","Cyxone AB","CYXO","T20K","Autoimmune/immunology","Inflammatory Bowel Disease (IBD)","IL-2 (Interleukin-2)",
"Suspended",,,,,,"Peptide","Intravenous (IV), Oral (PO)","Novo Nordisk A/S","NVO","NN1954","Endocrine","Diabetes Mellitus, Type I","Insulin Receptor","05/01/2013"
"Suspended",,,,,"05/10/2012","Peptide","Intravenous (IV), Oral (PO)","Novo Nordisk A/S","NVO","NN1954","Endocrine","Diabetes Mellitus, Type II","Insulin Receptor","05/10/2012"
"Suspended",,,,"02/08/2010",,"Peptide","Intravenous (IV), Oral (PO)","Cara Therapeutics, Inc.","CARA","Korsuva","Neurology","Neuropathic Pain","Opioid receptors",
"III","09/09/2015","09/09/2015","01/12/2009","01/12/2009","04/28/2008","Peptide","Intravenous (IV), Oral (PO)","Cara Therapeutics, Inc.","CARA","Korsuva","Neurology","Postsurgical Pain","Opioid receptors","04/28/2008"
"Suspended",,,"08/17/2015","08/17/2015","11/30/2011","Peptide","Intravenous (IV), Oral (PO)","Cara Therapeutics, Inc.","CARA","Korsuva","Rheumatology (Non Autoimmune)","Osteoarthritis and Osteoarthritis Pain","Opioid receptors","05/19/2011"
"Development Outside U.S.",,,,,,"Peptide","Intravenous (IV), Oral (PO)","Cyxone AB","CYXO","T20K","Neurology","Multiple Sclerosis (MS)","IL-2 (Interleukin-2)",
"Suspended",,,,,,"Peptide","Intravenous (IV), Oral (PO), Topical","Takeda Pharmaceutical Co. Ltd.","TAK","Actovegin","Neurology","Diabetic Peripheral Neuropathy (DPN)","Unknown",
"Suspended",,,,,,"Peptide","Intravenous (IV), Oral (PO), Topical","Takeda Pharmaceutical Co. Ltd.","TAK","Actovegin","Neurology","Ischemic Stroke","Unknown",
"I",,,,,"11/30/2017","Peptide","Intravenous (IV), Subcutaneous (SQ)","Apellis Pharmaceuticals, Inc.","APLS","APL-9","Autoimmune/immunology","Complement Deficiencies / Abnormalities","Complement Pathway","11/30/2017"
"Suspended",,,,,,"Peptide","Intravenous (IV), Subcutaneous (SQ)","Anexon, Inc.",,"ANX-042","Cardiovascular","Acute Decompensated Heart Failure","Natriuretic Peptide Receptors","07/10/2012"
"Suspended",,,"07/11/2008","07/11/2008","05/31/2007","Peptide","Intravenous (IV), Subcutaneous (SQ)","Mayo Clinic",,"Cenderitide","Cardiovascular","Acute Decompensated Heart Failure","Natriuretic Peptide Receptors","01/20/2006"
"II",,,,"11/17/2010",,"Peptide","Intravenous (IV), Subcutaneous (SQ)","Zensun Sci & Tech Co., Ltd.",,"Neucardin","Cardiovascular","Congestive Heart Failure (CHF) and Cardiomyopathies","ErbB4/HER4,HER2/neu or ErbB-2",
"II",,,"05/10/2016","05/10/2016",,"Peptide","Intravenous (IV), Subcutaneous (SQ)","Eiger BioPharmaceuticals, Inc.","EIGR","Avexitide","Endocrine","Hyperinsulinemia/Hypoglycemia","GLP-1 Receptor","09/14/2015"
"Withdrawn from Market","10/11/2007","10/11/2007","07/11/2005","07/11/2005","10/04/2004","Peptide","Intravenous (IV), Subcutaneous (SQ)","Affymax, Inc.","AFFY","Omontys","Hematology","Anemia Due to Chronic Renal Failure, Dialysis-Dependent","Erythropoietin Receptor (EPOR)","10/04/2004"
"Suspended","10/11/2007","10/11/2007","04/07/2005","04/07/2005","10/04/2004","Peptide","Intravenous (IV), Subcutaneous (SQ)","Affymax, Inc.","AFFY","Omontys","Hematology","Anemia Due to Chronic Renal Failure, Dialysis-Independent","Erythropoietin Receptor (EPOR)","10/04/2004"
"Suspended",,,"01/30/2006","01/30/2006","10/04/2004","Peptide","Intravenous (IV), Subcutaneous (SQ)","Affymax, Inc.","AFFY","Omontys","Hematology","Anemia Due to Oncology Treatment","Erythropoietin Receptor (EPOR)","10/04/2004"
"I/II",,,"05/28/2020","05/28/2020",,"Peptide","Intravenous (IV), Subcutaneous (SQ)","Apellis Pharmaceuticals, Inc.","APLS","APL-9","Infectious Disease","COVID-19 Treatment","Complement Pathway",
"Preclinical",,,,,,"Peptide","Intravenous (IV), Subcutaneous (SQ)","Zensun Sci & Tech Co., Ltd.",,"Neucardin","Neurology","Neurofibromatosis (NF)","ErbB4/HER4,HER2/neu or ErbB-2",
"II",,,"09/14/2005","09/14/2005",,"Peptide","Intravenous (IV), Subcutaneous (SQ)","Ferring Pharmaceuticals",,"Barusiban","Obstetrics/Gynecology","Reproductive Disorder","Oxytocin Receptor",
"Approved in other than U.S./E.U.",,,,,,"Peptide","Intravenous (IV), Subcutaneous (SQ)","Novartis AG","NVS","Sandostatin","Endocrine","Hyperinsulinemia/Hypoglycemia","Somatostatin Receptors",
"Approved (Generic Competition)",,,,,,"Peptide","Intravenous (IV), Subcutaneous (SQ)","Novartis AG","NVS","Sandostatin","Endocrine","Acromegaly","Somatostatin Receptors",
"Approved (Generic Competition)",,,,,,"Peptide","Intravenous (IV), Subcutaneous (SQ)","Novartis AG","NVS","Sandostatin","Oncology","Neuroendocrine Tumors (NET)","Somatostatin Receptors",
"Approved",,"02/05/2003",,,,"Peptide","Intravenous (IV), Subcutaneous (SQ)","Sanofi","SNY","Apidra","Endocrine","Diabetes Mellitus, Type I","Insulin Receptor",
"Approved",,"02/05/2003",,,,"Peptide","Intravenous (IV), Subcutaneous (SQ)","Sanofi","SNY","Apidra","Endocrine","Diabetes Mellitus, Type II","Insulin Receptor",
"Approved",,,,,,"Peptide","Intravenous (IV), Subcutaneous (SQ), Intramuscular (IM)","Novo Nordisk A/S","NVO","GlucaGen","Endocrine","Hyperinsulinemia/Hypoglycemia","Glucagon Receptor",
"Preclinical",,,,,,"Peptide","N/A","Anergis SA",,"Der p 2 COPs SVLP","Allergy","Allergy","Toll-Like Receptor (TLR) Family",
"Preclinical",,,,,,"Peptide","N/A","selectION, Inc.",,"si-544","Autoimmune/immunology","Autoimmune Disorders","Potassium channels",
"Suspended",,,,,,"Peptide","N/A","Medicenna Therapeutics Corp.","MDNAF","MDNA209","Autoimmune/immunology","Autoimmune Disorders","Cluster of Differentiation 122 (CD122),IL-2 Receptor (IL-2R) ",
"Preclinical",,,,,,"Peptide","N/A","RegeneRx Biopharmaceuticals, Inc.","RGRX","Thymosin beta 4 Program (RegeneRx)","Autoimmune/immunology","Chronic Granulomatous Disease","Actin Filaments,ATP Synthase,Hypoxia Inducible Factor-1 alpha (HIF-1a),Integrin-linked kinase (ILK)",
"Suspended",,,,,,"Peptide","N/A","Biogen, Inc.","BIIB","CB 2782","Autoimmune/immunology","Delayed Graft Function (DGF)","Complement Pathway",
"Suspended",,,,,,"Peptide","N/A","NephRx Corporation",,"NX002","Autoimmune/immunology","Inflammatory Bowel Disease (IBD)",,
"Suspended",,,,,,"Peptide","N/A","Celtaxsys Inc.",,"CRC-4273","Autoimmune/immunology","Inflammatory Disorders",,"09/09/2013"
"Suspended",,,,,,"Peptide","N/A","BioLineRx Ltd.","BLRX","BL-7060","Autoimmune/immunology","Inflammatory Disorders","FPRL1 - Formyl peptide receptor homolog-1,MAS G-protein coupled receptor ",
"Suspended",,,,,"11/18/2010","Peptide","N/A","NephRx Corporation",,"NX001","Autoimmune/immunology","Kidney Transplant Rejection","Unknown","11/18/2010"
"Suspended",,,,,,"Peptide","N/A","NephRx Corporation",,"NX002","Autoimmune/immunology","Mucositis",,
"Preclinical",,,,,,"Peptide","N/A","CEL-SCI Corporation","CVM","CEL-2000","Autoimmune/immunology","Rheumatoid Arthritis (RA)","Immune System",
"Preclinical",,,,,,"Peptide","N/A","Silver Creek Pharmaceuticals",,"SGF-1","Cardiovascular","Atherosclerosis","Apoptosis (Cell Death),IGF-1R (Insulin-like Growth Factor-1 Receptor) ",
"Preclinical",,,,,,"Peptide","N/A","Palatin Technologies, Inc.","PTN","PL-5028","Cardiovascular","Cardiovascular Disease","Natriuretic Peptide Receptors",
"Preclinical",,,,,,"Peptide","N/A","Corvidia Therapeutics",,"COR-003","Cardiovascular","Dyslipidemia / Hypercholesterolemia","Apolipoprotein C-II (apoCII, apo-CII, apo-C2),Apolipoprotein C-III (apoCIII, apo-CIII, apo-C3)",
"Suspended",,,,,,"Peptide","N/A","Thrombotargets Europe SL",,"TT-120","Cardiovascular","Peripheral Arterial Disease (PAD)",,
"Suspended",,,,"08/16/2004",,"Peptide","N/A","XOMA Corporation","XOMA","XOMA 629","Dermatology","Acne","Unknown",
"Preclinical",,,,,,"Peptide","N/A","Serodus ASA",,"SER140","Endocrine","Diabetes Mellitus, Type I","IL-1 Receptor (IL-1R)",
"Suspended",,,,,,"Peptide","N/A","Perle Bioscience",,"PRL002","Endocrine","Diabetes Mellitus, Type I","Regenerating Protein Family (REG Family) Receptors",
"Suspended",,,,,,"Peptide","N/A","Serpin Pharma LLC",,"SP16","Endocrine","Diabetes Mellitus, Type I","Alpha-1-antitrypsin (A1AT)",
"I",,,,,"08/22/2017","Peptide","N/A","Zealand Pharma A/S","ZEAL","BI 473494","Endocrine","Diabetes Mellitus, Type II","Amylin Receptor","08/22/2017"
"Preclinical",,,,,,"Peptide","N/A","Serodus ASA",,"SER140","Endocrine","Diabetes Mellitus, Type II","IL-1 Receptor (IL-1R)",
"Preclinical",,,,,,"Peptide","N/A","Velocity Pharmaceutical Development, LLC",,"SP-1373","Endocrine","Diabetes Mellitus, Type II","GLP-1 Receptor,Glucagon Receptor",
"Preclinical",,,,,,"Peptide","N/A","CohBar, Inc.","CWBR","CB4211","Endocrine","Diabetes Mellitus, Type II","Mitochondria",
"Preclinical",,,,,,"Peptide","N/A","CohBar, Inc.","CWBR","CB5064","Endocrine","Diabetes Mellitus, Type II","Apelin Receptor (APJ)",
"Preclinical",,,,,,"Peptide","N/A","Intarcia Therapeutics, Inc.","ITCA","ITCA 650/Peptide 1 Program","Endocrine","Diabetes Mellitus, Type II","GLP-1 Receptor",
"Preclinical",,,,,,"Peptide","N/A","Intarcia Therapeutics, Inc.","ITCA","ITCA 650/Peptide 2 Program","Endocrine","Diabetes Mellitus, Type II","GLP-1 Receptor",
"Suspended",,,,,,"Peptide","N/A","Perle Bioscience",,"PRL002","Endocrine","Diabetes Mellitus, Type II","Regenerating Protein Family (REG Family) Receptors",
"Suspended",,,,,,"Peptide","N/A","Intarcia Therapeutics, Inc.","ITCA","ITCA 650/Calibr Peptide Program","Endocrine","Diabetes Mellitus, Type II","GLP-1 Receptor",
"Suspended",,,,,"05/06/2009","Peptide","N/A","Pfizer Inc.","PFE","OAP-189","Endocrine","Diabetes Mellitus, Type II","GLP-1 Receptor,Glucagon Receptor","01/26/2009"
"I",,,,,"02/21/2017","Peptide","N/A","MorphoSys AG","MOR","MOR107","Endocrine","Diabetic Nephropathy","Angiotensin II Receptor Type 2 (AT2)","02/21/2017"
"Preclinical",,,,,,"Peptide","N/A","Pfenex Inc.","PFNX","PF810","Endocrine","Endocrine Disorder","Unknown",
"Suspended",,,,,,"Peptide","N/A","APEPTICO GmbH",,"Enaritide","Endocrine","Endocrine Disorder","Sodium Channels",
"Suspended",,,,,,"Peptide","N/A","EpiVax, Inc.",,"Treg-BT","Endocrine","Hyperthyroidism / Graves' Disease","Immune System,T-Cell Receptor (TCR),Thyroid stimulating hormone receptor (TSHR)",
"I",,,,,"12/08/2020","Peptide","N/A","Altimmune Inc. ","ALT","ALT-801","Endocrine","Non-Alcoholic Steatohepatitis (NASH)","GLP-1 Receptor,Glucagon Receptor","12/08/2020"
"I",,,,,"07/12/2018","Peptide","N/A","CohBar, Inc.","CWBR","CB4211","Endocrine","Non-Alcoholic Steatohepatitis (NASH)","Mitochondria","07/12/2018"
"I",,,,,,"Peptide","N/A","Novo Nordisk A/S","NVO","NN6177","Endocrine","Non-Alcoholic Steatohepatitis (NASH)","GLP-1 Receptor,Glucagon Receptor","02/05/2020"
"Preclinical",,,,,,"Peptide","N/A","Velocity Pharmaceutical Development, LLC",,"SP-1373","Endocrine","Non-Alcoholic Steatohepatitis (NASH)","GLP-1 Receptor,Glucagon Receptor",
"II",,,,"11/02/2020",,"Peptide","N/A","D&D Pharmatech",,"P4M01","ENT/Dental","Periodontitis","antimicrobial",
"II",,,,"03/07/2014",,"Peptide","N/A","Armata Pharmaceuticals, Inc.","ARMP","C16G2","ENT/Dental","Periodontitis","Streptococcus mutans","02/19/2013"
"Suspended",,,,,,"Peptide","N/A","Thrombotargets Europe SL",,"TT-120","Hematology","Anticoagulation",,
"Preclinical",,,,,,"Peptide","N/A","ContraFect Corporation.","CFRX","App2-M1","Infectious Disease","Antibacterial - General",,
"Suspended",,,,,,"Peptide","N/A","NovoBiotic Pharmaceuticals, LLC",,"Lassomycin","Infectious Disease","Antibacterial - General","Protease",
"Suspended",,,,,,"Peptide","N/A","Nektar Therapeutics","NKTR","NKTR-223","Infectious Disease","Antibacterial - General","Unknown",
"Suspended",,,,,,"Peptide","N/A","VG Life Sciences Inc.","VGLS","VGV-L","Infectious Disease","Antibacterial and Antifungal - Miscellaneous Vaccines and Treatments","Borrelia (Lyme disease)",
"Preclinical",,,,,,"Peptide","N/A","Peptilogics, Inc.",,"PLG0206","Infectious Disease","Bone and Joint Infections (Antibacterial)","Cell Membrane",
"Preclinical",,,,,,"Peptide","N/A","Bolder BioTechnology, Inc.",,"BBT-032","Infectious Disease","COVID-19 Treatment","Interferon-beta (IFNb),SARS-CoV-2",
"Preclinical",,,,,,"Peptide","N/A","Kalos Therapeutics, Inc.",,"KTH 222","Infectious Disease","COVID-19 Treatment","MAPK/ERK (mitogen-activated protein kinases/extracellular signal-regulated kinases; Ras-Raf-MEK-ERK pathway)",
"Preclinical",,,,,,"Peptide","N/A","48Hour Discovery, Inc.",,"Peptide-Based COVID-19 Anti-Viral Program (48Hour)","Infectious Disease","COVID-19 Treatment","Immune System,SARS-CoV-2",
"Preclinical",,,,,,"Peptide","N/A","CohBar, Inc.","CWBR","CB5064","Infectious Disease","COVID-19 Treatment","Apelin Receptor (APJ)",
"Suspended",,,,,,"Peptide","N/A","ISA Pharmaceuticals B.V.",,"ISA204","Infectious Disease","Hepatitis B (HBV) Treatment (Antiviral)","Immune System,Toll-Like Receptor 1 (TLR1),Toll-Like Receptor 2 (TLR2)",
"Suspended",,,,,,"Peptide","N/A","Alexion Pharmaceuticals Inc.","ALXN","TRI-1144","Infectious Disease","HIV / AIDS","gp41","05/08/2008"
"Suspended",,,,,,"Peptide","N/A","VG Life Sciences Inc.","VGLS","VGX-X","Infectious Disease","HIV / AIDS",,
"Preclinical",,,,,,"Peptide","N/A","Adenium Biotech ApS",,"AA139","Infectious Disease","Hospital Acquired (Nosocomial) Pneumonia (HAP) (Antibacterial)","Cell wall,DNA,Gram-Negative Bacteria",
"Suspended",,,,,,"Peptide","N/A","EnBiotix, Inc.",,"EBX-004","Infectious Disease","Hospital Acquired (Nosocomial) Pneumonia (HAP) (Antibacterial)","Penicillin Binding Proteins (PBP)",
"Suspended",,,,,,"Peptide","N/A","IMV Inc.","IMV","DepoVax-HPV16","Infectious Disease","Human Papillomavirus (HPV) Treatment (Antiviral)","Human Papillomavirus (HPV),Immune System",
"Preclinical",,,,,,"Peptide","N/A","Tokyo Metropolitan Institute of Medical Science",,"PD-001","Infectious Disease","Influenza (including vaccines)","Influenza Virus",
"Suspended",,,,,,"Peptide","N/A","Serpin Pharma LLC",,"SP14","Infectious Disease","Sepsis and Septic Shock","Protease",
"Suspended",,,"07/24/2008","07/24/2008",,"Peptide","N/A","XOMA Corporation","XOMA","XOMA 629","Infectious Disease","Skin and Skin-Structure Infections (Antibacterial)","Unknown",
"Preclinical",,,,,,"Peptide","N/A","Adenium Biotech ApS",,"AP-138","Infectious Disease","Staphylococcal Vaccines and Other Staphylococcus-Specific Agents (Antibacterial)","Cell wall synthesis",
"Preclinical",,,,,,"Peptide","N/A","Adenium Biotech ApS",,"AA139","Infectious Disease","Urinary Tract and Reproductive Tract Infections (Antibacterial)","Cell wall,DNA,Gram-Negative Bacteria",
"I",,,,,,"Peptide","N/A","Antag Therapeutics ApS",,"GIP Receptor Antagonist Program (Antag)","Metabolic","Metabolic - General","GIP Receptor (GIPR)/Glucose-Dependent Insulinotropic Polypeptide Receptor","06/26/2017"
"Preclinical",,,,,,"Peptide","N/A","Palatin Technologies, Inc.","PTN","PL-8905","Metabolic","Metabolic - General","Melanocortin (MC) receptors",
"Preclinical",,,,,,"Peptide","N/A","Zealand Pharma A/S","ZEAL","Peptide Therapeutic Program (Zealand/UniQuest)","Metabolic","Metabolic - General",,
"I",,,,,"07/12/2018","Peptide","N/A","CohBar, Inc.","CWBR","CB4211","Metabolic","Obesity","Mitochondria","07/12/2018"
"I",,,,,"08/22/2017","Peptide","N/A","Zealand Pharma A/S","ZEAL","BI 473494","Metabolic","Obesity","Amylin Receptor","08/22/2017"
"Preclinical",,,,,,"Peptide","N/A","Kallyope Inc.",,"Gut-Brain Axis Program (Kallyope)","Metabolic","Obesity",,
"Preclinical",,,,,,"Peptide","N/A","Palatin Technologies, Inc.","PTN","PL-8905","Metabolic","Obesity","Melanocortin (MC) receptors",
"Suspended",,,,,,"Peptide","N/A","Pfizer Inc.","PFE","OAP-189","Metabolic","Obesity","GLP-1 Receptor,Glucagon Receptor","08/31/2005"
"Preclinical",,,,,,"Peptide","N/A","Neurotez, Inc.",,"NT2","Neurology","Alzheimer's Disease (AD)","Cytoplasmic linker protein 170 (CLIP-170) ,Presenilin 1 (PS1)",
"Preclinical",,,,,,"Peptide","N/A","NervGen Pharma Corp.","NGENF","NVG-291","Neurology","Alzheimer's Disease (AD)","PTP-1b (Tyrosine phosphatase 1B inhibitor)",
"Suspended",,,,,,"Peptide","N/A","New World Laboratories, Inc.",,"NWL-154","Neurology","Alzheimer's Disease (AD)","Caspases",
"Suspended",,,,,,"Peptide","N/A","New World Laboratories, Inc.",,"NWL-53","Neurology","Alzheimer's Disease (AD)","Caspases",
"Suspended",,,,,,"Peptide","N/A","Araclon Biotech S.L.",,"S-14","Neurology","Alzheimer's Disease (AD)","Somatostatin Receptors",
"Suspended",,,,,,"Peptide","N/A","Senexis Ltd.",,"SEN304","Neurology","Alzheimer's Disease (AD)","Amyloid Beta/Amyloid Plaques",
"Suspended",,,,,,"Peptide","N/A","Alzinova AB","ALZ","ALZ-301","Neurology","Alzheimer's Disease (AD)","Amyloid Beta/Amyloid Plaques",
"Suspended",,,,,,"Peptide","N/A","New World Laboratories, Inc.",,"NWL-154","Neurology","Huntington's Disease","Caspases",
"Preclinical",,,,,,"Peptide","N/A","NervGen Pharma Corp.","NGENF","NVG-291","Neurology","Multiple Sclerosis (MS)","PTP-1b (Tyrosine phosphatase 1B inhibitor)",
"Suspended",,,,,,"Peptide","N/A","Xenetic Biosciences, Inc.","XBIO","MyeloXen","Neurology","Multiple Sclerosis (MS)","Mannose",
"Preclinical",,,,,,"Peptide","N/A","PeptiDream Inc.",4587,"PDPS Program (JCR/PeptiDream)","Neurology","Neurology - Other",,
"Suspended",,,,"07/31/2003",,"Peptide","N/A","Horizon Therapeutics plc","HZNP","Prosaptide","Neurology","Neuropathic Pain",,
"Preclinical",,,,,,"Peptide","N/A","Seelos Therapeutics, Inc.","SEEL","SLS-007","Neurology","Parkinson's Disease (PD)","Alpha-synuclein",
"Suspended",,,,,,"Peptide","N/A","New World Laboratories, Inc.",,"NWL-53","Neurology","Parkinson's Disease (PD)","Caspases",
"IND",,,,,,"Peptide","N/A","NervGen Pharma Corp.","NGENF","NVG-291","Neurology","Spinal Cord Injury (SCI)","PTP-1b (Tyrosine phosphatase 1B inhibitor)",
"Preclinical",,,,,,"Peptide","N/A","Silver Creek Pharmaceuticals",,"SGF-1","Neurology","Traumatic Brain Injury (TBI)","Apoptosis (Cell Death),IGF-1R (Insulin-like Growth Factor-1 Receptor) ",
"Suspended",,,,,,"Peptide","N/A","VG Life Sciences Inc.","VGLS","VG1177","Neurology","Traumatic Brain Injury (TBI)","Immune System",
"Preclinical",,,,,,"Peptide","N/A","ValiRx Plc","VAL","VAL301","Obstetrics/Gynecology","Endometriosis","Androgen receptors,Src Kinase Family",
"Suspended",,,,,,"Peptide","N/A","S1 Biopharma, Inc.",,"S1B-307","Obstetrics/Gynecology","Female Sexual Arousal Disorder","Unknown",
"Suspended",,,,,,"Peptide","N/A","Palatin Technologies, Inc.","PTN","PL-8905","Obstetrics/Gynecology","Female Sexual Arousal Disorder","Melanocortin (MC) receptors",
"II",,,,"07/13/2015",,"Peptide","N/A","Ferring Pharmaceuticals",,"FE-202767","Obstetrics/Gynecology","Milk Letdown","Oxytocin Receptor",
"Investigator Initiated",,,,"12/23/2010",,"Peptide","N/A","Formula Pharmaceuticals, Inc.",,"FPI-01","Oncology","Acute Lymphoblastic Leukemia (ALL)","Immune System,Wilms' Tumor Protein 1 (WT1)",
"Suspended",,,,,,"Peptide","N/A","Polyphor AG","POLN","POL5551","Oncology","Acute Lymphoblastic Leukemia (ALL)","Chemokine (C-X-C motif) Receptor 4 (CXCR4)",
"Investigator Initiated",,,,"12/23/2010",,"Peptide","N/A","Formula Pharmaceuticals, Inc.",,"FPI-01","Oncology","Acute Myelogenous Leukemia (AML)","Immune System,Wilms' Tumor Protein 1 (WT1)",
"Suspended",,,,,,"Peptide","N/A","Modulation Therapeutics",,"MTI-101","Oncology","Acute Myelogenous Leukemia (AML)","Cluster of Differentiation 44 (CD44)",
"Preclinical",,,,,,"Peptide","N/A","Neumedicines Inc.",,"NMHSS1-1","Oncology","Brain Cancer (Malignant Glioma; AA and glioblastoma (GBM))","Hematopoietic Signal peptide-containing Secreted 1 (HSS1)",
"Preclinical",,,,,,"Peptide","N/A","PepVax, Inc.",,"PVX-009","Oncology","Breast Cancer","Melanoma antigen-encoding gene (MAGE)",
"Preclinical",,,,,,"Peptide","N/A","CEL-SCI Corporation","CVM","J-HER","Oncology","Breast Cancer","HER2/neu or ErbB-2,Immune System",
"Preclinical",,,,,,"Peptide","N/A","EpiVax Therapeutics",,"Ancer Epitope Platform","Oncology","Cancer","Tumor Cells",
"Preclinical",,,,,,"Peptide","N/A","Apeiron Biologics AG",,"APN431","Oncology","Cancer","CBL-B,E3 ubiquitin ligase",
"Suspended",,,,,,"Peptide","N/A","PeptiMimesis Pharma",,"Ipsen/PeptiMimesis Oncology Peptide Program","Oncology","Cancer","Unknown",
"Suspended",,,,,,"Peptide","N/A","AbbVie Inc.","ABBV","AbbVie/Pure	MHC Peptide Program","Oncology","Cancer","Unknown",
"Suspended",,,,,,"Peptide","N/A","Ipsen SA","IPSEY","IPN-01087","Oncology","Cancer - Imaging","NT1 (Neurotensin receptor type 1),Radiopharmaceutical",
"Suspended",,"01/04/2001",,"12/10/1998",,"Peptide","N/A","Sarepta Therapeutics, Inc.","SRPT","Avicine","Oncology","Colorectal Cancer (CRC)","Human chorionic gonadotropin (hCG) ,Immune System",
"Preclinical",,,,,,"Peptide","N/A","selectION, Inc.",,"si-544","Oncology","Cutaneous T-Cell Lymphoma (CTCL) - NHL","Potassium channels",
"Suspended",,,,,,"Peptide","N/A","Shionogi & Co. Ltd.",4507,"S-488410","Oncology","Esophageal Cancer","Immune System",
"Preclinical",,,,,,"Peptide","N/A","Neumedicines Inc.",,"NMHSS1-1","Oncology","Hematologic Cancer","Hematopoietic Signal peptide-containing Secreted 1 (HSS1)",
"Suspended",,,,,,"Peptide","N/A","Sumitomo Dainippon Pharma Co., Ltd.",4506,"WT2725","Oncology","Hematologic Cancer","Immune System,Wilms' Tumor Protein 1 (WT1)","07/31/2013"
"Suspended",,,,,,"Peptide","N/A","Relief Therapeutics Holding AG","RLFTF","DasKloster 0014","Oncology","Hepatocellular (Liver) Cancer (HCC) (Including Secondary Metastases)",,
"I/II",,,"12/15/2020","12/15/2020",,"Peptide","N/A","IO Biotech ApS",,"IO103","Oncology","Melanoma","Programmed death-1 receptor (PD-1) / Programmed death ligands (PD-L1 and PD-L2)",
"Preclinical",,,,,,"Peptide","N/A","9 Meters Biopharma, Inc. ","NMTR","NM-102","Oncology","Melanoma","Unknown",
"Suspended",,,,,,"Peptide","N/A","Modulation Therapeutics",,"MTI-101","Oncology","Multiple Myeloma (MM)","Cluster of Differentiation 44 (CD44)",
"I",,,,,,"Peptide","N/A","RadioMedix, Inc.",,"AlphaMedix","Oncology","Neuroendocrine Tumors (NET)","Radiopharmaceutical,Somatostatin Receptors","05/31/2017"
"Suspended",,"08/03/2016",,,,"Peptide","N/A","Adlai Nortye Biopharma Co., Ltd.",,"AN-2109","Oncology","Non-Small Cell Lung Cancer (NSCLC)","Unknown",
"Suspended",,,"02/14/2012","02/14/2012",,"Peptide","N/A","SELLAS Life Sciences Group, Inc.","SLS","GALE-301","Oncology","Ovarian Cancer","Folate Binding Protein,Immune System",
"I/II",,,"02/15/2018","02/15/2018",,"Peptide","N/A","Ipsen SA","IPSEY","IPN-01087","Oncology","Pancreatic Cancer","NT1 (Neurotensin receptor type 1),Radiopharmaceutical",
"Preclinical",,,,,,"Peptide","N/A","Kalos Therapeutics, Inc.",,"KTH 222","Oncology","Pancreatic Cancer","MAPK/ERK (mitogen-activated protein kinases/extracellular signal-regulated kinases; Ras-Raf-MEK-ERK pathway)",
"Suspended",,,,,"06/14/2011","Peptide","N/A","Otsuka Holdings Co., Ltd.",4578,"OCV-105","Oncology","Pancreatic Cancer","Immune System",
"Suspended",,,,"06/02/1999",,"Peptide","N/A","Sarepta Therapeutics, Inc.","SRPT","Avicine","Oncology","Pancreatic Cancer","Human chorionic gonadotropin (hCG) ,Immune System",
"I/II",,,,"06/22/2018","06/22/2018","Peptide","N/A","Novartis AG","NVS","177Lu-PSMA-SR6","Oncology","Prostate Cancer","Prostate-specific Membrane Antigen (PSMA),Radiopharmaceutical",
"Suspended",,,,,,"Peptide","N/A","ValiRx Plc","VAL","VAL101","Oncology","Prostate Cancer","B-cell lymphoma 2 (Bcl-2)/Bcl-2 Family,Histone Deacetylase (HDAC)",
"I",,,,,,"Peptide","N/A","Sumitomo Dainippon Pharma Co., Ltd.",4506,"WT2725","Oncology","Solid Tumors","Immune System,Wilms' Tumor Protein 1 (WT1)","06/06/2012"
"I/II",,,"03/27/2018","03/27/2018",,"Peptide","N/A","Bicycle Therapeutics, plc","BCYC","BT1718","Oncology","Solid Tumors","Antibody-drug Conjugate (ADC),Microtubules (Tubulin),MMP (metalloproteinase)",
"I/II",,,,"09/10/2020","09/10/2020","Peptide","N/A","Bicycle Therapeutics, plc","BCYC","BT8009","Oncology","Solid Tumors","Antibody-drug Conjugate (ADC),Nectin-4",
"Preclinical",,,,,,"Peptide","N/A","Neumedicines Inc.",,"NMHSS1-1","Oncology","Solid Tumors","Hematopoietic Signal peptide-containing Secreted 1 (HSS1)",
"Preclinical",,,,,,"Peptide","N/A","Alkermes plc","ALKS","IL-10-Fc program (Alkermes)","Oncology","Solid Tumors","IL-10 (Interleukin-10) and IL-10 Receptor (IL-10R)",
"Preclinical",,,,,,"Peptide","N/A","Scancell","SCLP","AMPLIVANT:Modi-1 Conjugate Therapy","Oncology","Solid Tumors","Dendritic cells,Immune System,T lymphocytes,Toll-Like Receptor (TLR) Family,Toll-Like Receptor 1 (TLR1),Toll-Like Receptor 2 (TLR2),Vimentin",
"Preclinical",,,,,,"Peptide","N/A","Scancell","SCLP","Modi-1","Oncology","Solid Tumors","Immune System,Vimentin",
"Suspended",,,,,,"Peptide","N/A","Pierre Fabre",,"AUNP-12","Oncology","Solid Tumors","Immune System,Programmed death-1 receptor (PD-1) / Programmed death ligands (PD-L1 and PD-L2)",
"Suspended",,,,,,"Peptide","N/A","Biscayne Pharmaceuticals, Inc.",,"BIS-1602","Oncology","Solid Tumors","Growth Hormone Releasing Hormone (GHRH) Receptor",
"Suspended",,,,,,"Peptide","N/A","CytImmune Sciences Inc.",,"CYT-61000","Oncology","Solid Tumors","Interferon-alpha (IFNa),Protein synthesis,RNA synthesis",
"Suspended",,,,,,"Peptide","N/A","Aeterna Zentaris Inc.","AEZS","AEZS-138","Oncology","Solid Tumors","Gonadotropin-Releasing Hormone (GnRH)",
"Suspended",,,,,,"Peptide","N/A","Aileron Therapeutics, Inc","ALRN","ATSP-7041","Oncology","Solid Tumors","Mdm2,Mdmx/Mdm4",
"Suspended",,,,,"03/14/2012","Peptide","N/A","Seagen Inc. ","SGEN","ONT-10","Oncology","Solid Tumors","Immune System,Mucin 1 (MUC-1),Toll-like receptor 4 (TLR4)","03/14/2012"
"Suspended",,,,,,"Peptide","N/A","Targovax ASA","TRVX","TG03","Oncology","Solid Tumors","Immune System",
"Suspended",,,"02/14/2012","09/26/2011",,"Peptide","N/A","SELLAS Life Sciences Group, Inc.","SLS","GALE-301","Oncology","Uterine (Endometrial) Cancer","Folate Binding Protein,Immune System",
"Preclinical",,,,,,"Peptide","N/A","Biogen, Inc.","BIIB","CB 2782","Ophthalmology","Dry Age-Related Macular Degeneration (Dry AMD)/Geographic Atrophy (Ophthalmology)","Complement Pathway",
"Preclinical",,,,,,"Peptide","N/A","OKYO Pharma Limited","OKYO","OKYO-0201","Ophthalmology","Ocular Pain and/or Inflammation (Ophthalmology)","MAS-Related G Protein-Coupled Receptors (MRGPR) ",
"Suspended",,,,,,"Peptide","N/A","Palatin Technologies, Inc.","PTN","PL-8331","Ophthalmology","Ocular Pain and/or Inflammation (Ophthalmology)","Melanocortin (MC) receptors",
"Suspended",,,,,,"Peptide","N/A","BioLineRx Ltd.","BLRX","BL-8010","Ophthalmology","Other Retinopathy (Ophthalmology)","Angiopoietin Receptors (TIE-1 and TIE-2)",
"Preclinical",,,,,,"Peptide","N/A","Protagenic Therapeutics, Inc.","OTCQB:PTIX","PT00114","Psychiatry","Generalized Anxiety Disorder (GAD)","Corticotropin Releasing Factor (CRF) / Corticotropin Releasing Hormone (CRH)",
"Preclinical",,,,,,"Peptide","N/A","Protagenic Therapeutics, Inc.","OTCQB:PTIX","PT00114","Psychiatry","Major Depressive Disorder (MDD)","Corticotropin Releasing Factor (CRF) / Corticotropin Releasing Hormone (CRH)",
"Preclinical",,,,,,"Peptide","N/A","Protagenic Therapeutics, Inc.","OTCQB:PTIX","PT00114","Psychiatry","Post-Traumatic Stress Disorder (PTSD)","Corticotropin Releasing Factor (CRF) / Corticotropin Releasing Hormone (CRH)",
"Preclinical",,,,,,"Peptide","N/A","OrthoTrophix, Inc.",,"TPX-200","Renal","Renal Disease / Renal Failure","Phosphate",
"Suspended",,,"07/03/2013","07/03/2013",,"Peptide","N/A","Thrasos Theraputics, Inc.",,"THR-184","Renal","Renal Disease / Renal Failure","Apoptosis (Cell Death),Bone morphogenetic protein (BMP),Smad","10/25/2012"
"Suspended",,,,,,"Peptide","N/A","Synairgen plc","SNG","Synairgen IL4/IL13 Peptide","Respiratory","Asthma","IL-13 (Interleukin-13),IL-4 (Interleukin-4)",
"Suspended",,,,,,"Peptide","N/A","Serpin Pharma LLC",,"SP9","Respiratory","Cystic Fibrosis (CF)",,
"Suspended",,,,,,"Peptide","N/A","PhaseBio Pharmaceuticals, Inc.","PHAS","PB1120","Respiratory","Cystic Fibrosis (CF)","Vasoactive Intestinal Peptide (VIP) Receptor",
"Preclinical",,,,,,"Peptide","N/A","AstraZeneca PLC","AZN","AstraZeneca Bicycle Program","Respiratory","Respiratory Disease","Unknown",
"Suspended",,,,,,"Peptide","N/A","Palatin Technologies, Inc.","PTN","PL-8905","Urology","Erectile Dysfunction (ED)","Melanocortin (MC) receptors",
"Development Outside U.S.",,,,,,"Peptide","N/A","Vaxeal Holding SA",,"CBX-1","Oncology","Cancer","Cyclin B1,Immune System",
"Development Outside U.S.",,,,,,"Peptide","N/A","Edinburgh Molecular Imaging, Ltd.",,"EMT-100","Oncology","Cancer","Hepatocyte growth factor receptor (c-Met, HGFR)",
"Development Outside U.S.",,,,,,"Peptide","N/A","Edinburgh Molecular Imaging, Ltd.",,"EMT101","Oncology","Cancer","Hepatocyte growth factor receptor (c-Met, HGFR)",
"Development Outside U.S.",,,,,,"Peptide","N/A","Vaxeal Holding SA",,"SVX-1","Oncology","Cancer","Immune System,Survivin",
"Development Outside U.S.",,,,,,"Peptide","N/A","ImmuPharma PLC","IMM","IPP-204106","Oncology","Cancer","Nucleolin",
"Development Outside U.S.",,,,,,"Peptide","N/A","Cellivery Therapeutics Inc",,"CV-15","Infectious Disease","COVID-19 Treatment","Immune System,SARS-CoV-2",
"Development Outside U.S.",,,,,,"Peptide","N/A","ImCyse S.A.",,"IMCY-0098","Endocrine","Diabetes Mellitus, Type I","Immune System",
"Development Outside U.S.",,,,,,"Peptide","N/A","Sihuan Pharmaceutical Holdings Group Ltd",460,"Insulin Degludec (Sihuan)","Endocrine","Diabetes Mellitus, Type II","Insulin Receptor",
"Development Outside U.S.",,,,,,"Peptide","N/A","Zion Medical",,"Gammora","Infectious Disease","HIV / AIDS","Human Immunodeficiency Virus (HIV) ",
"Development Outside U.S.",,,,,,"Peptide","N/A","Vac-4-All",,"Malaria Vaccine (PfPEBS)","Infectious Disease","Malaria","Immune System,Plasmodium",
"Development Outside U.S.",,,,,,"Peptide","N/A","Hanmi Pharmaceutical Co., Ltd.",128940,"HM15912","Gastroenterology (Non Inflammatory Bowel Disease)","Short Bowel Syndrome (SBS)","GLP-2 Receptor",
"Approved in Europe",,,,,,"Peptide","N/A","Sanofi","SNY","Modustatine","Hematology","Acute Hemorrhage","Somatostatin Receptors",
"III","06/10/2019","06/10/2019","09/21/2006","09/21/2006",,"Peptide","Oral (PO)","9 Meters Biopharma, Inc. ","NMTR","INN-202","Autoimmune/immunology","Celiac Disease","Zonulin and zonulin receptor","09/27/2005"
"I",,,,,"12/09/2020","Peptide","Oral (PO)","Johnson & Johnson","JNJ","PN-235","Autoimmune/immunology","Crohn's Disease","IL-23 (Interleukin-23)  ","12/09/2020"
"II",,,"11/06/2019","11/06/2019","11/09/2017","Peptide","Oral (PO)","Johnson & Johnson","JNJ","PTG-200","Autoimmune/immunology","Crohn's Disease","IL-23 (Interleukin-23)  ","11/09/2017"
"Preclinical",,,,,,"Peptide","Oral (PO)","Johnson & Johnson","JNJ","PN-232","Autoimmune/immunology","Crohn's Disease","IL-23 (Interleukin-23)  ",
"Suspended",,,,,,"Peptide","Oral (PO)","9 Meters Biopharma, Inc. ","NMTR","INN-289","Autoimmune/immunology","Crohn's Disease","Zonulin and zonulin receptor",
"I",,,,,"08/21/2019","Peptide","Oral (PO)","Ra Pharmaceuticals, Inc.","RARX","Cyclomimetic Program","Autoimmune/immunology","Hereditary Angioedema (HAE)","Kinin-Kallikrein System ","08/21/2019"
"Preclinical",,,,,,"Peptide","Oral (PO)","Zealand Pharma A/S","ZEAL","ZP10000","Autoimmune/immunology","Inflammatory Bowel Disease (IBD)","Integrin Alpha-4 beta-7/LPAM",
"Suspended",,,,,,"Peptide","Oral (PO)","Amgen, Inc.","AMGN","Large Molecule Program (Entera/Amgen)","Autoimmune/immunology","Inflammatory Disorders",,
"Suspended",,,,,,"Peptide","Oral (PO)","Allostera Pharma, Inc.",,"APG2305","Autoimmune/immunology","Psoriatic Arthritis (PA)","IL-23 (Interleukin-23)  ",
"Program Hold",,,,"08/19/2008",,"Peptide","Oral (PO)","Synthetic Biologics, Inc.","SYN","Oral dnaJP1","Autoimmune/immunology","Rheumatoid Arthritis (RA)","Immune System",
"Suspended",,,,,"11/12/2009","Peptide","Oral (PO)","arGentis Pharmaceuticals, LLC ",,"ARG301","Autoimmune/immunology","Rheumatoid Arthritis (RA)","T-Cell Receptor (TCR)","11/12/2009"
"I",,,,,"10/11/2012","Peptide","Oral (PO)","Bausch Health Companies Inc.","BHC","Dolcanatide","Autoimmune/immunology","Ulcerative Colitis (UC)","Guanylyl cyclase c Receptor","10/11/2012"
"II",,,"11/04/2020","11/04/2020","12/13/2018","Peptide","Oral (PO)","Protagonist Therapeutics, Inc.","PTGX","PN-943","Autoimmune/immunology","Ulcerative Colitis (UC)","Integrin Alpha-4 beta-7/LPAM","12/13/2018"
"Suspended",,,,,,"Peptide","Oral (PO)","Dr Kurt Wolff GmbH & Co KG",,"KdPT","Autoimmune/immunology","Ulcerative Colitis (UC)","Melanocortin (MC) receptors",
"Suspended",,,"01/17/2017","01/17/2017","01/08/2016","Peptide","Oral (PO)","Protagonist Therapeutics, Inc.","PTGX","PTG-100","Autoimmune/immunology","Ulcerative Colitis (UC)","Integrin Alpha-4 beta-7/LPAM","01/08/2016"
"Suspended",,,,,,"Peptide","Oral (PO)","Bruin Pharmaceuticals",,"6F","Cardiovascular","Atherosclerosis","Reverse Cholesterol Transport (RCT)",
"Suspended",,,,,,"Peptide","Oral (PO)","Novartis AG","NVS","APP018","Cardiovascular","Atherosclerosis","Reverse Cholesterol Transport (RCT)","04/21/2005"
"III","02/23/2016","02/23/2016",,,,"Peptide","Oral (PO)","Novo Nordisk A/S","NVO","Rybelsus","Cardiovascular","Cardiovascular Disease","GLP-1 Receptor",
"Suspended",,,,,,"Peptide","Oral (PO)","Dr Kurt Wolff GmbH & Co KG",,"KdPT","Dermatology","Dermatology","Melanocortin (MC) receptors",
"II",,,,"01/16/2014",,"Peptide","Oral (PO)","Biocon, Ltd.",,"IN-105","Endocrine","Diabetes Mellitus, Type I","Insulin Receptor","08/19/2010"
"II",,,,"09/24/2008",,"Peptide","Oral (PO)","Oramed Pharmaceuticals Inc.","ORMP","ORMD-0801","Endocrine","Diabetes Mellitus, Type I","Insulin Receptor","09/09/2008"
"Suspended",,,,"06/15/2005",,"Peptide","Oral (PO)","Diabetology Ltd.",,"Capsulin IR","Endocrine","Diabetes Mellitus, Type I","Insulin Receptor",
"Suspended",,,,,,"Peptide","Oral (PO)","DiaMedica Therapeutics Inc.","DMAC","DM99","Endocrine","Diabetes Mellitus, Type I",,
"Suspended",,,,,,"Peptide","Oral (PO)","9 Meters Biopharma, Inc. ","NMTR","INN-202","Endocrine","Diabetes Mellitus, Type I","Zonulin and zonulin receptor",
"Suspended",,,,,"12/07/2009","Peptide","Oral (PO)","Novo Nordisk A/S","NVO","NN1952","Endocrine","Diabetes Mellitus, Type I","Insulin Receptor","12/07/2009"
"Suspended",,,,,"04/28/2011","Peptide","Oral (PO)","Novo Nordisk A/S","NVO","NN1953","Endocrine","Diabetes Mellitus, Type I","Insulin Receptor","04/28/2011"
"Suspended",,,,,"11/20/2012","Peptide","Oral (PO)","Novo Nordisk A/S","NVO","NN1956","Endocrine","Diabetes Mellitus, Type I","Insulin Receptor","03/11/2013"
"I",,,,,,"Peptide","Oral (PO)","Oramed Pharmaceuticals Inc.","ORMP","ORMD-0901","Endocrine","Diabetes Mellitus, Type II","GLP-1 Receptor","09/09/2009"
"II",,,"12/26/2017","01/16/2014",,"Peptide","Oral (PO)","Biocon, Ltd.",,"IN-105","Endocrine","Diabetes Mellitus, Type II","Insulin Receptor",
"II/III","12/23/2008","12/23/2008",,"08/23/2007",,"Peptide","Oral (PO)","Diasome Pharmaceuticals",,"Oral HDV-I","Endocrine","Diabetes Mellitus, Type II","Insulin Receptor",
"III",,"11/24/2020","07/08/2013","04/14/2008",,"Peptide","Oral (PO)","Oramed Pharmaceuticals Inc.","ORMP","ORMD-0801","Endocrine","Diabetes Mellitus, Type II","Insulin Receptor","07/11/2006"
"Preclinical",,,,,,"Peptide","Oral (PO)","Longevity Biotech, Inc.",,"LBT-6030","Endocrine","Diabetes Mellitus, Type II","GIP Receptor (GIPR)/Glucose-Dependent Insulinotropic Polypeptide Receptor,GLP-1 Receptor",
"Suspended",,,,"06/25/2007",,"Peptide","Oral (PO)","Diabetology Ltd.",,"Capsulin OAD","Endocrine","Diabetes Mellitus, Type II","Insulin Receptor",
"Suspended",,,,,,"Peptide","Oral (PO)","Zydus Cadila","CDH","ZYOG1","Endocrine","Diabetes Mellitus, Type II","GLP-1 Receptor",
"Suspended",,,,,,"Peptide","Oral (PO)","DiaMedica Therapeutics Inc.","DMAC","DM99","Endocrine","Diabetes Mellitus, Type II",,
"Suspended",,,,,,"Peptide","Oral (PO)","Emisphere Technologies, Inc.","EMIS","Oral GLP-1","Endocrine","Diabetes Mellitus, Type II","GLP-1 Receptor","03/29/2007"
"Suspended",,,,,"12/07/2009","Peptide","Oral (PO)","Novo Nordisk A/S","NVO","NN1952","Endocrine","Diabetes Mellitus, Type II","Insulin Receptor","12/07/2009"
"Suspended",,,"06/11/2015","06/11/2015","04/28/2011","Peptide","Oral (PO)","Novo Nordisk A/S","NVO","NN1953","Endocrine","Diabetes Mellitus, Type II","Insulin Receptor","11/24/2008"
"Suspended",,,,,"03/11/2013","Peptide","Oral (PO)","Novo Nordisk A/S","NVO","NN1956","Endocrine","Diabetes Mellitus, Type II","Insulin Receptor","03/11/2013"
"Suspended",,,,,"06/25/2015","Peptide","Oral (PO)","Novo Nordisk A/S","NVO","NN1957","Endocrine","Diabetes Mellitus, Type II","Insulin Receptor","06/25/2015"
"Suspended",,,,,,"Peptide","Oral (PO)","Novo Nordisk A/S","NVO","NN9926","Endocrine","Diabetes Mellitus, Type II","GLP-1 Receptor","08/09/2011"
"Suspended",,,,,,"Peptide","Oral (PO)","Novo Nordisk A/S","NVO","NN9928","Endocrine","Diabetes Mellitus, Type II","GLP-1 Receptor","05/30/2013"
"Suspended",,,,,"08/31/2018","Peptide","Oral (PO)","Novo Nordisk A/S","NVO","OG2023SC","Endocrine","Diabetes Mellitus, Type II","GLP-1 Receptor","08/31/2018"
"Suspended",,,,,,"Peptide","Oral (PO)","Oramed Pharmaceuticals Inc.","ORMP","Insulin + GLP-1 Analog Combination (Oramed)","Endocrine","Diabetes Mellitus, Type II","GLP-1 Receptor,Insulin Receptor",
"II",,,"08/20/2014","08/20/2014",,"Peptide","Oral (PO)","Entera Bio Ltd.","ENTX","Oral PTH (1-34)","Endocrine","Hypoparathyroidism","Parathyroid Hormone Receptor (PTHR)",
"II",,,"12/02/2020","12/02/2020",,"Peptide","Oral (PO)","Oramed Pharmaceuticals Inc.","ORMP","ORMD-0801","Endocrine","Non-Alcoholic Steatohepatitis (NASH)","Insulin Receptor",
"Suspended",,,,,,"Peptide","Oral (PO)","9 Meters Biopharma, Inc. ","NMTR","INN-202","Endocrine","Non-Alcoholic Steatohepatitis (NASH)","Zonulin and zonulin receptor",
"Suspended",,,,,,"Peptide","Oral (PO)","9 Meters Biopharma, Inc. ","NMTR","INN-217","Endocrine","Non-Alcoholic Steatohepatitis (NASH)","Zonulin and zonulin receptor",
"IND",,,,,,"Peptide","Oral (PO)","Entera Bio Ltd.","ENTX","EB613","Endocrine","Osteoporosis / Osteopenia","Parathyroid Hormone Receptor (PTHR)",
"Suspended",,,"03/15/2011","03/15/2011","10/06/2008","Peptide","Oral (PO)","Unigene Laboratories, Inc.",,"Oral PTH","Endocrine","Osteoporosis / Osteopenia","Parathyroid Hormone Receptor (PTHR)","10/06/2008"
"Suspended",,,,,,"Peptide","Oral (PO)","Nordic Bioscience A/S",,"SAN 267","Endocrine","Osteoporosis / Osteopenia","GLP-2 Receptor",
"Suspended","08/14/2009","10/20/2009",,,,"Peptide","Oral (PO)","R-Pharm JSC",,"Tbria","Endocrine","Osteoporosis / Osteopenia","Calcitonin Receptor",
"Suspended",,,,"09/29/2009",,"Peptide","Oral (PO)","Botanix Pharmaceuticals Limited","BOT:AU","Capsitonin","Endocrine","Osteoporosis / Osteopenia","Calcitonin Receptor",
"Suspended",,,,"02/01/2008",,"Peptide","Oral (PO)","Botanix Pharmaceuticals Limited","BOT:AU","CaPTHymone","Endocrine","Osteoporosis / Osteopenia","Parathyroid Hormone Receptor (PTHR)",
"Suspended",,,,,,"Peptide","Oral (PO)","Zydus Cadila","CDH","ZYPH0907","Endocrine","Osteoporosis / Osteopenia","Parathyroid Hormone (PTH)",
"Suspended","02/27/2007","02/27/2007",,"02/26/2003",,"Peptide","Oral (PO)","Emisphere Technologies, Inc.","EMIS","Oral Salmon Calcitonin","Endocrine","Osteoporosis / Osteopenia","Calcitonin Receptor",
"Suspended",,,,,,"Peptide","Oral (PO)","Novartis AG","NVS","Oral PTH 1-34","Endocrine","Osteoporosis / Osteopenia","Parathyroid Hormone Receptor (PTHR)","05/04/2007"
"Preclinical",,,,,,"Peptide","Oral (PO)","Debiopharm S.A.",,"Debio 025","Gastroenterology (Non Inflammatory Bowel Disease)","Gastroenterologic Disorders","Cyclophilin",
"Suspended",,,,,,"Peptide","Oral (PO)","9 Meters Biopharma, Inc. ","NMTR","INN-202","Gastroenterology (Non Inflammatory Bowel Disease)","Liver Failure / Cirrhosis","Zonulin and zonulin receptor",
"II",,,,"10/31/2013",,"Peptide","Oral (PO)","Bausch Health Companies Inc.","BHC","Dolcanatide","Gastroenterology (Non Inflammatory Bowel Disease)","Opioid Induced Constipation (OIC)","Guanylyl cyclase c Receptor","10/02/2013"
"Suspended",,,"10/16/2014","06/11/2013",,"Peptide","Oral (PO)","Ironwood Pharmaceuticals, Inc.","IRWD","Linzess","Gastroenterology (Non Inflammatory Bowel Disease)","Opioid Induced Constipation (OIC)","Guanylyl cyclase c Receptor",
"Suspended",,"04/06/2015",,,,"Peptide","Oral (PO)","Nutrinia Ltd.",,"NTRA-9620","Gastroenterology (Non Inflammatory Bowel Disease)","Short Bowel Syndrome (SBS)","Insulin Receptor",
"Preclinical",,,,,,"Peptide","Oral (PO)","Oragenics, Inc.","OGEN","OG716","Infectious Disease","Clostridium difficile-Associated Diarrhea/Infection (CDAD/CDI)","Cell Membrane",
"Suspended",,"09/29/2011","04/08/2010","04/08/2010","02/13/2009","Peptide","Oral (PO)","Merck & Co., Inc.","MRK","Surotomycin","Infectious Disease","Clostridium difficile-Associated Diarrhea/Infection (CDAD/CDI)","Cell Membrane","12/23/2008"
"Suspended",,,,"01/25/2012",,"Peptide","Oral (PO)","Novartis AG","NVS","LFF571","Infectious Disease","Clostridium difficile-Associated Diarrhea/Infection (CDAD/CDI)","Protein synthesis",
"Suspended",,,,,,"Peptide","Oral (PO)","Oragenics, Inc.","OGEN","OG253","Infectious Disease","Clostridium difficile-Associated Diarrhea/Infection (CDAD/CDI)","Cell Membrane",
"Preclinical",,,,,,"Peptide","Oral (PO)","9 Meters Biopharma, Inc. ","NMTR","INN-202","Infectious Disease","COVID-19 Treatment","Zonulin and zonulin receptor",
"Suspended",,"01/27/2011",,"04/18/2007",,"Peptide","Oral (PO)","Debiopharm S.A.",,"Debio 025","Infectious Disease","Hepatitis C (HCV) (Antiviral)","Cyclophilin","10/31/2006"
"Program Hold",,,,,"11/09/2009","Peptide","Oral (PO)","Concert Pharmaceuticals, Inc.","CNCE","CTP-518","Infectious Disease","HIV / AIDS","HIV-1 protease (HIV PR)","11/09/2009"
"Suspended",,,,,,"Peptide","Oral (PO)","Debiopharm S.A.",,"Debio 025","Infectious Disease","HIV / AIDS","Cyclophilin","02/09/2006"
"Suspended",,,,,,"Peptide","Oral (PO)","Concert Pharmaceuticals, Inc.","CNCE","CTP-298","Infectious Disease","HIV / AIDS","HIV-1 protease (HIV PR)","06/20/2011"
"Preclinical",,,,,,"Peptide","Oral (PO)","Ra Pharmaceuticals, Inc.","RARX","RA101295","Infectious Disease","Sepsis and Septic Shock","Complement Pathway",
"Suspended",,,,,,"Peptide","Oral (PO)","Debiopharm S.A.",,"Debio 025","Metabolic","Duchenne Muscular Dystrophy (DMD)","Cyclophilin",
"Preclinical",,,,,,"Peptide","Oral (PO)","Palatin Technologies, Inc.","PTN","PL-9610","Metabolic","Metabolic - General","Melanocortin (MC) receptors",
"Suspended",,,,,,"Peptide","Oral (PO)","Unigene Laboratories, Inc.",,"UGP281","Metabolic","Obesity","Amylin Receptor",
"Suspended",,,,,,"Peptide","Oral (PO)","Zydus Cadila","CDH","ZYOG1","Metabolic","Obesity","GLP-1 Receptor",
"Suspended",,,,,,"Peptide","Oral (PO)","Emisphere Technologies, Inc.","EMIS","Oral PYY3-36","Metabolic","Obesity","Neuropeptide Y (NPY)/Peptide YY (PYY) Receptors","03/29/2007"
"Suspended",,,,,,"Peptide","Oral (PO)","PolyNovo Limited","PNV:AU","AOD9604","Metabolic","Obesity","Growth hormone receptor (GHR)",
"Preclinical",,,,,,"Peptide","Oral (PO)","Neuren Pharmaceuticals Limited","NEU","NNZ-2591","Metabolic","Phelan-McDermid Syndrome (PMS)","Unknown",
"III","12/16/2020","12/16/2020",,,,"Peptide","Oral (PO)","Novo Nordisk A/S","NVO","Rybelsus","Neurology","Alzheimer's Disease (AD)","GLP-1 Receptor",
"Preclinical",,,,,,"Peptide","Oral (PO)","Neuren Pharmaceuticals Limited","NEU","NNZ-2591","Neurology","Angelman Syndrome","Unknown",
"Suspended",,,,,,"Peptide","Oral (PO)","Neuren Pharmaceuticals Limited","NEU","NNZ-2591","Neurology","Fragile X Syndrome","Unknown",
"Preclinical",,,,,,"Peptide","Oral (PO)","Longevity Biotech, Inc.",,"LBT-3627","Neurology","Multiple Sclerosis (MS)","Vasoactive Intestinal Peptide (VIP) Receptor",
"Suspended",,,,,,"Peptide","Oral (PO)","Neuren Pharmaceuticals Limited","NEU","NNZ-2591","Neurology","Multiple Sclerosis (MS)","Unknown",
"I",,,,,"01/21/2020","Peptide","Oral (PO)","Stealth BioTherapeutics Inc.","MITO","SBT-272","Neurology","Neurology - Other","Mitochondria","01/21/2020"
"Preclinical",,,,,,"Peptide","Oral (PO)","Creative Bio-Peptides, Inc.",,"RAP-103","Neurology","Neurology - Other","Chemokine Receptor 2 (CCR2),Chemokine Receptor 5 (CCR5)",
"Preclinical",,,,,,"Peptide","Oral (PO)","Neuren Pharmaceuticals Limited","NEU","NNZ-2591","Neurology","Neurology - Other","Unknown",
"Preclinical",,,,,,"Peptide","Oral (PO)","Creative Bio-Peptides, Inc.",,"RAP-103","Neurology","Neuropathic Pain","Chemokine Receptor 2 (CCR2),Chemokine Receptor 5 (CCR5)",
"Preclinical",,,,,,"Peptide","Oral (PO)","Longevity Biotech, Inc.",,"LBT-3627","Neurology","Parkinson's Disease (PD)","Vasoactive Intestinal Peptide (VIP) Receptor",
"Suspended",,,,,,"Peptide","Oral (PO)","Neuren Pharmaceuticals Limited","NEU","NNZ-2591","Neurology","Parkinson's Disease (PD)","Unknown",
"Preclinical",,,,,,"Peptide","Oral (PO)","Circle Pharma, Inc.",,"Macrocycle Modulator of CXCR7 Program (Circle/Pfizer)","Not Specified","Undisclosed","Chemokine (C-X-C motif) Receptor 7 (CXCR7)",
"Preclinical",,,,,,"Peptide","Oral (PO)","Ferring Pharmaceuticals",,"Peptelligence Program (Ferring/Enteris)","Not Specified","Undisclosed","Unknown",
"Suspended",,,,"02/18/2013",,"Peptide","Oral (PO)","Chiasma, Inc.","CHMA","Mycapssa","Oncology","Neuroendocrine Tumors (NET)","Somatostatin Receptors",
"Suspended",,,"09/03/2010","09/03/2010",,"Peptide","Oral (PO)","Enzo Biochem, Inc.","ENZ","Optiquel","Ophthalmology","Uveitis (Ophthalmology)",,"03/13/2007"
"III","07/01/2010","07/01/2010",,"09/02/2005",,"Peptide","Oral (PO)","Denovo Biopharma LLC",,"Pomaglumetad Methionil","Psychiatry","Schizophrenia","Metabotropic Glutamate Receptor subtype 2  (mGluR2),Metabotropic Glutamate Receptor subtype 3 (mGluR3)",
"Preclinical",,,,,,"Peptide","Oral (PO)","9 Meters Biopharma, Inc. ","NMTR","INN-202","Respiratory","Acute Respiratory Failure, Acute Lung Injury (ALI), Acute Respiratory Distress Syndrome (ARDS)","Zonulin and zonulin receptor",
"Suspended",,,,"09/29/2009",,"Peptide","Oral (PO)","Botanix Pharmaceuticals Limited","BOT:AU","Capsitonin","Rheumatology (Non Autoimmune)","Osteoarthritis and Osteoarthritis Pain","Calcitonin Receptor",
"Suspended","05/24/2007","05/24/2007",,"12/12/2005",,"Peptide","Oral (PO)","Emisphere Technologies, Inc.","EMIS","Oral Salmon Calcitonin","Rheumatology (Non Autoimmune)","Osteoarthritis and Osteoarthritis Pain","Calcitonin Receptor",
"Approved in Europe",,,,,,"Peptide","Oral (PO)","Merck & Co., Inc.","MRK","Renormax","Cardiovascular","Hypertension (Systemic)","Angiotensin Converting Enzyme (ACE)",
"Approved (Generic Competition)",,,,,,"Peptide","Oral (PO)","AbbVie Inc.","ABBV","Gengraf","Autoimmune/immunology","Heart Transplant Rejection","Calcineurin phosphatase ",
"Approved (Generic Competition)",,,,,,"Peptide","Oral (PO)","AbbVie Inc.","ABBV","Gengraf","Autoimmune/immunology","Kidney Transplant Rejection","Calcineurin phosphatase ",
"Approved (Generic Competition)",,,,,,"Peptide","Oral (PO)","AbbVie Inc.","ABBV","Gengraf","Autoimmune/immunology","Liver Transplant Rejection","Calcineurin phosphatase ",
"Approved (Generic Competition)",,,,,,"Peptide","Oral (PO)","AbbVie Inc.","ABBV","Gengraf","Autoimmune/immunology","Psoriasis","Calcineurin phosphatase ",
"Approved (Generic Competition)",,,,,,"Peptide","Oral (PO)","AbbVie Inc.","ABBV","Gengraf","Autoimmune/immunology","Rheumatoid Arthritis (RA)","Calcineurin phosphatase ",
"Approved","01/06/2012","01/06/2012",,,,"Peptide","Oral (PO)","Chiasma, Inc.","CHMA","Mycapssa","Endocrine","Acromegaly","Somatostatin Receptors","06/14/2010"
"Approved","10/07/2011","10/07/2011","02/19/2010","03/19/2010",,"Peptide","Oral (PO)","Bausch Health Companies Inc.","BHC","Trulance","Gastroenterology (Non Inflammatory Bowel Disease)","Chronic Idiopathic Constipation","Guanylyl cyclase c Receptor","06/04/2008"
"Approved",,"09/16/2008",,"10/24/2006",,"Peptide","Oral (PO)","Ironwood Pharmaceuticals, Inc.","IRWD","Linzess","Gastroenterology (Non Inflammatory Bowel Disease)","Chronic Idiopathic Constipation","Guanylyl cyclase c Receptor","05/23/2006"
"Approved","02/16/2016","02/16/2016","12/02/2013","08/13/2013","12/21/2009","Peptide","Oral (PO)","Novo Nordisk A/S","NVO","Rybelsus","Endocrine","Diabetes Mellitus, Type II","GLP-1 Receptor","01/13/2010"
"Approved",,,,,,"Peptide","Oral (PO)","AbbVie Inc.","ABBV","Norvir","Infectious Disease","HIV / AIDS","Cytochrome p450,HIV-1 protease (HIV PR)",
"Approved",,,,,,"Peptide","Oral (PO)","GlaxoSmithKline plc","GSK","Viracept","Infectious Disease","HIV / AIDS","HIV-1 protease (HIV PR)",
"Approved",,"01/29/1996",,,,"Peptide","Oral (PO)","Merck & Co., Inc.","MRK","Crixivan","Infectious Disease","HIV / AIDS","HIV-1 protease (HIV PR)",
"Approved",,,,,,"Peptide","Oral (PO)","Roche Holding AG","RHHBY","Invirase ","Infectious Disease","HIV / AIDS","HIV-1 protease (HIV PR)",
"Approved","12/18/2014","12/18/2014","12/27/2012","12/27/2012",,"Peptide","Oral (PO)","Bausch Health Companies Inc.","BHC","Trulance","Gastroenterology (Non Inflammatory Bowel Disease)","Irritable Bowel Syndrome (IBS)","Guanylyl cyclase c Receptor","06/04/2008"
"Approved","01/14/2009","01/14/2009",,"04/13/2007",,"Peptide","Oral (PO)","Ironwood Pharmaceuticals, Inc.","IRWD","Linzess","Gastroenterology (Non Inflammatory Bowel Disease)","Irritable Bowel Syndrome (IBS)","Guanylyl cyclase c Receptor","05/23/2006"
"Suspended",,,"03/08/2013","03/08/2013","10/10/2007","Peptide","Oral (PO), Intravenous (IV)","Zealand Pharma A/S","ZEAL","Danegaptide","Cardiovascular","Acute Coronary Syndrome (ACS)","Gap Junction","10/10/2007"
"Suspended",,,,"09/14/2010",,"Peptide","Oral (PO), Intravenous (IV), Subcutaneous (SQ)","Stealth BioTherapeutics Inc.","MITO","Elamipretide (Systemic Delivery)","Cardiovascular","Acute Coronary Syndrome (ACS)","Mitochondria,Reactive Oxygen Species/Free Radicals","05/17/2010"
"II/III","05/08/2017","05/08/2017","06/27/2016","06/27/2016","12/20/2012","Peptide","Oral (PO), Intravenous (IV), Subcutaneous (SQ)","Stealth BioTherapeutics Inc.","MITO","Elamipretide (Systemic Delivery)","Cardiovascular","Congestive Heart Failure (CHF) and Cardiomyopathies","Mitochondria,Reactive Oxygen Species/Free Radicals","12/20/2012"
"Suspended","11/06/2017","11/06/2017","06/19/2015","02/17/2015",,"Peptide","Oral (PO), Intravenous (IV), Subcutaneous (SQ)","Stealth BioTherapeutics Inc.","MITO","Elamipretide (Systemic Delivery)","Metabolic","Mitochondrial Respiratory-Chain Diseases","Mitochondria,Reactive Oxygen Species/Free Radicals",
"II",,,"03/28/2019","03/28/2019",,"Peptide","Oral (PO), Intravenous (IV), Subcutaneous (SQ)","Stealth BioTherapeutics Inc.","MITO","Elamipretide (Systemic Delivery)","Ophthalmology","Dry Age-Related Macular Degeneration (Dry AMD)/Geographic Atrophy (Ophthalmology)","Mitochondria,Reactive Oxygen Species/Free Radicals","07/25/2016"
"Suspended",,,,"10/14/2014",,"Peptide","Oral (PO), Intravenous (IV), Subcutaneous (SQ)","Stealth BioTherapeutics Inc.","MITO","Elamipretide (Systemic Delivery)","Orthopedics","Orthopedic Disorder","Mitochondria,Reactive Oxygen Species/Free Radicals",
"Suspended",,,"11/19/2012","11/01/2012",,"Peptide","Oral (PO), Intravenous (IV), Subcutaneous (SQ)","Stealth BioTherapeutics Inc.","MITO","Elamipretide (Systemic Delivery)","Renal","Renal Disease / Renal Failure","Mitochondria,Reactive Oxygen Species/Free Radicals",
"Suspended",,,,"12/03/2009",,"Peptide","Oral (PO), Subcutaneous (SQ)","Constant Therapeutics, LLC",,"TXA127","Autoimmune/immunology","Bone Marrow and Stem Cell Transplant - Graft vs. Host Disease (GVHD) Prophylaxis","Angiotensin II Receptor Type 1 (AT1),Angiotensin II Receptor Type 2 (AT2)",
"Suspended",,,,,,"Peptide","Oral (PO), Subcutaneous (SQ)","Constant Therapeutics, LLC",,"TXA127","Cardiovascular","Peripheral Arterial Disease (PAD)","Angiotensin II Receptor Type 1 (AT1),Angiotensin II Receptor Type 2 (AT2)",
"Suspended",,,,,,"Peptide","Oral (PO), Subcutaneous (SQ)","Constant Therapeutics, LLC",,"TXA127","Cardiovascular","Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension (PH)","Angiotensin II Receptor Type 1 (AT1),Angiotensin II Receptor Type 2 (AT2)",
"Investigator Initiated",,,,,,"Peptide","Oral (PO), Subcutaneous (SQ)","Constant Therapeutics, LLC",,"TXA127","Infectious Disease","COVID-19 Treatment","Angiotensin II Receptor Type 1 (AT1),Angiotensin II Receptor Type 2 (AT2)",
"IND",,,,,,"Peptide","Oral (PO), Subcutaneous (SQ)","Constant Therapeutics, LLC",,"TXA127","Metabolic","Duchenne Muscular Dystrophy (DMD)","Angiotensin II Receptor Type 1 (AT1),Angiotensin II Receptor Type 2 (AT2)",
"Preclinical",,,,,,"Peptide","Oral (PO), Subcutaneous (SQ)","Constant Therapeutics, LLC",,"TXA127","Metabolic","Epidermolysis Bullosa","Angiotensin II Receptor Type 1 (AT1),Angiotensin II Receptor Type 2 (AT2)",
"Preclinical",,,,,,"Peptide","Oral (PO), Subcutaneous (SQ)","Constant Therapeutics, LLC",,"TXA127","Neurology","Ischemic Stroke","Angiotensin II Receptor Type 1 (AT1),Angiotensin II Receptor Type 2 (AT2)",
"Suspended",,,,,,"Peptide","Oral (PO), Subcutaneous (SQ)","Constant Therapeutics, LLC",,"TXA127","Oncology","Myelodysplastic Syndrome (MDS)","Angiotensin II Receptor Type 1 (AT1),Angiotensin II Receptor Type 2 (AT2)","06/28/2010"
"Suspended",,,,,,"Peptide","Oral (PO), Sublingual (SL)/Oral Transmucosal","Eastgate Biotech Corporation","ETBI","EGP-1214","Endocrine","Diabetes Mellitus, Type II","Insulin Receptor",
"Suspended",,,,,,"Peptide","Rectal","Oramed Pharmaceuticals Inc.","ORMP","ORMD-0802","Endocrine","Diabetes Mellitus, Type I","Insulin Receptor","02/04/2009"
"Preclinical",,,,,,"Peptide","Subcutaneous (SQ)","Mymetics Corporation","MYMX","Virosomes Allergy Program (Anergis/Mymetics)","Allergy","Allergic Rhinitis","Immune System",
"Suspended",,,,,,"Peptide","Subcutaneous (SQ)","Kineta, Inc.",,"Dalazatide","Autoimmune/immunology","Antineutrophil Cytoplasmic Antibodies (ANCA) Associated Vasculitis","Potassium channels","05/10/2016"
"II",,,"12/04/2019","10/10/2019",,"Peptide","Subcutaneous (SQ)","Ra Pharmaceuticals, Inc.","RARX","Zilucoplan","Autoimmune/immunology","Autoimmune Disorders","C5a Receptor,Complement Pathway",
"Preclinical",,,,,,"Peptide","Subcutaneous (SQ)","Ra Pharmaceuticals, Inc.","RARX","Zilucoplan ER","Autoimmune/immunology","Complement Deficiencies / Abnormalities","C5a Receptor,Complement Pathway",
"Suspended",,,"10/07/2003","10/07/2003",,"Peptide","Subcutaneous (SQ)","Takeda Pharmaceutical Co. Ltd.","TAK","Gattex","Autoimmune/immunology","Crohn's Disease","GLP-2 Receptor",
"Suspended",,,,,,"Peptide","Subcutaneous (SQ)","SciClone Pharmaceuticals, Inc.","SCLN","Zadaxin","Autoimmune/immunology","DiGeorge Syndrome","Immune System",
"Suspended",,,,,,"Peptide","Subcutaneous (SQ)","Eli Lilly and Company","LLY","Pegilodecakin","Autoimmune/immunology","Inflammatory Bowel Disease (IBD)","IL-10 (Interleukin-10) and IL-10 Receptor (IL-10R)",
"Suspended",,,,,"02/03/2009","Peptide","Subcutaneous (SQ)","Zealand Pharma A/S","ZEAL","Glepaglutide","Autoimmune/immunology","Inflammatory Bowel Disease (IBD)","GLP-2 Receptor","02/03/2009"
"Suspended",,,,"12/22/2008",,"Peptide","Subcutaneous (SQ)","SciClone Pharmaceuticals, Inc.","SCLN","SCV-07","Autoimmune/immunology","Mucositis","STAT3 Transcription Factor",
"III","10/02/2019","10/02/2019","10/18/2017","10/11/2017","12/02/2015","Peptide","Subcutaneous (SQ)","Ra Pharmaceuticals, Inc.","RARX","Zilucoplan","Autoimmune/immunology","Myasthenia Gravis (MG)","C5a Receptor,Complement Pathway","12/02/2015"
"Preclinical",,,,,,"Peptide","Subcutaneous (SQ)","Ra Pharmaceuticals, Inc.","RARX","RA101348","Autoimmune/immunology","Paroxysmal Nocturnal Hemoglobinuria (PNH)","Complement Pathway",
"Program Hold",,,"04/26/2017","03/08/2017","12/02/2015","Peptide","Subcutaneous (SQ)","Ra Pharmaceuticals, Inc.","RARX","Zilucoplan","Autoimmune/immunology","Paroxysmal Nocturnal Hemoglobinuria (PNH)","C5a Receptor,Complement Pathway","12/02/2015"
"Suspended",,,,,"10/14/2014","Peptide","Subcutaneous (SQ)","Kineta, Inc.",,"Dalazatide","Autoimmune/immunology","Psoriasis","Potassium channels","10/14/2014"
"Suspended",,,,,,"Peptide","Subcutaneous (SQ)","Kineta, Inc.",,"Dalazatide","Autoimmune/immunology","Psoriatic Arthritis (PA)","Potassium channels","08/21/2012"
"Suspended",,,,,,"Peptide","Subcutaneous (SQ)","Kineta, Inc.",,"Dalazatide","Autoimmune/immunology","Rheumatoid Arthritis (RA)","Potassium channels","05/10/2016"
"Suspended",,,,,,"Peptide","Subcutaneous (SQ)","Eton Pharmaceuticals, Inc.","ETON","CT-100","Autoimmune/immunology","Rheumatoid Arthritis (RA)","Corticotropin / Adrenocorticotropic Hormone (ACTH),Corticotropin Releasing Factor (CRF) / Corticotropin Releasing Hormone (CRH)","05/09/2017"
"Suspended",,,"12/01/2008","09/27/2010",,"Peptide","Subcutaneous (SQ)","Daval International Limited",,"Aimspro","Autoimmune/immunology","Scleroderma","Unknown",
"Suspended",,,,,,"Peptide","Subcutaneous (SQ)","XTL Biopharmaceuticals Ltd.","XTLB","hCDR1","Autoimmune/immunology","Sjogren's Syndrome","Immune System",
"Preclinical",,,,,,"Peptide","Subcutaneous (SQ)","Kineta, Inc.",,"Dalazatide","Autoimmune/immunology","Sporadic Inclusion Body Myositis (sIBM)","Potassium channels",
"II",,,"10/01/2005","10/01/2005",,"Peptide","Subcutaneous (SQ)","XTL Biopharmaceuticals Ltd.","XTLB","hCDR1","Autoimmune/immunology","Systemic Lupus Erythematosus (SLE)","Immune System",
"III","03/02/2011","03/02/2011","07/05/2006","07/05/2006",,"Peptide","Subcutaneous (SQ)","Avion Pharmaceuticals, LLC",,"Lupuzor","Autoimmune/immunology","Systemic Lupus Erythematosus (SLE)","T lymphocytes","05/10/2006"
"Suspended",,,,,,"Peptide","Subcutaneous (SQ)","Kineta, Inc.",,"Dalazatide","Autoimmune/immunology","Systemic Lupus Erythematosus (SLE)","Potassium channels","05/10/2016"
"Preclinical",,,,,,"Peptide","Subcutaneous (SQ)","Promore Pharma AB","PROMO","PXL-01","Autoimmune/immunology","Wound Healing","Lactoferrin Receptor",
"II",,,,"12/15/2020",,"Peptide","Subcutaneous (SQ)","Eli Lilly and Company","LLY","Tirzepatide","Cardiovascular","Congestive Heart Failure (CHF) and Cardiomyopathies","GIP Receptor (GIPR)/Glucose-Dependent Insulinotropic Polypeptide Receptor,GLP-1 Receptor",
"II",,,,"09/22/2008","10/31/2007","Peptide","Subcutaneous (SQ)","Palatin Technologies, Inc.","PTN","PL-3994","Cardiovascular","Congestive Heart Failure (CHF) and Cardiomyopathies","Natriuretic Peptide Receptors","10/31/2007"
"Investigator Initiated",,,"10/16/2013",,,"Peptide","Subcutaneous (SQ)","Novo Nordisk A/S","NVO","Victoza","Cardiovascular","Congestive Heart Failure (CHF) and Cardiomyopathies","GLP-1 Receptor",
"Preclinical",,,,,,"Peptide","Subcutaneous (SQ)","Antlia Bioscience, Inc.",,"LANA-CF","Cardiovascular","Congestive Heart Failure (CHF) and Cardiomyopathies","Unknown",
"Suspended",,,,"12/27/2002",,"Peptide","Subcutaneous (SQ)","Bristol Myers Squibb Company","BMY","AC2592","Cardiovascular","Congestive Heart Failure (CHF) and Cardiomyopathies","GLP-1 Receptor",
"Suspended",,,,"09/30/2010",,"Peptide","Subcutaneous (SQ)","GlaxoSmithKline plc","GSK","Tanzeum","Cardiovascular","Congestive Heart Failure (CHF) and Cardiomyopathies","GLP-1 Receptor",
"Suspended","12/02/2013","12/02/2013",,,,"Peptide","Subcutaneous (SQ)","Takeda Pharmaceutical Co. Ltd.","TAK","Firazyr","Cardiovascular","Drug-induced Angioedema","Bradykinin B2 Receptor","02/17/2003"
"I",,,,,"11/01/2019","Peptide","Subcutaneous (SQ)","Novo Nordisk A/S","NVO","NN6434","Cardiovascular","Dyslipidemia / Hypercholesterolemia","Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9)","08/20/2019"
"Suspended",,,,,,"Peptide","Subcutaneous (SQ)","Eli Lilly and Company","LLY","Pegilodecakin","Cardiovascular","Dyslipidemia / Hypercholesterolemia","IL-10 (Interleukin-10) and IL-10 Receptor (IL-10R)",
"Program Hold",,,"05/20/2008","05/20/2008",,"Peptide","Subcutaneous (SQ)","Palatin Technologies, Inc.","PTN","PL-3994","Cardiovascular","Hypertension (Systemic)","Natriuretic Peptide Receptors","02/11/2008"
"NDA","12/12/2016","12/12/2016","01/13/2014","01/13/2014",,"Peptide","Subcutaneous (SQ)","BioMarin Pharmaceutical Inc.","BMRN","Vosoritide","Endocrine","Achondroplasia","Natriuretic Peptide Receptors","01/03/2012"
"I",,,,,,"Peptide","Subcutaneous (SQ)","Enesi Pharma Limited",,"Glide Octreotide","Endocrine","Acromegaly","Somatostatin Receptors","05/19/2016"
"III","07/18/2019","07/18/2019",,,,"Peptide","Subcutaneous (SQ)","Novartis AG","NVS","CAM2029","Endocrine","Acromegaly","Somatostatin Receptors",
"Suspended",,,,,,"Peptide","Subcutaneous (SQ)","Italfarmaco S.p.A.",,"ITF-2984","Endocrine","Acromegaly","Somatostatin Receptors",
"Suspended",,,,,"05/21/2018","Peptide","Subcutaneous (SQ)","Midatech Pharma PLC","MTPH","Q-Octreotide","Endocrine","Acromegaly","Somatostatin Receptors","05/21/2018"
"I",,,,,"03/20/2019","Peptide","Subcutaneous (SQ)","Arecor Ltd.",,"AT247","Endocrine","Diabetes Mellitus, Type I","Insulin Receptor","03/20/2019"
"I",,,,,"02/25/2016","Peptide","Subcutaneous (SQ)","Gan & Lee Pharmaceuticals",,"Basalin","Endocrine","Diabetes Mellitus, Type I","Insulin Receptor","02/25/2016"
"I",,,,,"06/05/2019","Peptide","Subcutaneous (SQ)","Lannett Company, Inc.","LCI","Biosimilar Insulin Glargine (Lannett/HEC)","Endocrine","Diabetes Mellitus, Type I","Insulin Receptor","04/22/2016"
"I",,,,,"10/01/2012","Peptide","Subcutaneous (SQ)","Novo Nordisk A/S","NVO","Insulin icodec","Endocrine","Diabetes Mellitus, Type I","Insulin Receptor","11/20/2012"
"I",,,,,"06/30/2019","Peptide","Subcutaneous (SQ)","Novo Nordisk A/S","NVO","Insulin965","Endocrine","Diabetes Mellitus, Type I","Insulin Receptor","06/30/2019"
"I/II",,,,"11/13/2013",,"Peptide","Subcutaneous (SQ)","Adocia","ADOC:FP","BioChaperone Combo","Endocrine","Diabetes Mellitus, Type I","Insulin Receptor",
"I/II",,,,"11/30/2019","06/01/2017","Peptide","Subcutaneous (SQ)","Adocia","ADOC:FP","BioChaperone Glucagon","Endocrine","Diabetes Mellitus, Type I","Insulin Receptor","06/01/2017"
"I/II",,,,"11/30/2019","08/24/2015","Peptide","Subcutaneous (SQ)","Adocia","ADOC:FP","BioChaperone Lispro U200","Endocrine","Diabetes Mellitus, Type I","Insulin Receptor","08/24/2015"
"II",,,"07/07/2016","06/07/2016",,"Peptide","Subcutaneous (SQ)","Diasome Pharmaceuticals",,"HDV-L","Endocrine","Diabetes Mellitus, Type I","Insulin Receptor",
"II",,,,"01/06/2014",,"Peptide","Subcutaneous (SQ)","Adocia","ADOC:FP","BioChaperone Lispro U100","Endocrine","Diabetes Mellitus, Type I","Insulin Receptor",
"II",,,"07/06/2020","07/06/2020",,"Peptide","Subcutaneous (SQ)","Eli Lilly and Company","LLY","LY3209590","Endocrine","Diabetes Mellitus, Type I","Insulin Receptor",
"III","08/02/2017","08/02/2017",,,,"Peptide","Subcutaneous (SQ)","Sanofi","SNY","SAR341402","Endocrine","Diabetes Mellitus, Type I","Insulin Receptor","02/08/2017"
"III",,"11/01/2018",,,,"Peptide","Subcutaneous (SQ)","Viatris Inc.","VTRS","Biosimilar Insulin Aspart (Mylan/Biocon)","Endocrine","Diabetes Mellitus, Type I","Insulin Receptor","04/11/2018"
"Investigator Initiated",,,,,,"Peptide","Subcutaneous (SQ)","Zealand Pharma A/S","ZEAL","Dasiglucagon","Endocrine","Diabetes Mellitus, Type I","Glucagon Receptor",
"Suspended",,,,,,"Peptide","Subcutaneous (SQ)","Kineta, Inc.",,"Dalazatide","Endocrine","Diabetes Mellitus, Type I","Potassium channels","05/10/2016"
"Suspended",,,,"06/10/2008",,"Peptide","Subcutaneous (SQ)","Diasome Pharmaceuticals",,"HDV-B","Endocrine","Diabetes Mellitus, Type I","Insulin Receptor",
"Suspended",,,"07/07/2016","05/20/2008",,"Peptide","Subcutaneous (SQ)","Diasome Pharmaceuticals",,"HDV-I","Endocrine","Diabetes Mellitus, Type I","Insulin Receptor",
"Suspended",,,,,,"Peptide","Subcutaneous (SQ)","Adocia","ADOC:FP","Biochaperone Lispro Exenatide","Endocrine","Diabetes Mellitus, Type I","Insulin Receptor",
"Suspended",,,,,,"Peptide","Subcutaneous (SQ)","Adocia","ADOC:FP","BioChaperone Lispro U300","Endocrine","Diabetes Mellitus, Type I","Insulin Receptor",
"Suspended",,,,"06/24/2011",,"Peptide","Subcutaneous (SQ)","Adocia","ADOC:FP","HinsBet","Endocrine","Diabetes Mellitus, Type I","Insulin Receptor","03/15/2011"
"Suspended",,,,"01/13/2004",,"Peptide","Subcutaneous (SQ)","AstraZeneca PLC","AZN","Byetta","Endocrine","Diabetes Mellitus, Type I","GLP-1 Receptor",
"Suspended",,,,,,"Peptide","Subcutaneous (SQ)","Boston Therapeutics, Inc.","BTHE","HIP2B","Endocrine","Diabetes Mellitus, Type I","Human proIslet Peptide (HIP) Receptor","07/11/2012"
"Suspended",,,"10/31/2014","10/31/2014",,"Peptide","Subcutaneous (SQ)","GlaxoSmithKline plc","GSK","Tanzeum","Endocrine","Diabetes Mellitus, Type I","GLP-1 Receptor",
"Suspended",,,,"11/03/2008",,"Peptide","Subcutaneous (SQ)","Halozyme Therapeutics, Inc.","HALO","Analog Insulin-PH20","Endocrine","Diabetes Mellitus, Type I","Insulin Receptor","06/09/2008"
"Suspended","10/05/2005","10/05/2005",,"11/26/2001",,"Peptide","Subcutaneous (SQ)","Horizon Therapeutics plc","HZNP","DiaPep277","Endocrine","Diabetes Mellitus, Type I","Toll-Like Receptor 2 (TLR2)",
"Suspended",,"10/17/2011","01/21/2010","01/21/2010",,"Peptide","Subcutaneous (SQ)","Eli Lilly and Company","LLY","LY2605541","Endocrine","Diabetes Mellitus, Type I","Insulin Receptor",
"Suspended",,,,,,"Peptide","Subcutaneous (SQ)","Novo Nordisk A/S","NVO","NN1438","Endocrine","Diabetes Mellitus, Type I","Insulin Receptor","08/27/2014"
"Suspended","05/31/2012","05/31/2012",,"06/04/2011",,"Peptide","Subcutaneous (SQ)","Novo Nordisk A/S","NVO","Victoza","Endocrine","Diabetes Mellitus, Type I","GLP-1 Receptor",
"Suspended",,,,,"07/25/2017","Peptide","Subcutaneous (SQ)","Rezolute, Inc.","RZLT","AB101","Endocrine","Diabetes Mellitus, Type I","Insulin Receptor","07/25/2017"
"Suspended",,,,,,"Peptide","Subcutaneous (SQ)","Sanofi","SNY","SAR161271","Endocrine","Diabetes Mellitus, Type I","Insulin Receptor","04/29/2010"
"Suspended",,,,,"02/13/2015","Peptide","Subcutaneous (SQ)","Sanofi","SNY","SAR440067","Endocrine","Diabetes Mellitus, Type I","Insulin Receptor","02/13/2015"
"Suspended",,,,,,"Peptide","Subcutaneous (SQ)","Sanofi","SNY","TransCon Insulin","Endocrine","Diabetes Mellitus, Type I","Insulin Receptor",
"Suspended",,,,,,"Peptide","Subcutaneous (SQ)","Xenetic Biosciences, Inc.","XBIO","SuliXen","Endocrine","Diabetes Mellitus, Type I","Insulin Receptor","01/28/2008"
"Suspended",,,"04/24/2014","04/24/2014",,"Peptide","Subcutaneous (SQ)","Xeris Pharmaceuticals, Inc.","XERS","Gvoke RTU Micro","Endocrine","Diabetes Mellitus, Type I","Glucagon Receptor",
"Withdrawn from Market","02/28/2014","02/28/2014",,,,"Peptide","Subcutaneous (SQ)","Samsung Bioepis Co., Ltd.","207940.KS","Lusduna Nexvue","Endocrine","Diabetes Mellitus, Type I","Insulin Receptor","01/24/2011"
"I",,,,,"12/19/2018","Peptide","Subcutaneous (SQ)","Carmot Therapeutics Inc.",,"CT-868","Endocrine","Diabetes Mellitus, Type II","GIP Receptor (GIPR)/Glucose-Dependent Insulinotropic Polypeptide Receptor,GLP-1 Receptor","12/19/2018"
"I",,,,,"07/10/2015","Peptide","Subcutaneous (SQ)","Adocia","ADOC:FP","BioChaperone Combo","Endocrine","Diabetes Mellitus, Type II","Insulin Receptor","07/10/2015"
"I",,,,,,"Peptide","Subcutaneous (SQ)","Adocia","ADOC:FP","BioChaperone Lispro U100","Endocrine","Diabetes Mellitus, Type II","Insulin Receptor","09/30/2015"
"I",,,,,"12/12/2016","Peptide","Subcutaneous (SQ)","Eli Lilly and Company","LLY","LY3305677","Endocrine","Diabetes Mellitus, Type II","GLP-1 Receptor,Glucagon Receptor","12/12/2016"
"I",,,,,"03/13/2019","Peptide","Subcutaneous (SQ)","Eli Lilly and Company","LLY","LY3437943","Endocrine","Diabetes Mellitus, Type II","GIP Receptor (GIPR)/Glucose-Dependent Insulinotropic Polypeptide Receptor,GLP-1 Receptor,Glucagon Receptor","03/13/2019"
"I",,,,,"01/17/2019","Peptide","Subcutaneous (SQ)","Novo Nordisk A/S","NVO","Icosema","Endocrine","Diabetes Mellitus, Type II","GLP-1 Receptor,Insulin Receptor","01/17/2019"
"I",,,,,"03/04/2020","Peptide","Subcutaneous (SQ)","Novo Nordisk A/S","NVO","Insulin 147","Endocrine","Diabetes Mellitus, Type II","Insulin Receptor,Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9)","03/04/2020"
"I",,,,,"02/26/2020","Peptide","Subcutaneous (SQ)","Novo Nordisk A/S","NVO","NN9389","Endocrine","Diabetes Mellitus, Type II","GLP-1 Receptor","02/26/2020"
"II",,,"04/30/2020","04/30/2020","08/22/2017","Peptide","Subcutaneous (SQ)","Boehringer Ingelheim GmbH",,"BI 456906","Endocrine","Diabetes Mellitus, Type II","GLP-1 Receptor,Glucagon Receptor","08/22/2017"
"II",,,"07/12/2018","07/12/2018",,"Peptide","Subcutaneous (SQ)","Hanmi Pharmaceutical Co., Ltd.",128940,"Efinopegdutide","Endocrine","Diabetes Mellitus, Type II","GLP-1 Receptor,Glucagon Receptor","03/31/2014"
"II",,,"04/24/2019","11/15/2018",,"Peptide","Subcutaneous (SQ)","Eli Lilly and Company","LLY","LY3209590","Endocrine","Diabetes Mellitus, Type II","Insulin Receptor","10/21/2016"
"II",,,"05/15/2014","05/15/2014","12/12/2011","Peptide","Subcutaneous (SQ)","Opko Health","OPK","OPK-88003","Endocrine","Diabetes Mellitus, Type II","GLP-1 Receptor,Glucagon Receptor","12/12/2011"
"III",,"10/20/2017",,,,"Peptide","Subcutaneous (SQ)","Gan & Lee Pharmaceuticals",,"Basalin","Endocrine","Diabetes Mellitus, Type II","Insulin Receptor",
"III","04/08/2019","12/11/2018","06/04/2017","06/04/2017","05/20/2016","Peptide","Subcutaneous (SQ)","Eli Lilly and Company","LLY","Tirzepatide","Endocrine","Diabetes Mellitus, Type II","GIP Receptor (GIPR)/Glucose-Dependent Insulinotropic Polypeptide Receptor,GLP-1 Receptor","04/29/2016"
"III","12/01/2020","12/01/2020","11/29/2018","11/29/2018",,"Peptide","Subcutaneous (SQ)","Novo Nordisk A/S","NVO","Insulin icodec","Endocrine","Diabetes Mellitus, Type II","Insulin Receptor","01/31/2013"
"III","08/02/2017","08/02/2017",,,,"Peptide","Subcutaneous (SQ)","Sanofi","SNY","SAR341402","Endocrine","Diabetes Mellitus, Type II","Insulin Receptor",
"NDA","03/21/2013","03/21/2013","09/17/2009","09/17/2009",,"Peptide","Subcutaneous (SQ)","Intarcia Therapeutics, Inc.","ITCA","ITCA 650","Endocrine","Diabetes Mellitus, Type II","GLP-1 Receptor","04/24/2009"
"Preclinical",,,,,,"Peptide","Subcutaneous (SQ)","Delpor, Inc.",,"DLP-414","Endocrine","Diabetes Mellitus, Type II","GLP-1 Receptor",
"Preclinical",,,,,,"Peptide","Subcutaneous (SQ)","Enesi Pharma Limited",,"Glide Exenatide","Endocrine","Diabetes Mellitus, Type II","GLP-1 Receptor",
"Preclinical",,,,,,"Peptide","Subcutaneous (SQ)","Rezolute, Inc.","RZLT","AB101","Endocrine","Diabetes Mellitus, Type II","Insulin Receptor",
"Preclinical",,,,,,"Peptide","Subcutaneous (SQ)","Sun Pharma Advanced Research Company Ltd.","SPARC","SDE-124","Endocrine","Diabetes Mellitus, Type II","GLP-1 Receptor",
"Suspended",,,,"05/08/2003",,"Peptide","Subcutaneous (SQ)","ConjuChem, LLC",,"DAC:GLP-1","Endocrine","Diabetes Mellitus, Type II","GLP-1 Receptor",
"Suspended",,,,"11/30/2010",,"Peptide","Subcutaneous (SQ)","ImmunoForge, Co. Ltd.",,"Glymera","Endocrine","Diabetes Mellitus, Type II","GLP-1 Receptor",
"Suspended",,,,,,"Peptide","Subcutaneous (SQ)","Naia Pharmaceuticals, Inc.",,"NM-002","Endocrine","Diabetes Mellitus, Type II","GLP-1 Receptor","01/05/2015"
"Suspended","12/14/2017","12/14/2017",,"10/04/2011",,"Peptide","Subcutaneous (SQ)","Hanmi Pharmaceutical Co., Ltd.",128940,"Efpeglenatide","Endocrine","Diabetes Mellitus, Type II","GLP-1 Receptor",
"Suspended",,,,,,"Peptide","Subcutaneous (SQ)","Adocia","ADOC:FP","BioChaperone Glargine Dulaglutide","Endocrine","Diabetes Mellitus, Type II","GLP-1 Receptor,Insulin Receptor",
"Suspended",,,,,,"Peptide","Subcutaneous (SQ)","Adocia","ADOC:FP","BioChaperone Glargine Liraglutide","Endocrine","Diabetes Mellitus, Type II","GLP-1 Receptor,Insulin Receptor",
"Suspended",,,,,,"Peptide","Subcutaneous (SQ)","Adocia","ADOC:FP","BioChaperone Glucagon","Endocrine","Diabetes Mellitus, Type II","Insulin Receptor",
"Suspended",,,,"08/11/2014","11/07/2013","Peptide","Subcutaneous (SQ)","Albireo Pharma, Inc.","ALBO","BIOD-531","Endocrine","Diabetes Mellitus, Type II","Insulin Receptor","11/07/2013"
"Suspended",,,,,,"Peptide","Subcutaneous (SQ)","Avadel Pharmaceuticals plc","AVDL","FT-105","Endocrine","Diabetes Mellitus, Type II","Insulin Receptor","10/18/2007"
"Suspended",,,,,"08/05/2015","Peptide","Subcutaneous (SQ)","Avadel Pharmaceuticals plc","AVDL","FT228","Endocrine","Diabetes Mellitus, Type II","GLP-1 Receptor","08/05/2015"
"Suspended",,,"08/02/2017","03/30/2015","03/30/2015","Peptide","Subcutaneous (SQ)","AstraZeneca PLC","AZN","Cotadutide","Endocrine","Diabetes Mellitus, Type II","GLP-1 Receptor,Glucagon Receptor",
"Suspended",,,,,,"Peptide","Subcutaneous (SQ)","Boston Scientific Corporation","BSX","CM-3","Endocrine","Diabetes Mellitus, Type II","GLP-1 Receptor","12/22/2008"
"Suspended",,,,,,"Peptide","Subcutaneous (SQ)","Boston Therapeutics, Inc.","BTHE","HIP2B","Endocrine","Diabetes Mellitus, Type II","Human proIslet Peptide (HIP) Receptor","07/11/2012"
"Suspended",,,,,,"Peptide","Subcutaneous (SQ)","Zydus Cadila","CDH","ZYD1","Endocrine","Diabetes Mellitus, Type II","GLP-1 Receptor","04/07/2011"
"Suspended",,,"07/14/2009","07/14/2009",,"Peptide","Subcutaneous (SQ)","Halozyme Therapeutics, Inc.","HALO","Analog Insulin-PH20","Endocrine","Diabetes Mellitus, Type II","Insulin Receptor","06/09/2008"
"Suspended",,"06/09/2008",,"06/10/2006",,"Peptide","Subcutaneous (SQ)","Ipsen SA","IPSEY","Taspoglutide","Endocrine","Diabetes Mellitus, Type II","GLP-1 Receptor",
"Suspended",,,,,,"Peptide","Subcutaneous (SQ)","Eli Lilly and Company","LLY","DACRA-089","Endocrine","Diabetes Mellitus, Type II","Amylin Receptor,Calcitonin Receptor",
"Suspended",,,,"12/08/2008",,"Peptide","Subcutaneous (SQ)","Eli Lilly and Company","LLY","LY2428757","Endocrine","Diabetes Mellitus, Type II","GLP-1 Receptor",
"Suspended",,"10/26/2011","01/15/2010","01/15/2010",,"Peptide","Subcutaneous (SQ)","Eli Lilly and Company","LLY","LY2605541","Endocrine","Diabetes Mellitus, Type II","Insulin Receptor",
"Suspended",,,,,,"Peptide","Subcutaneous (SQ)","Millendo Therapeutics, Inc.","MLND","Livoletide","Endocrine","Diabetes Mellitus, Type II","Ghrelin Receptor","07/15/2013"
"Suspended",,,,,,"Peptide","Subcutaneous (SQ)","Novo Nordisk A/S","NVO","PYY 1562","Endocrine","Diabetes Mellitus, Type II","Neuropeptide Y (NPY)/Peptide YY (PYY) Receptors","04/29/2016"
"Suspended",,,,,,"Peptide","Subcutaneous (SQ)","Opko Health","OPK","MOD-6030","Endocrine","Diabetes Mellitus, Type II","GLP-1 Receptor,Glucagon Receptor",
"Suspended",,,,,"03/16/2016","Peptide","Subcutaneous (SQ)","Opko Health","OPK","MOD-6031","Endocrine","Diabetes Mellitus, Type II","GLP-1 Receptor,Glucagon Receptor","03/16/2016"
"Suspended",,,"10/20/2015","10/20/2015","06/04/2013","Peptide","Subcutaneous (SQ)","PhaseBio Pharmaceuticals, Inc.","PHAS","PE0139","Endocrine","Diabetes Mellitus, Type II","Insulin Receptor","06/04/2013"
"Suspended",,,,,,"Peptide","Subcutaneous (SQ)","Roche Holding AG","RHHBY","RO5095932","Endocrine","Diabetes Mellitus, Type II","Neuropeptide Y (NPY)/Peptide YY (PYY) Receptors","08/18/2009"
"Suspended",,,,,"06/13/2012","Peptide","Subcutaneous (SQ)","Rhythm Pharmaceuticals, Inc.","RYTM","Imcivree","Endocrine","Diabetes Mellitus, Type II","Insulin Receptor,Melanocortin (MC) receptors","06/13/2012"
"Suspended",,,,,,"Peptide","Subcutaneous (SQ)","Rezolute, Inc.","RZLT","AB301","Endocrine","Diabetes Mellitus, Type II","GLP-1 Receptor,Insulin Receptor",
"Suspended",,,,,,"Peptide","Subcutaneous (SQ)","Sanofi","SNY","AVE0010 Prolonged Release","Endocrine","Diabetes Mellitus, Type II","GLP-1 Receptor","02/12/2008"
"Suspended",,,,,,"Peptide","Subcutaneous (SQ)","Sanofi","SNY","HM14220","Endocrine","Diabetes Mellitus, Type II","GLP-1 Receptor,Insulin Receptor",
"Suspended",,,,,,"Peptide","Subcutaneous (SQ)","Sanofi","SNY","SAR161271","Endocrine","Diabetes Mellitus, Type II","Insulin Receptor","04/29/2010"
"Suspended",,,"12/01/2016","12/01/2016","07/31/2014","Peptide","Subcutaneous (SQ)","Sanofi","SNY","SAR425899","Endocrine","Diabetes Mellitus, Type II","GLP-1 Receptor,Glucagon Receptor","07/31/2014"
"Suspended",,,,,"02/13/2015","Peptide","Subcutaneous (SQ)","Sanofi","SNY","SAR440067","Endocrine","Diabetes Mellitus, Type II","Insulin Receptor","02/13/2015"
"Suspended",,,,,"07/29/2019","Peptide","Subcutaneous (SQ)","Sanofi","SNY","SAR441255","Endocrine","Diabetes Mellitus, Type II","GIP Receptor (GIPR)/Glucose-Dependent Insulinotropic Polypeptide Receptor,GLP-1 Receptor,Glucagon Receptor","07/29/2019"
"Suspended",,,,,,"Peptide","Subcutaneous (SQ)","Sanofi","SNY","TransCon Insulin","Endocrine","Diabetes Mellitus, Type II","Insulin Receptor",
"Suspended",,,,,,"Peptide","Subcutaneous (SQ)","Xenetic Biosciences, Inc.","XBIO","PSA-Oxyntomodulin","Endocrine","Diabetes Mellitus, Type II","GLP-1 Receptor,Glucagon Receptor",
"Suspended",,,,,,"Peptide","Subcutaneous (SQ)","Xenetic Biosciences, Inc.","XBIO","SuliXen","Endocrine","Diabetes Mellitus, Type II","Insulin Receptor","01/28/2008"
"Suspended",,,,,"09/13/2012","Peptide","Subcutaneous (SQ)","Zealand Pharma A/S","ZEAL","ZP2929","Endocrine","Diabetes Mellitus, Type II","GLP-1 Receptor,Glucagon Receptor","09/13/2012"
"Suspended",,,,,,"Peptide","Subcutaneous (SQ)","Zealand Pharma A/S","ZEAL","ZP3022","Endocrine","Diabetes Mellitus, Type II","Cholecystokinin 2 (CCK2 or CCKB) / Gastrin receptor,GLP-1 Receptor",
"Withdrawn from Market","02/28/2014","02/28/2014",,,,"Peptide","Subcutaneous (SQ)","Samsung Bioepis Co., Ltd.","207940.KS","Lusduna Nexvue","Endocrine","Diabetes Mellitus, Type II","Insulin Receptor","01/24/2011"
"Withdrawn from Market","02/17/2009","02/17/2009",,"03/02/2007",,"Peptide","Subcutaneous (SQ)","GlaxoSmithKline plc","GSK","Tanzeum","Endocrine","Diabetes Mellitus, Type II","GLP-1 Receptor","05/10/2006"
"II",,,,"09/25/2020",,"Peptide","Subcutaneous (SQ)","AstraZeneca PLC","AZN","Cotadutide","Endocrine","Diabetic Nephropathy","GLP-1 Receptor,Glucagon Receptor",
"III","06/18/2019","06/18/2019",,,,"Peptide","Subcutaneous (SQ)","Novo Nordisk A/S","NVO","Ozempic","Endocrine","Diabetic Nephropathy","GLP-1 Receptor",
"Suspended","06/02/2015",,,,,"Peptide","Subcutaneous (SQ)","Mundipharma International Limited",,"Eligard","Endocrine","Endocrine Disorder","Gonadotropin-Releasing Hormone (GnRH) Receptor",
"NDA","06/28/2017","06/28/2017","01/27/2016","01/27/2016",,"Peptide","Subcutaneous (SQ)","Zealand Pharma A/S","ZEAL","Dasiglucagon","Endocrine","Hyperinsulinemia/Hypoglycemia","Glucagon Receptor","11/17/2014"
"Preclinical",,,,,,"Peptide","Subcutaneous (SQ)","Adocia","ADOC:FP","BioChaperone Glucagon","Endocrine","Hyperinsulinemia/Hypoglycemia","Insulin Receptor",
"Suspended",,,,,,"Peptide","Subcutaneous (SQ)","Novo Nordisk A/S","NVO","Hypopen-1513","Endocrine","Hyperinsulinemia/Hypoglycemia","Glucagon Receptor","02/22/2018"
"Suspended",,,"03/03/2015","03/03/2015",,"Peptide","Subcutaneous (SQ)","Myovant Sciences Ltd.","MYOV","RVT-602","Endocrine","Hypogonadism","Gonadotropin-Releasing Hormone (GnRH)",
"II",,,"09/23/2019","09/23/2019",,"Peptide","Subcutaneous (SQ)","AstraZeneca PLC","AZN","Cotadutide","Endocrine","Non-Alcoholic Steatohepatitis (NASH)","GLP-1 Receptor,Glucagon Receptor","06/01/2018"
"II",,,"11/18/2019","11/18/2019",,"Peptide","Subcutaneous (SQ)","Eli Lilly and Company","LLY","Tirzepatide","Endocrine","Non-Alcoholic Steatohepatitis (NASH)","GIP Receptor (GIPR)/Glucose-Dependent Insulinotropic Polypeptide Receptor,GLP-1 Receptor","06/08/2019"
"II",,,"11/30/2016","11/30/2016","11/28/2017","Peptide","Subcutaneous (SQ)","Novo Nordisk A/S","NVO","Ozempic","Endocrine","Non-Alcoholic Steatohepatitis (NASH)","GLP-1 Receptor",
"Preclinical",,,,,,"Peptide","Subcutaneous (SQ)","Boehringer Ingelheim GmbH",,"BI 456906","Endocrine","Non-Alcoholic Steatohepatitis (NASH)","GLP-1 Receptor,Glucagon Receptor",
"Preclinical",,,,,,"Peptide","Subcutaneous (SQ)","Hanmi Pharmaceutical Co., Ltd.",128940,"Efinopegdutide","Endocrine","Non-Alcoholic Steatohepatitis (NASH)","GLP-1 Receptor,Glucagon Receptor",
"Preclinical",,,,,,"Peptide","Subcutaneous (SQ)","Sanofi","SNY","SAR425899","Endocrine","Non-Alcoholic Steatohepatitis (NASH)","GLP-1 Receptor,Glucagon Receptor",
"Suspended",,,,,,"Peptide","Subcutaneous (SQ)","Eli Lilly and Company","LLY","Pegilodecakin","Endocrine","Non-Alcoholic Steatohepatitis (NASH)","IL-10 (Interleukin-10) and IL-10 Receptor (IL-10R)",
"Suspended",,,,,,"Peptide","Subcutaneous (SQ)","Novo Nordisk A/S","NVO","Victoza","Endocrine","Non-Alcoholic Steatohepatitis (NASH)","GLP-1 Receptor",
"Suspended",,,,,,"Peptide","Subcutaneous (SQ)","Enesi Pharma Limited",,"Glide Teriparatide","Endocrine","Osteoporosis / Osteopenia","Parathyroid Hormone Receptor (PTHR)",
"Suspended",,,,"08/21/2009",,"Peptide","Subcutaneous (SQ)","Nordic Bioscience A/S",,"SAN 134","Endocrine","Osteoporosis / Osteopenia","GLP-2 Receptor",
"Withdrawn from Market",,,,,,"Peptide","Subcutaneous (SQ)","Novartis AG","NVS","Cibacalcin","Endocrine","Osteoporosis / Osteopenia","Calcitonin Receptor",
"Withdrawn from Market",,,,,,"Peptide","Subcutaneous (SQ)","Novartis AG","NVS","Cibacalcin","Endocrine","Paget Disease of Bone","Calcitonin Receptor",
"II",,,"06/04/2015","06/04/2015",,"Peptide","Subcutaneous (SQ)","Rhythm Pharmaceuticals, Inc.","RYTM","Imcivree","Endocrine","Prader-Willi Syndrome","Insulin Receptor,Melanocortin (MC) receptors",
"III",,"08/17/2015",,,,"Peptide","Subcutaneous (SQ)","Novo Nordisk A/S","NVO","Victoza","Endocrine","Prader-Willi Syndrome","GLP-1 Receptor",
"Suspended","03/14/2019","03/14/2019",,,,"Peptide","Subcutaneous (SQ)","Millendo Therapeutics, Inc.","MLND","Livoletide","Endocrine","Prader-Willi Syndrome","Ghrelin Receptor",
"Preclinical",,,,,,"Peptide","Subcutaneous (SQ)","ImmunoForge, Co. Ltd.",,"Glymera","Endocrine","Sarcopenia","GLP-1 Receptor",
"Suspended",,,,,"01/24/2013","Peptide","Subcutaneous (SQ)","Aileron Therapeutics, Inc","ALRN","ALRN-5281","Endocrine","Short Stature / Growth Hormone Deficiency","Growth Hormone Releasing Hormone (GHRH) Receptor","01/24/2013"
"II",,,"04/16/2013","04/16/2013",,"Peptide","Subcutaneous (SQ)","Allergan plc","AGN","Relamorelin","Gastroenterology (Non Inflammatory Bowel Disease)","Chronic Idiopathic Constipation","Ghrelin Receptor",
"III","10/05/2017","10/05/2017","05/04/2012","05/04/2012",,"Peptide","Subcutaneous (SQ)","Allergan plc","AGN","Relamorelin","Gastroenterology (Non Inflammatory Bowel Disease)","Diabetic Gastroparesis","Ghrelin Receptor","07/15/2011"
"Suspended",,,,"04/14/2010",,"Peptide","Subcutaneous (SQ)","7TM Pharma A/S",,"TM30339","Gastroenterology (Non Inflammatory Bowel Disease)","Gastroenterologic Disorders","Neuropeptide Y (NPY)/Peptide YY (PYY) Receptors",
"Suspended",,,,,,"Peptide","Subcutaneous (SQ)","Kineta, Inc.",,"Dalazatide","Gastroenterology (Non Inflammatory Bowel Disease)","Irritable Bowel Syndrome (IBS)","Potassium channels","05/10/2016"
"Suspended",,,,,,"Peptide","Subcutaneous (SQ)","Digna Biotech, S.L.",,"P17","Gastroenterology (Non Inflammatory Bowel Disease)","Liver Failure / Cirrhosis","Transforming Growth Factor-beta (TGF-beta) and Superfamily",
"Suspended",,,,,,"Peptide","Subcutaneous (SQ)","BioVie, Inc.","BIVI","PHT101","Gastroenterology (Non Inflammatory Bowel Disease)","Liver Failure / Cirrhosis","Vasopressin receptors",
"Preclinical",,,,,,"Peptide","Subcutaneous (SQ)","Takeda Pharmaceutical Co. Ltd.","TAK","Gattex","Gastroenterology (Non Inflammatory Bowel Disease)","Necrotizing Enterocolitis (NEC)","GLP-2 Receptor",
"I",,,,,,"Peptide","Subcutaneous (SQ)","Takeda Pharmaceutical Co. Ltd.","TAK","TAK-681","Gastroenterology (Non Inflammatory Bowel Disease)","Short Bowel Syndrome (SBS)","GLP-2 Receptor","03/26/2019"
"I",,,,,"06/26/2019","Peptide","Subcutaneous (SQ)","Zealand Pharma A/S","ZEAL","ZP7570","Gastroenterology (Non Inflammatory Bowel Disease)","Short Bowel Syndrome (SBS)","GLP-1 Receptor,GLP-2 Receptor","06/26/2019"
"I/II",,,,"06/24/2020",,"Peptide","Subcutaneous (SQ)","Naia Pharmaceuticals, Inc.",,"NM-002","Gastroenterology (Non Inflammatory Bowel Disease)","Short Bowel Syndrome (SBS)","GLP-1 Receptor",
"III","10/04/2018","10/04/2018","09/17/2015","09/17/2015",,"Peptide","Subcutaneous (SQ)","Zealand Pharma A/S","ZEAL","Glepaglutide","Gastroenterology (Non Inflammatory Bowel Disease)","Short Bowel Syndrome (SBS)","GLP-2 Receptor",
"Preclinical",,,,,,"Peptide","Subcutaneous (SQ)","Naia Pharmaceuticals, Inc.",,"NB1002","Gastroenterology (Non Inflammatory Bowel Disease)","Short Bowel Syndrome (SBS)","GLP-2 Receptor",
"I/II",,,,"11/23/2015","11/23/2015","Peptide","Subcutaneous (SQ)","BioLineRx Ltd.","BLRX","Motixafortide","Hematology","Aplastic Anemia","Chemokine (C-X-C motif) Receptor 4 (CXCR4)",
"I",,,,,"01/08/2018","Peptide","Subcutaneous (SQ)","Ra Pharmaceuticals, Inc.","RARX","Zilucoplan","Hematology","Hemolytic Uremic Syndrome (HUS)","C5a Receptor,Complement Pathway","01/08/2018"
"Preclinical",,,,,,"Peptide","Subcutaneous (SQ)","La Jolla Pharmaceutical Company","LJPC","LJPC-401","Hematology","Sickle Cell Anemia","Hepcidin",
"II",,,"12/04/2017","12/04/2017","10/19/2015","Peptide","Subcutaneous (SQ)","La Jolla Pharmaceutical Company","LJPC","LJPC-401","Hematology","Thalassemia","Hepcidin","10/19/2015"
"Suspended",,,"01/09/2019","01/09/2019","05/25/2017","Peptide","Subcutaneous (SQ)","Protagonist Therapeutics, Inc.","PTGX","PTG-300","Hematology","Thalassemia","Hepcidin","05/25/2017"
"Suspended",,,,,,"Peptide","Subcutaneous (SQ)","BioLineRx Ltd.","BLRX","Motixafortide","Hematology","Thrombocytopenia","Chemokine (C-X-C motif) Receptor 4 (CXCR4)",
"II",,,"07/07/2020","07/07/2020",,"Peptide","Subcutaneous (SQ)","Ra Pharmaceuticals, Inc.","RARX","Zilucoplan","Infectious Disease","COVID-19 Treatment","C5a Receptor,Complement Pathway",
"Investigator Initiated",,,,,,"Peptide","Subcutaneous (SQ)","Takeda Pharmaceutical Co. Ltd.","TAK","Firazyr","Infectious Disease","COVID-19 Treatment","Bradykinin B2 Receptor",
"Preclinical",,,,,,"Peptide","Subcutaneous (SQ)","Chrysalis BioTherapeutics, Inc.",,"TP508","Infectious Disease","COVID-19 Treatment","Thrombin (Coagulation Factor IIa)",
"Preclinical",,,,,,"Peptide","Subcutaneous (SQ)","BioLineRx Ltd.","BLRX","Motixafortide","Infectious Disease","COVID-19 Treatment","Chemokine (C-X-C motif) Receptor 4 (CXCR4)",
"Preclinical",,,,,,"Peptide","Subcutaneous (SQ)","ValiRx Plc","VAL","VAL201","Infectious Disease","COVID-19 Treatment","Androgen receptors,Src Kinase Family",
"Suspended",,,"06/27/2007","06/27/2007",,"Peptide","Subcutaneous (SQ)","SciClone Pharmaceuticals, Inc.","SCLN","SCV-07","Infectious Disease","Hepatitis C (HCV) (Antiviral)","STAT3 Transcription Factor",
"III","04/17/2019","04/17/2019",,"10/23/2018",,"Peptide","Subcutaneous (SQ)","MYR GmbH",,"Hepcludex","Infectious Disease","Hepatitis D (HDV) (Antiviral)","Hepatitis B/HBV,Hepatitis D/HDV",
"I",,,,,,"Peptide","Subcutaneous (SQ)","Navigen Inc",,"CPT31","Infectious Disease","HIV / AIDS","gp41","12/14/2020"
"Suspended",,,,,,"Peptide","Subcutaneous (SQ)","SciClone Pharmaceuticals, Inc.","SCLN","SCV-07","Infectious Disease","Influenza (excluding vaccines)","STAT3 Transcription Factor","03/06/2006"
"Investigator Initiated",,,,,,"Peptide","Subcutaneous (SQ)","AstraZeneca PLC","AZN","Byetta","Infectious Disease","Sepsis and Septic Shock","GLP-1 Receptor",
"Suspended",,,,"09/28/2002",,"Peptide","Subcutaneous (SQ)","SciClone Pharmaceuticals, Inc.","SCLN","SCV-07","Infectious Disease","Tuberculosis","STAT3 Transcription Factor","11/01/2005"
"Suspended",,,,"01/31/2008",,"Peptide","Subcutaneous (SQ)","Oxeia Biopharmaceuticals, Inc.",,"OXE-103","Metabolic","Cachexia / Weight Loss","Ghrelin Receptor",
"Suspended",,,,"12/06/2004",,"Peptide","Subcutaneous (SQ)","AKELA Pharma Inc.","AKLPF","AKL-0707","Metabolic","Cachexia / Weight Loss","Growth Hormone Releasing Hormone (GHRH) Receptor",
"Investigator Initiated",,,,,,"Peptide","Subcutaneous (SQ)","Shionogi & Co. Ltd.",4507,"S-005151","Metabolic","Epidermolysis Bullosa",,
"I",,,,,"02/26/2020","Peptide","Subcutaneous (SQ)","Novo Nordisk A/S","NVO","NN9389","Metabolic","Obesity","GLP-1 Receptor","02/26/2020"
"I",,,,,"10/15/2018","Peptide","Subcutaneous (SQ)","Novo Nordisk A/S","NVO","PYY1875","Metabolic","Obesity","Neuropeptide Y (NPY)/Peptide YY (PYY) Receptors","10/15/2018"
"II",,,"04/30/2020","04/30/2020","08/22/2017","Peptide","Subcutaneous (SQ)","Boehringer Ingelheim GmbH",,"BI 456906","Metabolic","Obesity","GLP-1 Receptor,Glucagon Receptor","08/22/2017"
"II",,,,"03/26/2018",,"Peptide","Subcutaneous (SQ)","Hanmi Pharmaceutical Co., Ltd.",128940,"Efinopegdutide","Metabolic","Obesity","GLP-1 Receptor,Glucagon Receptor",
"II",,,,"02/27/2014",,"Peptide","Subcutaneous (SQ)","Hanmi Pharmaceutical Co., Ltd.",128940,"Efpeglenatide","Metabolic","Obesity","GLP-1 Receptor",
"III","12/04/2019","12/04/2019",,,"09/13/2019","Peptide","Subcutaneous (SQ)","Eli Lilly and Company","LLY","Tirzepatide","Metabolic","Obesity","GIP Receptor (GIPR)/Glucose-Dependent Insulinotropic Polypeptide Receptor,GLP-1 Receptor","09/13/2019"
"Investigator Initiated",,,,,,"Peptide","Subcutaneous (SQ)","Arrowhead Pharmaceuticals, Inc.","ARWR","Adipotide","Metabolic","Obesity","Mitochondria,Prohibitin (PHB)","05/25/2012"
"Investigator Initiated",,,"12/08/2014",,,"Peptide","Subcutaneous (SQ)","AstraZeneca PLC","AZN","Bydureon","Metabolic","Obesity","GLP-1 Receptor",
"Investigator Initiated",,,,"03/05/2008",,"Peptide","Subcutaneous (SQ)","AstraZeneca PLC","AZN","Byetta","Metabolic","Obesity","GLP-1 Receptor",
"NDA","06/04/2018","06/04/2018",,"10/01/2015",,"Peptide","Subcutaneous (SQ)","Novo Nordisk A/S","NVO","Ozempic","Metabolic","Obesity","GLP-1 Receptor",
"Preclinical",,,,,,"Peptide","Subcutaneous (SQ)","Carmot Therapeutics Inc.",,"CT-868","Metabolic","Obesity","GIP Receptor (GIPR)/Glucose-Dependent Insulinotropic Polypeptide Receptor,GLP-1 Receptor",
"Suspended",,,,,,"Peptide","Subcutaneous (SQ)","Kineta, Inc.",,"Dalazatide","Metabolic","Obesity","Potassium channels",
"Suspended",,,,"07/07/2005",,"Peptide","Subcutaneous (SQ)","7TM Pharma A/S",,"Obinepitide","Metabolic","Obesity","Neuropeptide Y (NPY)/Peptide YY (PYY) Receptors",
"Suspended",,,,"03/08/2007",,"Peptide","Subcutaneous (SQ)","7TM Pharma A/S",,"TM30339","Metabolic","Obesity","Neuropeptide Y (NPY)/Peptide YY (PYY) Receptors",
"Suspended",,,,,"08/04/2011","Peptide","Subcutaneous (SQ)","AstraZeneca PLC","AZN","AZD2820","Metabolic","Obesity","Melanocortin (MC) receptors","08/04/2011"
"Suspended",,,,,,"Peptide","Subcutaneous (SQ)","Zydus Cadila","CDH","ZYD1","Metabolic","Obesity","GLP-1 Receptor","02/07/2012"
"Suspended",,,,,,"Peptide","Subcutaneous (SQ)","Eli Lilly and Company","LLY","DACRA-089","Metabolic","Obesity","Amylin Receptor,Calcitonin Receptor","07/21/2017"
"Suspended",,,,,,"Peptide","Subcutaneous (SQ)","Novo Nordisk A/S","NVO","NN9030","Metabolic","Obesity","Glucagon Receptor","09/09/2014"
"Suspended",,,"02/02/2010","02/02/2010",,"Peptide","Subcutaneous (SQ)","Novo Nordisk A/S","NVO","NN9161","Metabolic","Obesity","Unknown",
"Suspended",,,,,"10/27/2016","Peptide","Subcutaneous (SQ)","Novo Nordisk A/S","NVO","NN9277","Metabolic","Obesity","GLP-1 Receptor,Glucagon Receptor","10/27/2016"
"Suspended",,,,,"06/19/2018","Peptide","Subcutaneous (SQ)","Novo Nordisk A/S","NVO","PYY 1562","Metabolic","Obesity","Neuropeptide Y (NPY)/Peptide YY (PYY) Receptors","10/14/2015"
"Suspended",,,,,,"Peptide","Subcutaneous (SQ)","Opko Health","OPK","MOD-6030","Metabolic","Obesity","GLP-1 Receptor,Glucagon Receptor",
"Suspended",,,,,,"Peptide","Subcutaneous (SQ)","Opko Health","OPK","MOD-6031","Metabolic","Obesity","GLP-1 Receptor,Glucagon Receptor","03/16/2016"
"Suspended",,,,,,"Peptide","Subcutaneous (SQ)","PhaseBio Pharmaceuticals, Inc.","PHAS","Oxymera","Metabolic","Obesity","GLP-1 Receptor,Glucagon Receptor",
"Suspended",,,,,"07/29/2019","Peptide","Subcutaneous (SQ)","Sanofi","SNY","SAR441255","Metabolic","Obesity","GIP Receptor (GIPR)/Glucose-Dependent Insulinotropic Polypeptide Receptor,GLP-1 Receptor,Glucagon Receptor","07/29/2019"
"Suspended",,,,"10/21/2008",,"Peptide","Subcutaneous (SQ)","Takeda Pharmaceutical Co. Ltd.","TAK","Davalintide","Metabolic","Obesity","Amylin Receptor","01/30/2007"
"Suspended",,,,,"09/13/2012","Peptide","Subcutaneous (SQ)","Zealand Pharma A/S","ZEAL","ZP2929","Metabolic","Obesity","GLP-1 Receptor,Glucagon Receptor","09/13/2012"
"Investigator Initiated",,,,,,"Peptide","Subcutaneous (SQ)","Eli Lilly and Company","LLY","Humulin","Neurology","Alzheimer's Disease (AD)","Insulin Receptor",
"Investigator Initiated",,,,,,"Peptide","Subcutaneous (SQ)","Novo Nordisk A/S","NVO","Levemir","Neurology","Alzheimer's Disease (AD)","Insulin Receptor",
"Investigator Initiated",,,,,,"Peptide","Subcutaneous (SQ)","Novo Nordisk A/S","NVO","Victoza","Neurology","Alzheimer's Disease (AD)","GLP-1 Receptor",
"Suspended",,,,,,"Peptide","Subcutaneous (SQ)","Kineta, Inc.",,"Dalazatide","Neurology","Alzheimer's Disease (AD)","Potassium channels","05/10/2016"
"Suspended","10/14/2005","10/14/2005",,"02/16/2005",,"Peptide","Subcutaneous (SQ)","Voyager Pharmaceutical Corp.",,"Memryte","Neurology","Alzheimer's Disease (AD)","Gonadotropin-Releasing Hormone (GnRH) Receptor",
"Suspended",,,,,,"Peptide","Subcutaneous (SQ)","Intellect Neurosciences, Inc.","ILNS","RV01","Neurology","Alzheimer's Disease (AD)","Amyloid Beta/Amyloid Plaques,Immune System",
"Suspended",,,,,,"Peptide","Subcutaneous (SQ)","Intellect Neurosciences, Inc.","ILNS","RV02","Neurology","Alzheimer's Disease (AD)","Immune System,Tau proteins",
"Suspended",,,,,,"Peptide","Subcutaneous (SQ)","Intellect Neurosciences, Inc.","ILNS","RV03","Neurology","Alzheimer's Disease (AD)","Amyloid Beta/Amyloid Plaques,Immune System,Tau proteins",
"Suspended",,,,,,"Peptide","Subcutaneous (SQ)","Novo Nordisk A/S","NVO","Novolin","Neurology","Alzheimer's Disease (AD)","Insulin Receptor",
"Investigator Initiated",,,,,,"Peptide","Subcutaneous (SQ)","Ra Pharmaceuticals, Inc.","RARX","Zilucoplan","Neurology","Amyotrophic Lateral Sclerosis (ALS)","C5a Receptor,Complement Pathway",
"Suspended",,,,,,"Peptide","Subcutaneous (SQ)","Daval International Limited",,"Aimspro","Neurology","Amyotrophic Lateral Sclerosis (ALS)","Unknown","03/20/2013"
"Suspended",,,,"09/26/2006",,"Peptide","Subcutaneous (SQ)","Teva Pharmaceutical Industries Ltd.","TEVA","Copaxone","Neurology","Amyotrophic Lateral Sclerosis (ALS)","Myelin,T lymphocytes",
"Suspended",,,,"02/13/2007",,"Peptide","Subcutaneous (SQ)","Takeda Pharmaceutical Co. Ltd.","TAK","Firazyr","Neurology","Arthritis Pain","Bradykinin B2 Receptor",
"Preclinical",,,,,,"Peptide","Subcutaneous (SQ)","Avion Pharmaceuticals, LLC",,"Lupuzor","Neurology","Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)","T lymphocytes",
"Suspended",,,,"06/16/2011",,"Peptide","Subcutaneous (SQ)","Cebix Incorporated",,"Ersatta","Neurology","Diabetic Peripheral Neuropathy (DPN)","Unknown",
"Suspended",,,"09/01/2010","09/26/2010",,"Peptide","Subcutaneous (SQ)","Daval International Limited",,"Aimspro","Neurology","Multiple Sclerosis (MS)","Unknown",
"Suspended",,,,,,"Peptide","Subcutaneous (SQ)","Kineta, Inc.",,"Dalazatide","Neurology","Multiple Sclerosis (MS)","Potassium channels","05/10/2016"
"Suspended",,,,,,"Peptide","Subcutaneous (SQ)","CuroNZ",,"NRP2945","Neurology","Multiple Sclerosis (MS)",,
"Suspended",,,"11/12/2013","11/12/2013",,"Peptide","Subcutaneous (SQ)","Merck KGaA","MKKGY","PI-2301","Neurology","Multiple Sclerosis (MS)","T lymphocytes","10/03/2007"
"Suspended",,,,,,"Peptide","Subcutaneous (SQ)","Xenetic Biosciences, Inc.","XBIO","SuliXen","Neurology","Neurology - Other","Insulin Receptor",
"Suspended",,,"12/10/2008","03/31/2009",,"Peptide","Subcutaneous (SQ)","Amgen, Inc.","AMGN","KAI-1678","Neurology","Neuropathic Pain","Protein Kinase C (PKC)",
"Investigator Initiated",,,"07/23/2014",,,"Peptide","Subcutaneous (SQ)","AstraZeneca PLC","AZN","Bydureon","Neurology","Parkinson's Disease (PD)","GLP-1 Receptor",
"Preclinical",,,,,,"Peptide","Subcutaneous (SQ)","Peptron inc.",87010,"SR-Exenatide","Neurology","Parkinson's Disease (PD)","GLP-1 Receptor",
"Suspended",,,"12/10/2008","12/10/2008",,"Peptide","Subcutaneous (SQ)","Amgen, Inc.","AMGN","KAI-1678","Neurology","Postsurgical Pain","Protein Kinase C (PKC)","11/19/2008"
"II",,,,"10/21/2020",,"Peptide","Subcutaneous (SQ)","Oxeia Biopharmaceuticals, Inc.",,"OXE-103","Neurology","Traumatic Brain Injury (TBI)","Ghrelin Receptor",
"Preclinical",,,,,,"Peptide","Subcutaneous (SQ)","Chrysalis BioTherapeutics, Inc.",,"TP508","Not Specified","Acute Radiation Syndrome (ARS)","Thrombin (Coagulation Factor IIa)",
"Suspended",,,,,,"Peptide","Subcutaneous (SQ)","ValiRx Plc","VAL","VAL201","Obstetrics/Gynecology","Endometriosis","Androgen receptors,Src Kinase Family",
"II",,,"01/08/2019","05/23/2018",,"Peptide","Subcutaneous (SQ)","Myovant Sciences Ltd.","MYOV","RVT-602","Obstetrics/Gynecology","Reproductive Disorder","Gonadotropin-Releasing Hormone (GnRH)","11/13/2017"
"IIb",,,"09/04/2012","09/04/2012",,"Peptide","Subcutaneous (SQ)","BioLineRx Ltd.","BLRX","Motixafortide","Oncology","Acute Myelogenous Leukemia (AML)","Chemokine (C-X-C motif) Receptor 4 (CXCR4)",
"III","01/08/2020","01/08/2020","12/23/2010","12/23/2010",,"Peptide","Subcutaneous (SQ)","SELLAS Life Sciences Group, Inc.","SLS","Zeltherva","Oncology","Acute Myelogenous Leukemia (AML)","Immune System,Wilms' Tumor Protein 1 (WT1)","11/09/2006"
"Suspended",,,,,,"Peptide","Subcutaneous (SQ)","Otsuka Holdings Co., Ltd.",4578,"OCV-501","Oncology","Acute Myelogenous Leukemia (AML)","Immune System,Wilms' Tumor Protein 1 (WT1)",
"Suspended",,,,,,"Peptide","Subcutaneous (SQ)","Otsuka Holdings Co., Ltd.",4578,"Elpamotide","Oncology","Biliary Tract Cancer","VEGF Receptor (VEGFR)",
"Suspended",,,,,,"Peptide","Subcutaneous (SQ)","Shionogi & Co. Ltd.",4507,"S-288310","Oncology","Bladder Cancer","Immune System",
"III","12/21/2017","12/21/2017","03/23/2016","03/23/2016",,"Peptide","Subcutaneous (SQ)","BioLineRx Ltd.","BLRX","Motixafortide","Oncology","Bone Marrow Transplant and Stem Cell Transplant","Chemokine (C-X-C motif) Receptor 4 (CXCR4)","08/12/2014"
"II",,,"06/01/2015","06/01/2015","11/29/2010","Peptide","Subcutaneous (SQ)","MimiVax, LLC",,"SurVaxM","Oncology","Brain Cancer (Malignant Glioma; AA and glioblastoma (GBM))","Immune System,Survivin","09/11/2012"
"Suspended",,,,,,"Peptide","Subcutaneous (SQ)","IMV Inc.","IMV","DPX-Survivac","Oncology","Brain Cancer (Malignant Glioma; AA and glioblastoma (GBM))","Immune System,Survivin",
"Suspended",,,,,,"Peptide","Subcutaneous (SQ)","SELLAS Life Sciences Group, Inc.","SLS","Zeltherva","Oncology","Brain Cancer (Malignant Glioma; AA and glioblastoma (GBM))","Immune System,Wilms' Tumor Protein 1 (WT1)",
"I",,,,,"06/13/2013","Peptide","Subcutaneous (SQ)","ValiRx Plc","VAL","VAL201","Oncology","Breast Cancer","Androgen receptors,Src Kinase Family","06/13/2013"
"II",,,"03/31/2019","03/31/2019","06/26/2012","Peptide","Subcutaneous (SQ)","Marker Therapeutics, Inc.","MRKR","TPIV 110","Oncology","Breast Cancer","HER2/neu or ErbB-2,Immune System,Major Histocompatibility Complex (MHC)","08/11/2011"
"Suspended",,,,,,"Peptide","Subcutaneous (SQ)","IMV Inc.","IMV","DPX-0907","Oncology","Breast Cancer","Abelson Interactor 2 (Abi-2),B-cell receptor-associated protein 31(Bap31),Epithelial Discoidin Domain Receptor 1 (EDDR1),Immune System,Integrin Beta-8 (ITGB8),Junction Plakoblobin (JUP)/Gamma-Catenin,TACE/ADAM 17,Topoisomerase II (DNA gyrase)",
"Suspended",,,,,"11/25/2013","Peptide","Subcutaneous (SQ)","Eli Lilly and Company","LLY","Pegilodecakin","Oncology","Breast Cancer","IL-10 (Interleukin-10) and IL-10 Receptor (IL-10R)","11/25/2013"
"Suspended",,,,,"07/16/2017","Peptide","Subcutaneous (SQ)","Spectrum Pharmaceuticals Inc.","SPPI","Rolontis","Oncology","Breast Cancer","Granulocyte-colony Stimulating Factor (G-CSFR)/CD114","07/16/2017"
"II",,,,"10/31/2018",,"Peptide","Subcutaneous (SQ)","SELLAS Life Sciences Group, Inc.","SLS","Zeltherva","Oncology","Cancer","Immune System,Wilms' Tumor Protein 1 (WT1)",
"Suspended",,,,,"12/21/2017","Peptide","Subcutaneous (SQ)","Eli Lilly and Company","LLY","Pegilodecakin","Oncology","Cancer","IL-10 (Interleukin-10) and IL-10 Receptor (IL-10R)","12/21/2017"
"II",,,"10/26/2020","10/26/2020",,"Peptide","Subcutaneous (SQ)","PDS Biotechnology Corporation","PDSB","PDS0101","Oncology","Cervical Cancer","Human Papillomavirus (HPV),Immune System","11/01/2013"
"I",,,,,,"Peptide","Subcutaneous (SQ)","PDS Biotechnology Corporation","PDSB","PDS0101","Oncology","Cervical Dysplasia","Human Papillomavirus (HPV),Immune System","11/01/2013"
"Suspended",,,"03/02/2012","05/06/2009",,"Peptide","Subcutaneous (SQ)","Zealand Pharma A/S","ZEAL","Elsiglutide","Oncology","Chemotherapy Induced Diarrhea","GLP-2 Receptor","11/27/2008"
"Investigator Initiated",,,,,,"Peptide","Subcutaneous (SQ)","BioLineRx Ltd.","BLRX","Motixafortide","Oncology","Chronic Myelogenous Leukemia (CML)","Chemokine (C-X-C motif) Receptor 4 (CXCR4)",
"Suspended",,,,,,"Peptide","Subcutaneous (SQ)","SELLAS Life Sciences Group, Inc.","SLS","Zeltherva","Oncology","Chronic Myelogenous Leukemia (CML)","Immune System,Wilms' Tumor Protein 1 (WT1)",
"I/II",,,"04/10/2018","04/10/2018",,"Peptide","Subcutaneous (SQ)","Treos Bio Limited",,"PolyPEPI1018","Oncology","Colorectal Cancer (CRC)","Immune System,T lymphocytes",
"Suspended",,,,,,"Peptide","Subcutaneous (SQ)","Otsuka Holdings Co., Ltd.",4578,"OCV-C02","Oncology","Colorectal Cancer (CRC)","Tumor Cells",
"Suspended",,,,,"11/25/2013","Peptide","Subcutaneous (SQ)","Eli Lilly and Company","LLY","Pegilodecakin","Oncology","Colorectal Cancer (CRC)","IL-10 (Interleukin-10) and IL-10 Receptor (IL-10R)","11/25/2013"
"Suspended",,,,,,"Peptide","Subcutaneous (SQ)","OSE Immunotherapeutics","OSE","Tedopi","Oncology","Colorectal Cancer (CRC)","Immune System",
"II",,,"03/24/2015","10/01/2014",,"Peptide","Subcutaneous (SQ)","IMV Inc.","IMV","DPX-Survivac","Oncology","Diffuse Large B-Cell Lymphoma (DLBCL) - NHL","Immune System,Survivin",
"I/II",,,"10/18/2017","10/18/2017",,"Peptide","Subcutaneous (SQ)","BioLineRx Ltd.","BLRX","Motixafortide","Oncology","Gastric Cancer","Chemokine (C-X-C motif) Receptor 4 (CXCR4)",
"II",,,"11/09/2020","11/09/2020",,"Peptide","Subcutaneous (SQ)","PDS Biotechnology Corporation","PDSB","PDS0101","Oncology","Head and Neck Cancer","Human Papillomavirus (HPV),Immune System",
"Suspended",,,"06/23/2005","06/23/2005",,"Peptide","Subcutaneous (SQ)","AbbVie Inc.","ABBV","ABT-510","Oncology","Head and Neck Cancer","Fas ligand (FasL),Src Kinase Family,VEGF (Vascular endothelial growth factor)",
"Suspended",,,,"08/14/2007",,"Peptide","Subcutaneous (SQ)","AbbVie Inc.","ABBV","ABT-510","Oncology","Hematologic Cancer","Fas ligand (FasL),Src Kinase Family,VEGF (Vascular endothelial growth factor)",
"Suspended",,,,,,"Peptide","Subcutaneous (SQ)","Ono Pharmaceutical Company, Ltd.","4528:JP","ONO-7268MX1","Oncology","Hepatocellular (Liver) Cancer (HCC) (Including Secondary Metastases)","Immune System",
"Suspended",,,,"08/04/2004",,"Peptide","Subcutaneous (SQ)","SciClone Pharmaceuticals, Inc.","SCLN","Zadaxin","Oncology","Hepatocellular (Liver) Cancer (HCC) (Including Secondary Metastases)","Immune System",
"I",,,,,"12/06/2018","Peptide","Subcutaneous (SQ)","Neon Therapeutics, Inc.",,"NEO-PV-01","Oncology","Melanoma","Immune System,Tumor Cells","12/06/2018"
"I/II",,,,"08/31/2017",,"Peptide","Subcutaneous (SQ)","IO Biotech ApS",,"IO101","Oncology","Melanoma","IDO (Indoleamine 2,3-dioxygenase)","08/31/2017"
"I/II",,,"12/15/2020","12/15/2020",,"Peptide","Subcutaneous (SQ)","IO Biotech ApS",,"IO102","Oncology","Melanoma","IDO (Indoleamine 2,3-dioxygenase)",
"Suspended",,,,,,"Peptide","Subcutaneous (SQ)","AbbVie Inc.","ABBV","ABT-510","Oncology","Melanoma","Fas ligand (FasL),Src Kinase Family,VEGF (Vascular endothelial growth factor)",
"Suspended",,"09/28/2004",,,,"Peptide","Subcutaneous (SQ)","Bristol Myers Squibb Company","BMY","MDX-1379","Oncology","Melanoma","HLA-A,Immune System",
"Suspended",,,,,"11/25/2013","Peptide","Subcutaneous (SQ)","Eli Lilly and Company","LLY","Pegilodecakin","Oncology","Melanoma","IL-10 (Interleukin-10) and IL-10 Receptor (IL-10R)","11/25/2013"
"Suspended",,"11/17/2008",,"08/04/2004",,"Peptide","Subcutaneous (SQ)","SciClone Pharmaceuticals, Inc.","SCLN","Zadaxin","Oncology","Melanoma","Immune System",
"II",,,,"09/04/2014",,"Peptide","Subcutaneous (SQ)","SELLAS Life Sciences Group, Inc.","SLS","Zeltherva","Oncology","Mesothelioma","Immune System,Wilms' Tumor Protein 1 (WT1)","11/09/2006"
"I/II",,,"03/18/2009","07/24/2012",,"Peptide","Subcutaneous (SQ)","BioLineRx Ltd.","BLRX","Motixafortide","Oncology","Multiple Myeloma (MM)","Chemokine (C-X-C motif) Receptor 4 (CXCR4)",
"I/II",,,,"06/30/2014",,"Peptide","Subcutaneous (SQ)","SELLAS Life Sciences Group, Inc.","SLS","Zeltherva","Oncology","Multiple Myeloma (MM)","Immune System,Wilms' Tumor Protein 1 (WT1)",
"Investigator Initiated",,,,,,"Peptide","Subcutaneous (SQ)","MimiVax, LLC",,"SurVaxM","Oncology","Multiple Myeloma (MM)","Immune System,Survivin",
"I",,,,,"05/19/2016","Peptide","Subcutaneous (SQ)","Enesi Pharma Limited",,"Glide Octreotide","Oncology","Neuroendocrine Tumors (NET)","Somatostatin Receptors","05/19/2016"
"Suspended",,,,,,"Peptide","Subcutaneous (SQ)","Midatech Pharma PLC","MTPH","Q-Octreotide","Oncology","Neuroendocrine Tumors (NET)","Somatostatin Receptors",
"Suspended",,,"07/24/2012","07/24/2012",,"Peptide","Subcutaneous (SQ)","BioLineRx Ltd.","BLRX","Motixafortide","Oncology","Non-Hodgkin's Lymphoma (NHL)","Chemokine (C-X-C motif) Receptor 4 (CXCR4)",
"I",,,,,"03/07/2018","Peptide","Subcutaneous (SQ)","Neon Therapeutics, Inc.",,"NEO-PV-01","Oncology","Non-Small Cell Lung Cancer (NSCLC)","Immune System,Tumor Cells","03/07/2018"
"I/II",,,"08/22/2018","08/22/2018",,"Peptide","Subcutaneous (SQ)","IO Biotech ApS",,"IO102","Oncology","Non-Small Cell Lung Cancer (NSCLC)","IDO (Indoleamine 2,3-dioxygenase)",
"IIb",,,,"12/18/2007",,"Peptide","Subcutaneous (SQ)","Vaxon Biotech",,"Vx-001","Oncology","Non-Small Cell Lung Cancer (NSCLC)","Immune System,Telomerase",
"III","01/06/2016","01/06/2016",,"12/21/2004",,"Peptide","Subcutaneous (SQ)","OSE Immunotherapeutics","OSE","Tedopi","Oncology","Non-Small Cell Lung Cancer (NSCLC)","Immune System","09/28/2004"
"Investigator Initiated",,,,,,"Peptide","Subcutaneous (SQ)","IO Biotech ApS",,"IO101","Oncology","Non-Small Cell Lung Cancer (NSCLC)","IDO (Indoleamine 2,3-dioxygenase)",
"Suspended",,,"03/01/2018","03/01/2018","11/25/2013","Peptide","Subcutaneous (SQ)","Eli Lilly and Company","LLY","Pegilodecakin","Oncology","Non-Small Cell Lung Cancer (NSCLC)","IL-10 (Interleukin-10) and IL-10 Receptor (IL-10R)","11/25/2013"
"I/II",,,"05/02/2016","05/02/2016",,"Peptide","Subcutaneous (SQ)","SELLAS Life Sciences Group, Inc.","SLS","Zeltherva","Oncology","Ovarian Cancer","Immune System,Wilms' Tumor Protein 1 (WT1)",
"II",,,,"06/20/2011",,"Peptide","Subcutaneous (SQ)","IMV Inc.","IMV","DPX-Survivac","Oncology","Ovarian Cancer","Immune System,Survivin",
"Preclinical",,,,,,"Peptide","Subcutaneous (SQ)","ValiRx Plc","VAL","VAL201","Oncology","Ovarian Cancer","Androgen receptors,Src Kinase Family",
"Suspended",,,,,"03/02/2015","Peptide","Subcutaneous (SQ)","Almac Group",,"ALM201","Oncology","Ovarian Cancer","Microtubules (Tubulin)","03/02/2015"
"Suspended",,,,,,"Peptide","Subcutaneous (SQ)","IMV Inc.","IMV","DPX-0907","Oncology","Ovarian Cancer","Abelson Interactor 2 (Abi-2),B-cell receptor-associated protein 31(Bap31),Epithelial Discoidin Domain Receptor 1 (EDDR1),Immune System,Integrin Beta-8 (ITGB8),Junction Plakoblobin (JUP)/Gamma-Catenin,TACE/ADAM 17,Topoisomerase II (DNA gyrase)",
"Suspended",,,,,"11/25/2013","Peptide","Subcutaneous (SQ)","Eli Lilly and Company","LLY","Pegilodecakin","Oncology","Ovarian Cancer","IL-10 (Interleukin-10) and IL-10 Receptor (IL-10R)","11/25/2013"
"IIb",,,"09/20/2016","09/20/2016",,"Peptide","Subcutaneous (SQ)","BioLineRx Ltd.","BLRX","Motixafortide","Oncology","Pancreatic Cancer","Chemokine (C-X-C motif) Receptor 4 (CXCR4)",
"Suspended",,,,,,"Peptide","Subcutaneous (SQ)","OncoTherapy Science, Inc.","4564:JP","OCV-101","Oncology","Pancreatic Cancer","Angiogenesis",
"Suspended",,,,,,"Peptide","Subcutaneous (SQ)","Otsuka Holdings Co., Ltd.",4578,"Elpamotide","Oncology","Pancreatic Cancer","VEGF Receptor (VEGFR)",
"Suspended","01/03/2017","01/03/2017",,,"11/25/2013","Peptide","Subcutaneous (SQ)","Eli Lilly and Company","LLY","Pegilodecakin","Oncology","Pancreatic Cancer","IL-10 (Interleukin-10) and IL-10 Receptor (IL-10R)","11/25/2013"
"II",,,"10/30/2019","10/30/2019",,"Peptide","Subcutaneous (SQ)","Protagonist Therapeutics, Inc.","PTGX","PTG-300","Oncology","Polycythemia Vera (PV)","Hepcidin",
"I/II",,,"10/14/2014","10/14/2014","06/13/2013","Peptide","Subcutaneous (SQ)","ValiRx Plc","VAL","VAL201","Oncology","Prostate Cancer","Androgen receptors,Src Kinase Family","06/13/2013"
"IIb",,,,"03/30/2017",,"Peptide","Subcutaneous (SQ)","RhoVac AB","RHOVAC","RV001","Oncology","Prostate Cancer","Immune System,Rho GTPase/Rho Kinase,Tumor Cells",
"NDA","09/08/2014","09/08/2014",,,,"Peptide","Subcutaneous (SQ)","Foresee Pharmaceuticals Co., Ltd.",6576,"FP-001","Oncology","Prostate Cancer","Gonadotropin-Releasing Hormone (GnRH)",
"Preclinical",,,,,,"Peptide","Subcutaneous (SQ)","Veru Inc.","VERU","VERU-100","Oncology","Prostate Cancer","Gonadotropin-Releasing Hormone (GnRH) Receptor",
"Suspended","05/29/2012","03/10/2011",,,,"Peptide","Subcutaneous (SQ)","Ipsen SA","IPSEY","Somatuline Autogel","Oncology","Prostate Cancer","Somatostatin Receptors",
"Suspended",,,"11/23/2010","11/23/2010",,"Peptide","Subcutaneous (SQ)","Myovant Sciences Ltd.","MYOV","RVT-602","Oncology","Prostate Cancer","Gonadotropin-Releasing Hormone (GnRH)","02/01/2012"
"Suspended",,,,,,"Peptide","Subcutaneous (SQ)","FUJIFILM Holdings Corp.","TYO:4901","ITK-1","Oncology","Prostate Cancer","HLA-A,Immune System",
"Suspended",,,,"08/14/2007",,"Peptide","Subcutaneous (SQ)","AbbVie Inc.","ABBV","ABT-510","Oncology","Renal Cell Cancer (RCC)","Fas ligand (FasL),Src Kinase Family,VEGF (Vascular endothelial growth factor)",
"Suspended",,,,"07/07/2011",,"Peptide","Subcutaneous (SQ)","Eli Lilly and Company","LLY","LY2510924","Oncology","Renal Cell Cancer (RCC)","Chemokine (C-X-C motif) Receptor 4 (CXCR4)",
"Suspended",,,,,"11/25/2013","Peptide","Subcutaneous (SQ)","Eli Lilly and Company","LLY","Pegilodecakin","Oncology","Renal Cell Cancer (RCC)","IL-10 (Interleukin-10) and IL-10 Receptor (IL-10R)","11/25/2013"
"Suspended",,,,"11/28/2007",,"Peptide","Subcutaneous (SQ)","AbbVie Inc.","ABBV","ABT-510","Oncology","Sarcoma","Fas ligand (FasL),Src Kinase Family,VEGF (Vascular endothelial growth factor)",
"Suspended",,,"10/14/2011","10/14/2011",,"Peptide","Subcutaneous (SQ)","Eli Lilly and Company","LLY","LY2510924","Oncology","Small Cell Lung Cancer (SCLC)","Chemokine (C-X-C motif) Receptor 4 (CXCR4)",
"I",,,,,"10/03/2016","Peptide","Subcutaneous (SQ)","Neon Therapeutics, Inc.",,"NEO-PV-01","Oncology","Solid Tumors","Immune System,Tumor Cells","10/03/2016"
"I",,,,,"10/20/2016","Peptide","Subcutaneous (SQ)","Eli Lilly and Company","LLY","LY2510924","Oncology","Solid Tumors","Chemokine (C-X-C motif) Receptor 4 (CXCR4)","10/20/2016"
"II",,,"02/07/2019","02/07/2019",,"Peptide","Subcutaneous (SQ)","IMV Inc.","IMV","DPX-Survivac","Oncology","Solid Tumors","Immune System,Survivin",
"IND",,,,,,"Peptide","Subcutaneous (SQ)","BioLineRx Ltd.","BLRX","Motixafortide","Oncology","Solid Tumors","Chemokine (C-X-C motif) Receptor 4 (CXCR4)",
"Preclinical",,,,,,"Peptide","Subcutaneous (SQ)","Medicenna Therapeutics Corp.","MDNAF","MDNA11","Oncology","Solid Tumors","IL-2 Receptor (IL-2R) ",
"Suspended",,,,,,"Peptide","Subcutaneous (SQ)","AbbVie Inc.","ABBV","ABT-510","Oncology","Solid Tumors","Fas ligand (FasL),Src Kinase Family,VEGF (Vascular endothelial growth factor)","08/01/2005"
"Suspended",,,,,,"Peptide","Subcutaneous (SQ)","IMV Inc.","IMV","DPX-0907","Oncology","Solid Tumors","Abelson Interactor 2 (Abi-2),B-cell receptor-associated protein 31(Bap31),Epithelial Discoidin Domain Receptor 1 (EDDR1),Immune System,Integrin Beta-8 (ITGB8),Junction Plakoblobin (JUP)/Gamma-Catenin,TACE/ADAM 17,Topoisomerase II (DNA gyrase)","03/26/2010"
"Suspended",,,,,,"Peptide","Subcutaneous (SQ)","Medicenna Therapeutics Corp.","MDNAF","MDNA19","Oncology","Solid Tumors","Cluster of Differentiation 122 (CD122),IL-2 Receptor (IL-2R) ",
"III","05/08/2019","05/08/2019",,,,"Peptide","Subcutaneous (SQ)","Novo Nordisk A/S","NVO","Ozempic","Ophthalmology","Diabetic Retinopathy (Ophthalmology)","GLP-1 Receptor",
"Suspended",,"03/05/2009",,,,"Peptide","Subcutaneous (SQ)","Teva Pharmaceutical Industries Ltd.","TEVA","Copaxone","Ophthalmology","Optic Neuritis (Ophthalmology)","Myelin,T lymphocytes",
"Suspended",,,"02/07/2006",,,"Peptide","Subcutaneous (SQ)","Ipsen SA","IPSEY","Somatuline Autogel","Ophthalmology","Thyroid Eye Disease (TED)","Somatostatin Receptors",
"Suspended",,,,,,"Peptide","Subcutaneous (SQ)","Kineta, Inc.",,"Dalazatide","Ophthalmology","Uveitis (Ophthalmology)","Potassium channels","03/19/2015"
"Suspended",,,,,,"Peptide","Subcutaneous (SQ)","Shionogi & Co. Ltd.",4507,"S-646240","Ophthalmology","Wet Age-Related Macular Degeneration (Wet AMD) (Ophthalmology)","Unknown",
"II",,,"07/16/2012","07/16/2012",,"Peptide","Subcutaneous (SQ)","Allergan plc","AGN","Relamorelin","Psychiatry","Eating Disorders","Ghrelin Receptor",
"Preclinical",,,,,,"Peptide","Subcutaneous (SQ)","Ferring Pharmaceuticals",,"FP-004","Psychiatry","Substance Use Disorder","Opioid receptors",
"Suspended",,,,,,"Peptide","Subcutaneous (SQ)","Kineta, Inc.",,"Dalazatide","Respiratory","Asthma","Potassium channels","05/10/2016"
"Suspended",,,,"03/03/2011",,"Peptide","Subcutaneous (SQ)","Palatin Technologies, Inc.","PTN","PL-3994","Respiratory","Asthma","Natriuretic Peptide Receptors",
"Suspended",,,,,,"Peptide","Subcutaneous (SQ)","Digna Biotech, S.L.",,"Disitertide (Subcutaneous)","Respiratory","Pulmonary Fibrosis","Transforming Growth Factor-beta (TGF-beta) and Superfamily",
"Development Outside U.S.",,,,,,"Peptide","Subcutaneous (SQ)","Shionogi & Co. Ltd.",4507,"S-588410","Oncology","Bladder Cancer","Immune System",
"Development Outside U.S.",,,,,,"Peptide","Subcutaneous (SQ)","ORYX GmbH & Co. KG",,"MicOryx","Oncology","Colorectal Cancer (CRC)","Immune System",
"Development Outside U.S.",,,,,"04/16/2018","Peptide","Subcutaneous (SQ)","Adocia","ADOC:FP","Biochaperone Lispro Pramlintide","Endocrine","Diabetes Mellitus, Type I","Insulin Receptor",
"Development Outside U.S.",,,,,,"Peptide","Subcutaneous (SQ)","Scohia Pharma, Inc.",,"TAK-094","Endocrine","Diabetes Mellitus, Type II","GIP Receptor (GIPR)/Glucose-Dependent Insulinotropic Polypeptide Receptor,GLP-1 Receptor",
"Development Outside U.S.",,,,,,"Peptide","Subcutaneous (SQ)","Peptron inc.",87010,"SR-Exenatide","Endocrine","Diabetes Mellitus, Type II","GLP-1 Receptor",
"Development Outside U.S.",,,,,,"Peptide","Subcutaneous (SQ)","EyeGene, Inc.",185490,"EG-Mirotin","Ophthalmology","Diabetic Retinopathy (Ophthalmology)","Angiopoietins",
"Development Outside U.S.",,,,,,"Peptide","Subcutaneous (SQ)","Shionogi & Co. Ltd.",4507,"S-588410","Oncology","Esophageal Cancer","Immune System",
"Development Outside U.S.",,,,,,"Peptide","Subcutaneous (SQ)","Ergomed plc","ERGO","ReadyFlow","Hematology","Hemostasis","Fibrinogen (Coagulation Factor I)",
"Development Outside U.S.",,,,,,"Peptide","Subcutaneous (SQ)","MYR GmbH",,"Hepcludex","Infectious Disease","Hepatitis B (HBV) Treatment (Antiviral)","Hepatitis B/HBV,Hepatitis D/HDV",
"Development Outside U.S.",,,"05/02/2017",,,"Peptide","Subcutaneous (SQ)","Stealth BioTherapeutics Inc.","MITO","SBT-20","Neurology","Huntington's Disease","Mitochondria",
"Development Outside U.S.",,,,,,"Peptide","Subcutaneous (SQ)","Kineta, Inc.",,"KCP506","Neurology","Inflammatory Pain","Nicotinic Acetylcholine Receptors (nAChR) ",
"Development Outside U.S.",,,,,,"Peptide","Subcutaneous (SQ)","Shionogi & Co. Ltd.",4507,"S-005151","Neurology","Ischemic Stroke",,
"Development Outside U.S.",,,,,,"Peptide","Subcutaneous (SQ)","CuroNZ",,"NRP2945","Neurology","Lennox-Gastaut Syndrome (LGS; Epilepsy)",,
"Development Outside U.S.",,,,,,"Peptide","Subcutaneous (SQ)","Shionogi & Co. Ltd.",4507,"S-005151","Gastroenterology (Non Inflammatory Bowel Disease)","Liver Failure / Cirrhosis",,
"Development Outside U.S.",,,,,,"Peptide","Subcutaneous (SQ)","Novartis AG","NVS","CAM2029","Oncology","Neuroendocrine Tumors (NET)","Somatostatin Receptors",
"Development Outside U.S.",,,,,,"Peptide","Subcutaneous (SQ)","Kineta, Inc.",,"KCP506","Neurology","Neuropathic Pain","Nicotinic Acetylcholine Receptors (nAChR) ",
"Development Outside U.S.",,,,,,"Peptide","Subcutaneous (SQ)","Eli Lilly and Company","LLY","LY3305677","Metabolic","Obesity","GLP-1 Receptor,Glucagon Receptor",
"Development Outside U.S.",,,,,,"Peptide","Subcutaneous (SQ)","Shionogi & Co. Ltd.",4507,"S-005151","Rheumatology (Non Autoimmune)","Osteoarthritis and Osteoarthritis Pain",,
"Development Outside U.S.",,,"02/26/2019",,,"Peptide","Subcutaneous (SQ)","OSE Immunotherapeutics","OSE","Tedopi","Oncology","Pancreatic Cancer","Immune System",
"Development Outside U.S.",,,,,,"Peptide","Subcutaneous (SQ)","Debiopharm S.A.",,"Debio 8206","Oncology","Prostate Cancer","Gonadotropin-Releasing Hormone (GnRH) Receptor",
"Development Outside U.S.",,,,,,"Peptide","Subcutaneous (SQ)","Camurus AB","CAMX","Prosenze","Oncology","Prostate Cancer","Gonadotropin-Releasing Hormone (GnRH) Receptor",
"Development Outside U.S.",,,,,,"Peptide","Subcutaneous (SQ)","CuroNZ",,"NRP2945","Neurology","Seizure Disorders (Epilepsy)",,
"Development Outside U.S.","09/26/2016",,,,,"Peptide","Subcutaneous (SQ)","SciClone Pharmaceuticals, Inc.","SCLN","Zadaxin","Infectious Disease","Sepsis and Septic Shock","Immune System",
"Development Outside U.S.",,,,,,"Peptide","Subcutaneous (SQ)","Hanmi Pharmaceutical Co., Ltd.",128940,"HM10560A","Endocrine","Short Stature / Growth Hormone Deficiency","Growth hormone receptor (GHR)",
"Development Outside U.S.",,,,,,"Peptide","Subcutaneous (SQ)","ORYX GmbH & Co. KG",,"VicOryx","Oncology","Solid Tumors","Cyclin Dependent Kinase (CDK),Immune System",
"Development Outside U.S.",,,"01/31/2018",,,"Peptide","Subcutaneous (SQ)","Otsuka Holdings Co., Ltd.",4578,"TAS0313","Oncology","Solid Tumors",,
"Development Outside U.S.",,,,,,"Peptide","Subcutaneous (SQ)","Promore Pharma AB","PROMO","PXL-01","Not Specified","Surgical and Procedure Complications","Lactoferrin Receptor",
"BLA","01/29/2016","01/29/2016","01/09/2013","09/07/2012","12/22/2009","Peptide","Subcutaneous (SQ)","Spectrum Pharmaceuticals Inc.","SPPI","Rolontis","Hematology","Neutropenia / Leukopenia","Granulocyte-colony Stimulating Factor (G-CSFR)/CD114","12/22/2009"
"Approved in other than U.S./E.U.",,,,,,"Peptide","Subcutaneous (SQ)","GC Pharma",6280,"Biosimilar Lantus (Green Cross)","Endocrine","Diabetes Mellitus, Type I","Insulin Receptor",
"Approved in other than U.S./E.U.",,,,,,"Peptide","Subcutaneous (SQ)","Jiangsu Hansoh Pharmaceutical Group Co., Ltd",,"PEX168","Endocrine","Diabetes Mellitus, Type II","GLP-1 Receptor",
"Approved in other than U.S./E.U.",,,,,,"Peptide","Subcutaneous (SQ)","GC Pharma",6280,"Biosimilar Lantus (Green Cross)","Endocrine","Diabetes Mellitus, Type II","Insulin Receptor",
"Approved in other than U.S./E.U.",,,,,,"Peptide","Subcutaneous (SQ)","SciClone Pharmaceuticals, Inc.","SCLN","Zadaxin","Infectious Disease","Hepatitis B (HBV) Treatment (Antiviral)","Immune System",
"Approved in other than U.S./E.U.","09/15/2003","09/15/2003",,,,"Peptide","Subcutaneous (SQ)","SciClone Pharmaceuticals, Inc.","SCLN","Zadaxin","Infectious Disease","Hepatitis C (HCV) (Antiviral)","Immune System",
"Approved in other than U.S./E.U.",,,,"01/12/2010",,"Peptide","Subcutaneous (SQ)","SciClone Pharmaceuticals, Inc.","SCLN","Zadaxin","Infectious Disease","Influenza (excluding vaccines)","Immune System",
"Approved in other than U.S./E.U.",,,,,,"Peptide","Subcutaneous (SQ)","Asahi Kasei Corporation","AHKSY","Teribone","Endocrine","Osteoporosis / Osteopenia","Parathyroid Hormone Receptor (PTHR)",
"Approved in other than U.S./E.U.",,,,,,"Peptide","Subcutaneous (SQ)","AbbVie Inc.","ABBV","Lupron","Metabolic","Spinal Bulbar Muscular Atrophy (SBMA, Kennedy's Disease, X-linked spinal muscular atrophy type 1)","Gonadotropin-Releasing Hormone (GnRH) Receptor",
"Approved in Europe",,,,,,"Peptide","Subcutaneous (SQ)","AbbVie Inc.","ABBV","Lupron","Oncology","Breast Cancer","Gonadotropin-Releasing Hormone (GnRH) Receptor",
"Approved in Europe",,,,,,"Peptide","Subcutaneous (SQ)","Novo Nordisk A/S","NVO","Actraphane","Endocrine","Diabetes Mellitus, Type I","Insulin Receptor",
"Approved in Europe",,,,,,"Peptide","Subcutaneous (SQ)","Novo Nordisk A/S","NVO","Actrapid","Endocrine","Diabetes Mellitus, Type I","Insulin Receptor",
"Approved in Europe",,,,,,"Peptide","Subcutaneous (SQ)","Novo Nordisk A/S","NVO","Insulatard","Endocrine","Diabetes Mellitus, Type I","Insulin Receptor",
"Approved in Europe","09/16/2009","09/16/2009",,"01/31/2008",,"Peptide","Subcutaneous (SQ)","Novo Nordisk A/S","NVO","Ryzodeg 70/30","Endocrine","Diabetes Mellitus, Type I","Insulin Receptor","10/27/2006"
"Approved in Europe",,,,,,"Peptide","Subcutaneous (SQ)","Sanofi","SNY","Insuman","Endocrine","Diabetes Mellitus, Type I","Insulin Receptor",
"Approved in Europe",,,,,,"Peptide","Subcutaneous (SQ)","Novo Nordisk A/S","NVO","Actraphane","Endocrine","Diabetes Mellitus, Type II","Insulin Receptor",
"Approved in Europe",,,,,,"Peptide","Subcutaneous (SQ)","Novo Nordisk A/S","NVO","Actrapid","Endocrine","Diabetes Mellitus, Type II","Insulin Receptor",
"Approved in Europe",,,,,,"Peptide","Subcutaneous (SQ)","Novo Nordisk A/S","NVO","Insulatard","Endocrine","Diabetes Mellitus, Type II","Insulin Receptor",
"Approved in Europe","11/05/2009","11/05/2009","01/31/2008","01/31/2008","10/27/2006","Peptide","Subcutaneous (SQ)","Novo Nordisk A/S","NVO","Ryzodeg 70/30","Endocrine","Diabetes Mellitus, Type II","Insulin Receptor","10/27/2006"
"Approved in Europe",,,,,,"Peptide","Subcutaneous (SQ)","Sanofi","SNY","Insuman","Endocrine","Diabetes Mellitus, Type II","Insulin Receptor",
"Approved (Generic Competition)",,"02/17/2003",,,,"Peptide","Subcutaneous (SQ)","Takeda Pharmaceutical Co. Ltd.","TAK","Firazyr","Autoimmune/immunology","Hereditary Angioedema (HAE)","Bradykinin B2 Receptor",
"Approved (Generic Competition)",,,,,,"Peptide","Subcutaneous (SQ)","Momenta Pharmaceuticals, Inc.","MNTA","Glatopa","Neurology","Multiple Sclerosis (MS)","T lymphocytes",
"Approved (Generic Competition)",,,,"08/13/1987",,"Peptide","Subcutaneous (SQ)","Teva Pharmaceutical Industries Ltd.","TEVA","Copaxone","Neurology","Multiple Sclerosis (MS)","Myelin,T lymphocytes",
"Approved",,"10/16/2006",,,,"Peptide","Subcutaneous (SQ)","Ipsen SA","IPSEY","Somatuline Autogel","Endocrine","Acromegaly","Somatostatin Receptors",
"Approved",,,,,,"Peptide","Subcutaneous (SQ)","AbbVie Inc.","ABBV","Lupron","Hematology","Anemia","Gonadotropin-Releasing Hormone (GnRH) Receptor",
"Approved",,"07/22/2011",,,,"Peptide","Subcutaneous (SQ)","Eli Lilly and Company","LLY","Trulicity","Cardiovascular","Cardiovascular Disease","GLP-1 Receptor",
"Approved","02/21/2013","02/21/2013",,,,"Peptide","Subcutaneous (SQ)","Novo Nordisk A/S","NVO","Ozempic","Cardiovascular","Cardiovascular Disease","GLP-1 Receptor",
"Approved","05/06/2010","05/06/2010",,,,"Peptide","Subcutaneous (SQ)","Novo Nordisk A/S","NVO","Victoza","Cardiovascular","Cardiovascular Disease","GLP-1 Receptor",
"Approved","08/19/2011","08/19/2011",,"01/11/2011",,"Peptide","Subcutaneous (SQ)","Eli Lilly and Company","LLY","Basaglar","Endocrine","Diabetes Mellitus, Type I","Insulin Receptor",
"Approved",,,,,,"Peptide","Subcutaneous (SQ)","Eli Lilly and Company","LLY","Humalog","Endocrine","Diabetes Mellitus, Type I","Insulin Receptor",
"Approved",,,,,,"Peptide","Subcutaneous (SQ)","Eli Lilly and Company","LLY","Humalog Mix","Endocrine","Diabetes Mellitus, Type I","Insulin Receptor",
"Approved",,,,,,"Peptide","Subcutaneous (SQ)","Eli Lilly and Company","LLY","Humulin","Endocrine","Diabetes Mellitus, Type I","Insulin Receptor",
"Approved","07/19/2017","07/19/2017",,,"03/04/2016","Peptide","Subcutaneous (SQ)","Eli Lilly and Company","LLY","Lyumjev","Endocrine","Diabetes Mellitus, Type I","Insulin Receptor","03/04/2016"
"Approved",,"08/26/2013",,,"05/11/2010","Peptide","Subcutaneous (SQ)","Novo Nordisk A/S","NVO","FIAsp","Endocrine","Diabetes Mellitus, Type I","Insulin Receptor","05/11/2010"
"Approved",,,,,,"Peptide","Subcutaneous (SQ)","Novo Nordisk A/S","NVO","Levemir","Endocrine","Diabetes Mellitus, Type I","Insulin Receptor",
"Approved",,,,,,"Peptide","Subcutaneous (SQ)","Novo Nordisk A/S","NVO","Mixtard","Endocrine","Diabetes Mellitus, Type I","Insulin Receptor",
"Approved",,,,,,"Peptide","Subcutaneous (SQ)","Novo Nordisk A/S","NVO","Novolin","Endocrine","Diabetes Mellitus, Type I","Insulin Receptor",
"Approved",,,,,,"Peptide","Subcutaneous (SQ)","Novo Nordisk A/S","NVO","NovoLog","Endocrine","Diabetes Mellitus, Type I","Insulin Receptor",
"Approved",,,,,,"Peptide","Subcutaneous (SQ)","Novo Nordisk A/S","NVO","NovoLog Mix","Endocrine","Diabetes Mellitus, Type I","Insulin Receptor",
"Approved","09/22/2009","09/22/2009",,"01/31/2008",,"Peptide","Subcutaneous (SQ)","Novo Nordisk A/S","NVO","Tresiba","Endocrine","Diabetes Mellitus, Type I","Insulin Receptor",
"Approved",,"10/26/2014",,,,"Peptide","Subcutaneous (SQ)","Sanofi","SNY","Admelog","Endocrine","Diabetes Mellitus, Type I","Insulin Receptor","07/31/2013"
"Approved",,,,,,"Peptide","Subcutaneous (SQ)","Sanofi","SNY","Lantus","Endocrine","Diabetes Mellitus, Type I","Insulin Receptor",
"Approved",,"09/12/2012",,"08/06/2012","09/06/2011","Peptide","Subcutaneous (SQ)","Sanofi","SNY","Toujeo","Endocrine","Diabetes Mellitus, Type I","Insulin Receptor","05/31/2011"
"Approved","08/26/2014","08/26/2014",,,,"Peptide","Subcutaneous (SQ)","Viatris Inc.","VTRS","Semglee","Endocrine","Diabetes Mellitus, Type I","Insulin Receptor","04/27/2012"
"Approved","03/24/2006","03/24/2006","03/30/2004","06/25/2002","03/26/2001","Peptide","Subcutaneous (SQ)","AstraZeneca PLC","AZN","Bydureon","Endocrine","Diabetes Mellitus, Type II","GLP-1 Receptor","03/26/2001"
"Approved","12/10/2001","12/10/2001","06/30/1999","06/30/1999","08/18/1998","Peptide","Subcutaneous (SQ)","AstraZeneca PLC","AZN","Byetta","Endocrine","Diabetes Mellitus, Type II","GLP-1 Receptor","08/18/1998"
"Approved","08/19/2011","08/19/2011",,"01/11/2011",,"Peptide","Subcutaneous (SQ)","Eli Lilly and Company","LLY","Basaglar","Endocrine","Diabetes Mellitus, Type II","Insulin Receptor",
"Approved",,,,,,"Peptide","Subcutaneous (SQ)","Eli Lilly and Company","LLY","Humalog","Endocrine","Diabetes Mellitus, Type II","Insulin Receptor",
"Approved",,,,,,"Peptide","Subcutaneous (SQ)","Eli Lilly and Company","LLY","Humalog Mix","Endocrine","Diabetes Mellitus, Type II","Insulin Receptor",
"Approved",,,,,,"Peptide","Subcutaneous (SQ)","Eli Lilly and Company","LLY","Humulin","Endocrine","Diabetes Mellitus, Type II","Insulin Receptor",
"Approved","07/26/2017","07/26/2017",,,"03/04/2016","Peptide","Subcutaneous (SQ)","Eli Lilly and Company","LLY","Lyumjev","Endocrine","Diabetes Mellitus, Type II","Insulin Receptor","03/04/2016"
"Approved","08/28/2008","08/28/2008",,"07/11/2008",,"Peptide","Subcutaneous (SQ)","Eli Lilly and Company","LLY","Trulicity","Endocrine","Diabetes Mellitus, Type II","GLP-1 Receptor","12/07/2006"
"Approved","09/16/2013","09/16/2013",,,"05/11/2010","Peptide","Subcutaneous (SQ)","Novo Nordisk A/S","NVO","FIAsp","Endocrine","Diabetes Mellitus, Type II","Insulin Receptor","05/11/2010"
"Approved",,,,,,"Peptide","Subcutaneous (SQ)","Novo Nordisk A/S","NVO","Levemir","Endocrine","Diabetes Mellitus, Type II","Insulin Receptor",
"Approved",,,,,,"Peptide","Subcutaneous (SQ)","Novo Nordisk A/S","NVO","Mixtard","Endocrine","Diabetes Mellitus, Type II","Insulin Receptor",
"Approved",,,,,,"Peptide","Subcutaneous (SQ)","Novo Nordisk A/S","NVO","Novolin","Endocrine","Diabetes Mellitus, Type II","Insulin Receptor",
"Approved",,,,,,"Peptide","Subcutaneous (SQ)","Novo Nordisk A/S","NVO","NovoLog","Endocrine","Diabetes Mellitus, Type II","Insulin Receptor",
"Approved",,,,,,"Peptide","Subcutaneous (SQ)","Novo Nordisk A/S","NVO","NovoLog Mix","Endocrine","Diabetes Mellitus, Type II","Insulin Receptor",
"Approved",,"06/21/2012",,"06/12/2008",,"Peptide","Subcutaneous (SQ)","Novo Nordisk A/S","NVO","Ozempic","Endocrine","Diabetes Mellitus, Type II","GLP-1 Receptor","01/31/2008"
"Approved","09/03/2009","09/03/2009",,"01/31/2008",,"Peptide","Subcutaneous (SQ)","Novo Nordisk A/S","NVO","Tresiba","Endocrine","Diabetes Mellitus, Type II","Insulin Receptor",
"Approved","01/27/2006","01/27/2006",,"02/10/2003",,"Peptide","Subcutaneous (SQ)","Novo Nordisk A/S","NVO","Victoza","Endocrine","Diabetes Mellitus, Type II","GLP-1 Receptor",
"Approved","05/29/2008","06/02/2008",,"06/25/2003",,"Peptide","Subcutaneous (SQ)","Sanofi","SNY","Adlyxin","Endocrine","Diabetes Mellitus, Type II","GLP-1 Receptor",
"Approved","01/20/2015","11/18/2014",,,,"Peptide","Subcutaneous (SQ)","Sanofi","SNY","Admelog","Endocrine","Diabetes Mellitus, Type II","Insulin Receptor","06/16/2014"
"Approved",,,,,,"Peptide","Subcutaneous (SQ)","Sanofi","SNY","Lantus","Endocrine","Diabetes Mellitus, Type II","Insulin Receptor",
"Approved",,"01/15/2014","11/21/2011","11/21/2011",,"Peptide","Subcutaneous (SQ)","Sanofi","SNY","Soliqua 100/33","Endocrine","Diabetes Mellitus, Type II","GLP-1 Receptor,Insulin Receptor","02/10/2010"
"Approved","02/08/2012","02/08/2012",,,"09/06/2011","Peptide","Subcutaneous (SQ)","Sanofi","SNY","Toujeo","Endocrine","Diabetes Mellitus, Type II","Insulin Receptor","09/06/2011"
"Approved","08/26/2014","08/26/2014",,,,"Peptide","Subcutaneous (SQ)","Viatris Inc.","VTRS","Semglee","Endocrine","Diabetes Mellitus, Type II","Insulin Receptor","04/27/2012"
"Approved","06/02/2015","06/02/2015",,,,"Peptide","Subcutaneous (SQ)","Tolmar Pharmaceuticals, Inc.",,"Fensolvi","Endocrine","Endocrine Disorder","Gonadotropin-Releasing Hormone (GnRH) Receptor",
"Approved",,,,,,"Peptide","Subcutaneous (SQ)","AbbVie Inc.","ABBV","Lupron","Endocrine","Endocrine Disorder","Gonadotropin-Releasing Hormone (GnRH) Receptor",
"Approved",,,,,,"Peptide","Subcutaneous (SQ)","AbbVie Inc.","ABBV","Lupron","Obstetrics/Gynecology","Endometriosis","Gonadotropin-Releasing Hormone (GnRH) Receptor",
"Approved",,,,,,"Peptide","Subcutaneous (SQ)","Alexion Pharmaceuticals Inc.","ALXN","Fuzeon","Infectious Disease","HIV / AIDS","gp41",
"Approved","02/13/2017","02/13/2017","10/17/2013","10/17/2013",,"Peptide","Subcutaneous (SQ)","Xeris Pharmaceuticals, Inc.","XERS","Gvoke RTU Micro","Endocrine","Hyperinsulinemia/Hypoglycemia","Glucagon Receptor",
"Approved","02/28/2017","02/28/2017","01/04/2013","01/04/2013","06/13/2012","Peptide","Subcutaneous (SQ)","Rhythm Pharmaceuticals, Inc.","RYTM","Imcivree","Metabolic","Metabolic - General","Insulin Receptor,Melanocortin (MC) receptors","06/13/2012"
"Approved","03/20/2009","06/01/2006",,,,"Peptide","Subcutaneous (SQ)","Ipsen SA","IPSEY","Somatuline Autogel","Oncology","Neuroendocrine Tumors (NET)","Somatostatin Receptors",
"Approved","08/23/2018","08/23/2018",,,,"Peptide","Subcutaneous (SQ)","RadioMedix, Inc.",,"Detectnet","Oncology","Neuroendocrine Tumors (NET) - Imaging","Somatostatin Receptors",
"Approved","10/01/2008","10/01/2008","10/06/2006","10/27/2006",,"Peptide","Subcutaneous (SQ)","Novo Nordisk A/S","NVO","Saxenda","Metabolic","Obesity","GLP-1 Receptor",
"Approved",,,,,,"Peptide","Subcutaneous (SQ)","Eli Lilly and Company","LLY","Forteo","Endocrine","Osteoporosis / Osteopenia","Parathyroid Hormone Receptor (PTHR)",
"Approved","12/22/2016","12/22/2016",,,"01/14/2016","Peptide","Subcutaneous (SQ)","Pfenex Inc.","PFNX","Bonsity","Endocrine","Osteoporosis / Osteopenia","Parathyroid Hormone Receptor (PTHR)","01/14/2016"
"Approved",,,,,,"Peptide","Subcutaneous (SQ)","Mundipharma International Limited",,"Eligard","Oncology","Prostate Cancer","Gonadotropin-Releasing Hormone (GnRH) Receptor",
"Approved","04/07/2006","04/07/2006",,"10/05/2004",,"Peptide","Subcutaneous (SQ)","Ferring Pharmaceuticals",,"Firmagon","Oncology","Prostate Cancer","Gonadotropin-Releasing Hormone (GnRH) Receptor",
"Approved",,,,,,"Peptide","Subcutaneous (SQ)","AbbVie Inc.","ABBV","Lupron","Oncology","Prostate Cancer","Gonadotropin-Releasing Hormone (GnRH) Receptor",
"Approved","04/06/2004","04/06/2004",,,,"Peptide","Subcutaneous (SQ)","Takeda Pharmaceutical Co. Ltd.","TAK","Gattex","Gastroenterology (Non Inflammatory Bowel Disease)","Short Bowel Syndrome (SBS)","GLP-2 Receptor","06/29/2000"
"Approved",,,,,,"Peptide","Subcutaneous (SQ)","Ferring Pharmaceuticals",,"Zomacton","Endocrine","Short Stature / Growth Hormone Deficiency","Growth hormone receptor (GHR)",
"Approved",,,,,,"Peptide","Subcutaneous (SQ)","AbbVie Inc.","ABBV","Lupron","Obstetrics/Gynecology","Uterine Fibroids","Gonadotropin-Releasing Hormone (GnRH) Receptor",
"Preclinical",,,,,,"Peptide","Subcutaneous (SQ), Intradermal","Anergis SA",,"AllerDM","Allergy","Allergic Rhinitis","Immune System",
"Suspended",,,,,,"Peptide","Subcutaneous (SQ), Intradermal","Anergis SA",,"AllerR","Allergy","Allergic Rhinitis","Immune System",
"Suspended",,,,,,"Peptide","Subcutaneous (SQ), Intradermal","Anergis SA",,"AllerT","Allergy","Allergic Rhinitis","Immune System",
"Preclinical",,,,,,"Peptide","Subcutaneous (SQ), Intradermal","KAEL Co. Ltd.",82270,"GV1001","Infectious Disease","Hepatitis B Prevention (Vaccines, Antiviral)","Immune System,Telomerase",
"I/II",,,,"10/21/2013",,"Peptide","Subcutaneous (SQ), Intradermal","Vaxil Bio Ltd.",,"ImMucin","Oncology","Breast Cancer","Immune System,Mucin 1 (MUC-1)",
"Suspended",,,,"11/06/2007",,"Peptide","Subcutaneous (SQ), Intradermal","KAEL Co. Ltd.",82270,"GV1001","Oncology","Hepatocellular (Liver) Cancer (HCC) (Including Secondary Metastases)","Immune System,Telomerase",
"Suspended",,,,"06/03/2003",,"Peptide","Subcutaneous (SQ), Intradermal","KAEL Co. Ltd.",82270,"GV1001","Oncology","Melanoma","Immune System,Telomerase",
"I/II",,,,"10/31/2013",,"Peptide","Subcutaneous (SQ), Intradermal","Vaxil Bio Ltd.",,"ImMucin","Oncology","Multiple Myeloma (MM)","Immune System,Mucin 1 (MUC-1)",
"Suspended",,"04/13/2012",,"06/03/2003",,"Peptide","Subcutaneous (SQ), Intradermal","KAEL Co. Ltd.",82270,"GV1001","Oncology","Non-Small Cell Lung Cancer (NSCLC)","Immune System,Telomerase",
"Suspended","03/15/2007","03/15/2007",,"06/03/2003",,"Peptide","Subcutaneous (SQ), Intradermal","KAEL Co. Ltd.",82270,"GV1001","Oncology","Pancreatic Cancer","Immune System,Telomerase",
"Development Outside U.S.",,,,,,"Peptide","Subcutaneous (SQ), Intradermal","KAEL Co. Ltd.",82270,"GV1001","Neurology","Alzheimer's Disease (AD)","Immune System,Telomerase",
"Suspended",,,,,,"Peptide","Subcutaneous (SQ), Intradermal, Intranasal","Theratechnologies Inc.","THTX","TH1173","Endocrine","Short Stature / Growth Hormone Deficiency","Growth Hormone Releasing Hormone (GHRH) Receptor",
"Suspended",,,,"02/24/2013",,"Peptide","Subcutaneous (SQ), Intramuscular (IM)","Recordati SpA","REC:IM","Signifor","Gastroenterology (Non Inflammatory Bowel Disease)","Dumping Syndrome","Somatostatin Receptors",
"I/II",,,"12/09/2009","12/09/2009",,"Peptide","Subcutaneous (SQ), Intramuscular (IM)","AC Immune SA","ACIU","ACI-24","Neurology","Alzheimer's Disease (AD)","Amyloid Beta/Amyloid Plaques,Immune System",
"I",,,,,"04/05/2016","Peptide","Subcutaneous (SQ), Intramuscular (IM)","AC Immune SA","ACIU","ACI-24","Neurology","Down Syndrome","Amyloid Beta/Amyloid Plaques,Immune System","04/05/2016"
"Suspended",,,,,,"Peptide","Subcutaneous (SQ), Intramuscular (IM)","Recordati SpA","REC:IM","Signifor","Not Specified","Surgical and Procedure Complications","Somatostatin Receptors",
"III",,"09/07/2006",,,,"Peptide","Subcutaneous (SQ), Intramuscular (IM)","Verity Pharmaceuticals, Inc.",,"Trelstar","Oncology","Breast Cancer","Gonadotropin-Releasing Hormone (GnRH) Receptor",
"Investigator Initiated",,,"07/16/2015",,,"Peptide","Subcutaneous (SQ), Intramuscular (IM)","Verity Pharmaceuticals, Inc.",,"Trelstar","Oncology","Head and Neck Cancer","Gonadotropin-Releasing Hormone (GnRH) Receptor",
"Suspended",,,,,,"Peptide","Subcutaneous (SQ), Intramuscular (IM)","Recordati SpA","REC:IM","Signifor","Oncology","Merkel Cell Carcinoma","Somatostatin Receptors","08/03/2012"
"Suspended","04/07/2008","04/07/2008",,"06/06/2006",,"Peptide","Subcutaneous (SQ), Intramuscular (IM)","Recordati SpA","REC:IM","Signifor","Oncology","Neuroendocrine Tumors (NET)","Somatostatin Receptors",
"Suspended",,,,,"04/15/2013","Peptide","Subcutaneous (SQ), Intramuscular (IM)","Recordati SpA","REC:IM","Signifor","Oncology","Prostate Cancer","Somatostatin Receptors","07/18/2012"
"Suspended",,,,,,"Peptide","Subcutaneous (SQ), Intramuscular (IM)","Recordati SpA","REC:IM","Signifor","Renal","Polycystic Kidney Disease","Somatostatin Receptors",
"Development Outside U.S.",,,,,,"Peptide","Subcutaneous (SQ), Intramuscular (IM)","Antev Limited",,"Teverelix","Urology","Benign Prostatic Hyperplasia (BPH)","Gonadotropin-Releasing Hormone (GnRH)",
"Development Outside U.S.",,,,,,"Peptide","Subcutaneous (SQ), Intramuscular (IM)","Antev Limited",,"Teverelix","Obstetrics/Gynecology","Endometriosis","Gonadotropin-Releasing Hormone (GnRH)",
"Development Outside U.S.",,,,,,"Peptide","Subcutaneous (SQ), Intramuscular (IM)","Antev Limited",,"Teverelix","Oncology","Prostate Cancer","Gonadotropin-Releasing Hormone (GnRH)",
"Approved in other than U.S./E.U.",,,,,,"Peptide","Subcutaneous (SQ), Intramuscular (IM)","Verity Pharmaceuticals, Inc.",,"Trelstar","Obstetrics/Gynecology","Endometriosis","Gonadotropin-Releasing Hormone (GnRH) Receptor",
"Approved","01/14/2008","01/14/2008",,"01/31/2007",,"Peptide","Subcutaneous (SQ), Intramuscular (IM)","Recordati SpA","REC:IM","Signifor","Endocrine","Acromegaly","Somatostatin Receptors",
"Approved","01/31/2007","01/31/2007",,"04/01/2004",,"Peptide","Subcutaneous (SQ), Intramuscular (IM)","Recordati SpA","REC:IM","Signifor","Endocrine","Cushing's Syndrome","Somatostatin Receptors",
"Approved",,,,,,"Peptide","Subcutaneous (SQ), Intramuscular (IM)","Verity Pharmaceuticals, Inc.",,"Trelstar","Oncology","Prostate Cancer","Gonadotropin-Releasing Hormone (GnRH) Receptor",
"Suspended",,,,"04/27/2012","10/07/2009","Peptide","Subcutaneous (SQ), Intranasal","Azelon Pharmaceuticals",,"ZT-034","Endocrine","Osteoporosis / Osteopenia","Parathyroid Hormone Receptor (PTHR)","10/07/2009"
"II",,,,"11/05/2009",,"Peptide","Subcutaneous (SQ), Intranasal","ISA Pharmaceuticals B.V.",,"ISA101","Infectious Disease","Human Papillomavirus (HPV) Treatment (Antiviral)","Immune System",
"I/II",,,,"10/29/2013",,"Peptide","Subcutaneous (SQ), Intranasal","ISA Pharmaceuticals B.V.",,"ISA101","Oncology","Cervical Cancer","Immune System","06/02/2010"
"II",,,"12/07/2015","12/07/2015",,"Peptide","Subcutaneous (SQ), Intranasal","ISA Pharmaceuticals B.V.",,"ISA101","Oncology","Head and Neck Cancer","Immune System",
"Suspended",,,"03/06/2006","03/06/2006","11/29/2002","Peptide","Subcutaneous (SQ), Intravenous (IV)","Serodus ASA",,"SER100","Cardiovascular","Acute Decompensated Heart Failure","Opioid receptors","11/29/2002"
"Suspended",,,"08/08/2016","08/08/2016",,"Peptide","Subcutaneous (SQ), Intravenous (IV)","PhaseBio Pharmaceuticals, Inc.","PHAS","Vasomera","Cardiovascular","Congestive Heart Failure (CHF) and Cardiomyopathies","Vasoactive Intestinal Peptide (VIP) Receptor",
"Suspended",,,"11/05/2013","11/05/2013",,"Peptide","Subcutaneous (SQ), Intravenous (IV)","Serodus ASA",,"SER100","Cardiovascular","Hypertension (Systemic)","Opioid receptors","09/02/2010"
"Suspended",,,,,"02/22/2012","Peptide","Subcutaneous (SQ), Intravenous (IV)","PhaseBio Pharmaceuticals, Inc.","PHAS","Vasomera","Cardiovascular","Hypertension (Systemic)","Vasoactive Intestinal Peptide (VIP) Receptor","02/22/2012"
"Suspended",,"01/10/2001",,,,"Peptide","Subcutaneous (SQ), Intravenous (IV)","Debiopharm S.A.",,"Sanvar IR","Cardiovascular","Portal Hypertension","Somatostatin Receptors",
"IIb",,,"08/07/2018","08/07/2018","10/20/2017","Peptide","Subcutaneous (SQ), Intravenous (IV)","PhaseBio Pharmaceuticals, Inc.","PHAS","Vasomera","Cardiovascular","Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension (PH)","Vasoactive Intestinal Peptide (VIP) Receptor","10/20/2017"
"Suspended",,,,,,"Peptide","Subcutaneous (SQ), Intravenous (IV)","Serodus ASA",,"SER100","Cardiovascular","Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension (PH)","Opioid receptors",
"I",,,,,"01/10/2020","Peptide","Subcutaneous (SQ), Intravenous (IV)","Eli Lilly and Company","LLY","LY3493269","Endocrine","Diabetes Mellitus, Type II","GIP Receptor (GIPR)/Glucose-Dependent Insulinotropic Polypeptide Receptor,GLP-1 Receptor","01/10/2020"
"I/II",,,,"10/09/2018",,"Peptide","Subcutaneous (SQ), Intravenous (IV)","TherAchon AG",,"Apraglutide","Gastroenterology (Non Inflammatory Bowel Disease)","Short Bowel Syndrome (SBS)","GLP-2 Receptor","01/17/2018"
"Suspended",,,"07/16/2020","07/16/2020",,"Peptide","Subcutaneous (SQ), Intravenous (IV)","PhaseBio Pharmaceuticals, Inc.","PHAS","Vasomera","Infectious Disease","COVID-19 Treatment","Vasoactive Intestinal Peptide (VIP) Receptor",
"Suspended",,,"08/08/2016","08/08/2016",,"Peptide","Subcutaneous (SQ), Intravenous (IV)","PhaseBio Pharmaceuticals, Inc.","PHAS","Vasomera","Metabolic","Muscular Dystrophy","Vasoactive Intestinal Peptide (VIP) Receptor",
"Suspended",,,,"01/30/2018",,"Peptide","Subcutaneous (SQ), Intravenous (IV)","TherAchon AG",,"Apraglutide","Oncology","Hodgkin's Lymphoma","GLP-2 Receptor",
"Suspended",,,,"01/30/2018",,"Peptide","Subcutaneous (SQ), Intravenous (IV)","TherAchon AG",,"Apraglutide","Oncology","Non-Hodgkin's Lymphoma (NHL)","GLP-2 Receptor",
"Suspended",,,,,,"Peptide","Subcutaneous (SQ), Intravenous (IV)","PhaseBio Pharmaceuticals, Inc.","PHAS","Vasomera","Respiratory","Cystic Fibrosis (CF)","Vasoactive Intestinal Peptide (VIP) Receptor",
"Approved in other than U.S./E.U.",,,,,,"Peptide","Subcutaneous (SQ), Intravenous (IV)","Biocon, Ltd.",,"Insugen","Endocrine","Diabetes Mellitus, Type I","Insulin Receptor",
"Approved in other than U.S./E.U.",,,,,,"Peptide","Subcutaneous (SQ), Intravenous (IV)","Biocon, Ltd.",,"Insugen","Endocrine","Diabetes Mellitus, Type II","Insulin Receptor",
"II",,,,"03/03/2014",,"Peptide","Subcutaneous (SQ), Intravenous (IV), Intradermal","Apitope Technology (Bristol) Ltd",,"ATX-MS-1467","Neurology","Multiple Sclerosis (MS)","Immune System,Myelin Basic Protein (MBP)","02/06/2007"
"Preclinical",,,,,,"Peptide","Subcutaneous (SQ), Oral (PO)","Bioniz Therapeutics, Inc.",,"BNZ-2","Autoimmune/immunology","Celiac Disease","IL-15 (Interleukin-15)/IL-15 Receptor,IL-21 (Interleukin-21)",
"Preclinical",,,,,,"Peptide","Subcutaneous (SQ), Oral (PO)","Bioniz Therapeutics, Inc.",,"BNZ-2","Autoimmune/immunology","Inflammatory Bowel Disease (IBD)","IL-15 (Interleukin-15)/IL-15 Receptor,IL-21 (Interleukin-21)",
"I",,,,,"02/05/2018","Peptide","Subcutaneous (SQ), Oral (PO)","Palatin Technologies, Inc.","PTN","PL-8177","Autoimmune/immunology","Ulcerative Colitis (UC)","Melanocortin (MC) receptors","02/05/2018"
"Preclinical",,,,,,"Peptide","Subcutaneous (SQ), Oral (PO)","Palatin Technologies, Inc.","PTN","PL-8177","Infectious Disease","COVID-19 Treatment","Melanocortin (MC) receptors",
"Preclinical",,,,,,"Peptide","Subcutaneous (SQ), Oral (PO)","Palatin Technologies, Inc.","PTN","PL-8177","Ophthalmology","Diabetic Retinopathy (Ophthalmology)","Melanocortin (MC) receptors",
"Preclinical",,,,,,"Peptide","Subcutaneous (SQ), Oral (PO)","Palatin Technologies, Inc.","PTN","PL-8177","Ophthalmology","Uveitis (Ophthalmology)","Melanocortin (MC) receptors",
"II",,,"09/12/2019","09/12/2019","05/08/2018","Peptide","Subcutaneous (SQ), Percutaneous Catheter/Injection","Ascendis Pharma A/S","ASND","TransCon CNP","Endocrine","Achondroplasia","Natriuretic Peptide Receptors","05/08/2018"
"Preclinical",,,,,,"Peptide","Sublingual (SL)/Oral Transmucosal","Aquestive Therapeutics, Inc.","AQST","AQST-305","Endocrine","Acromegaly","Somatostatin Receptors",
"Suspended",,,,,,"Peptide","Sublingual (SL)/Oral Transmucosal","NHTherapeutics, Inc.",,"NH901","Endocrine","Hypogonadism","Gonadotropin-Releasing Hormone (GnRH) Receptor",
"Suspended",,,,,,"Peptide","Sublingual (SL)/Oral Transmucosal","Albireo Pharma, Inc.","ALBO","VIAcal","Endocrine","Osteoporosis / Osteopenia","Calcitonin Receptor",
"Suspended",,,,,,"Peptide","Surgical Implantation","Aevi Genomic Medicine, Inc.","GNMX","MDGN-205","Gastroenterology (Non Inflammatory Bowel Disease)","Short Bowel Syndrome (SBS)",,
"I/II",,,"03/10/2020","03/10/2020","03/10/2020","Peptide","Topical","Amytrx Therapeutics, Inc.",,"AMTX-100","Allergy","Atopic Dermatitis (Eczema)","Unknown",
"II",,,"01/16/2019","01/16/2019","03/23/2017","Peptide","Topical","Brickell Biotech, Inc.","BBI","BBI-2000","Allergy","Atopic Dermatitis (Eczema)",,"03/23/2017"
"Suspended",,,,,,"Peptide","Topical","Kv1.3 Therapeutics, Inc.",,"KPI-150","Allergy","Atopic Dermatitis (Eczema)","Potassium channels",
"Suspended",,,,,,"Peptide","Topical","Kv1.3 Therapeutics, Inc.",,"KPI-150","Autoimmune/immunology","Psoriasis","Potassium channels",
"Suspended",,,"12/28/2005","08/01/2003",,"Peptide","Topical","TG Therapeutics, Inc.","TGTX","Topical PTH (1-34)","Autoimmune/immunology","Psoriasis","Parathyroid Hormone Receptor (PTHR)",
"Suspended",,,,"06/27/2011",,"Peptide","Topical","Digna Biotech, S.L.",,"Disitertide (Topical)","Autoimmune/immunology","Scleroderma","Transforming Growth Factor-beta (TGF-beta) and Superfamily",
"Suspended",,,,,,"Peptide","Topical","Kv1.3 Therapeutics, Inc.",,"KPI-150","Autoimmune/immunology","Systemic Lupus Erythematosus (SLE)","Potassium channels",
"II",,,,"10/08/2011",,"Peptide","Topical","FirstString Research, Inc.",,"Granexin Gel","Autoimmune/immunology","Wound Healing","Unknown","09/08/2010"
"Suspended",,,,,,"Peptide","Topical","Integra LifeSciences Holdings Corporation","IART","Aclerastide","Autoimmune/immunology","Wound Healing","Unknown",
"II",,,"04/15/2014","12/08/2005",,"Peptide","Topical","Maruho Co., Ltd.",,"CLS001","Dermatology","Acne","Unknown",
"Preclinical",,,,,,"Peptide","Topical","CLINUVEL PHARMACEUTICALS LIMITED","CLVLY","CUV9900","Dermatology","Dermatology","Melanocortin (MC) receptors",
"Suspended",,,"11/25/2015",,,"Peptide","Topical","Maruho Co., Ltd.",,"CLS001","Dermatology","Dermatology","Unknown",
"Suspended","10/14/2015","10/14/2015","01/22/2007","01/22/2007",,"Peptide","Topical","Maruho Co., Ltd.",,"CLS001","Dermatology","Rosacea","Unknown","12/08/2005"
"III","07/31/2015","07/31/2015",,"10/07/2011",,"Peptide","Topical","FirstString Research, Inc.",,"Granexin Gel","Endocrine","Diabetic Foot and Other Ulcers","Unknown","09/08/2010"
"Suspended","02/06/2013","02/06/2013","11/20/2008","11/20/2008",,"Peptide","Topical","Integra LifeSciences Holdings Corporation","IART","Aclerastide","Endocrine","Diabetic Foot and Other Ulcers","Unknown",
"Suspended",,"07/26/1999",,,,"Peptide","Topical","PLx Pharma Inc.","PLXP","Locilex","Endocrine","Diabetic Foot and Other Ulcers","Bacteria-miscellaneous,Cell Membrane",
"Suspended",,,,,,"Peptide","Topical","Promore Pharma AB","PROMO","LL-37","Endocrine","Diabetic Foot and Other Ulcers",,
"Suspended",,,,,,"Peptide","Topical","Acologix, Inc.",,"AC-100","Endocrine","Osteopetrosis",,
"Suspended",,,,"07/24/2006",,"Peptide","Topical","Acologix, Inc.",,"AC-100","ENT/Dental","Periodontitis",,"10/04/2004"
"Suspended",,,"09/26/2006","11/02/2004",,"Peptide","Topical","G-treeBNT Co., Ltd",,"RGN-137","Hematology","Chronic Pressure Ulcers","Actin Filaments,ATP Synthase,Integrin-linked kinase (ILK)",
"II",,,,"10/11/2011",,"Peptide","Topical","FirstString Research, Inc.",,"Granexin Gel","Hematology","Chronic Venous Ulcers","Unknown","09/08/2010"
"Suspended",,,,"12/20/2004",,"Peptide","Topical","G-treeBNT Co., Ltd",,"RGN-137","Hematology","Chronic Venous Ulcers","Actin Filaments,ATP Synthase,Integrin-linked kinase (ILK)",
"Program Hold",,,"03/20/2017","03/20/2017","07/30/2014","Peptide","Topical","Ergomed plc","ERGO","PeproStat","Hematology","Hemostasis","Fibrinogen (Coagulation Factor I)","07/30/2014"
"Suspended","06/27/2005","06/27/2005",,"02/09/2005",,"Peptide","Topical","BioWest Therapeutics, Inc.","BWE:CN","Omigard","Infectious Disease","Antibacterial - General","Cell Membrane",
"Suspended",,,,"03/07/2006",,"Peptide","Topical","Dr. Reddy's Laboratories Ltd.","RDY","OP-145","Infectious Disease","Ear Infections (Antibacterial)","Biofilms","01/15/2004"
"Suspended",,,,"05/18/2010",,"Peptide","Topical","NovaBiotics Ltd",,"Novexatin","Infectious Disease","Fungal Infections - Non-Systemic","Cell Membrane",
"Preclinical",,,,,,"Peptide","Topical","NovaBiotics Ltd",,"Novamycin","Infectious Disease","Fungal Infections - Systemic","Cell Membrane",
"Suspended",,,,,,"Peptide","Topical","Promore Pharma AB","PROMO","LL-37","Infectious Disease","Hepatitis C (HCV) (Antiviral)",,
"Suspended",,,"07/27/2016","07/27/2016",,"Peptide","Topical","Maruho Co., Ltd.",,"CLS001","Infectious Disease","Human Papillomavirus (HPV) Treatment (Antiviral)","Unknown","07/20/2016"
"Suspended",,,,"07/01/2005",,"Peptide","Topical","Takeda Pharmaceutical Co. Ltd.","TAK","R-851","Infectious Disease","Human Papillomavirus (HPV) Treatment (Antiviral)","Human Papillomavirus (HPV),Immune System","03/01/2005"
"Suspended",,,"09/01/2010","09/01/2010",,"Peptide","Topical","Lytix Biopharma AS",,"Lytixar","Infectious Disease","Skin and Skin-Structure Infections (Antibacterial)","Cell Membrane","08/19/2009"
"Suspended",,,,,,"Peptide","Topical","PLx Pharma Inc.","PLXP","Locilex","Infectious Disease","Skin and Skin-Structure Infections (Antibacterial)","Bacteria-miscellaneous,Cell Membrane","07/17/2014"
"Suspended",,,,"05/20/2010",,"Peptide","Topical","Lytix Biopharma AS",,"Lytixar","Infectious Disease","Staphylococcal Vaccines and Other Staphylococcus-Specific Agents (Antibacterial)","Cell Membrane",
"II",,,,"06/04/2004",,"Peptide","Topical","G-treeBNT Co., Ltd",,"RGN-137","Metabolic","Epidermolysis Bullosa","Actin Filaments,ATP Synthase,Integrin-linked kinase (ILK)",
"III",,"12/18/2017",,,,"Peptide","Topical","FirstString Research, Inc.",,"Granexin Gel","Not Specified","Acute Radiation Syndrome (ARS)","Unknown",
"I/II",,,,"12/10/2014",,"Peptide","Topical","Stealth BioTherapeutics Inc.","MITO","Elamipretide (Ophthalmic Delivery)","Ophthalmology","Diabetic Macular Edema (Ophthalmology)","Reactive Oxygen Species/Free Radicals",
"I/II",,,,"12/10/2014",,"Peptide","Topical","Stealth BioTherapeutics Inc.","MITO","Elamipretide (Ophthalmic Delivery)","Ophthalmology","Dry Age-Related Macular Degeneration (Dry AMD)/Geographic Atrophy (Ophthalmology)","Reactive Oxygen Species/Free Radicals",
"I/II",,,,"07/20/2017",,"Peptide","Topical","TearSolutions, Inc.",,"Lacripep","Ophthalmology","Dry Eye (Ophthalmology)","Cluster of Differentiation 138 (CD138)/ Syndecan 1 (SDC1)",
"III","09/16/2015","09/16/2015","09/14/2010","05/14/2010",,"Peptide","Topical","RegeneRx Biopharmaceuticals, Inc.","RGRX","RGN-259","Ophthalmology","Dry Eye (Ophthalmology)","Actin Filaments,ATP Synthase,Integrin-linked kinase (ILK)",
"Preclinical",,,,,,"Peptide","Topical","OKYO Pharma Limited","OKYO","OKYO-0101","Ophthalmology","Dry Eye (Ophthalmology)","ChemR23,GPR1",
"Suspended",,,,,,"Peptide","Topical","Kv1.3 Therapeutics, Inc.",,"KPI-190","Ophthalmology","Dry Eye (Ophthalmology)","Potassium channels",
"II",,,"04/14/2016","04/14/2016",,"Peptide","Topical","Stealth BioTherapeutics Inc.","MITO","Elamipretide (Ophthalmic Delivery)","Ophthalmology","Leber's Hereditary Optic Neuropathy (LHON) (Ophthalmology)","Reactive Oxygen Species/Free Radicals",
"III","09/21/2015","09/21/2015",,"04/30/2007",,"Peptide","Topical","RegeneRx Biopharmaceuticals, Inc.","RGRX","RGN-259","Ophthalmology","Ophthalmic Wound Healing (Ophthalmology)","Actin Filaments,ATP Synthase,Integrin-linked kinase (ILK)",
"II",,,"03/08/2016","03/08/2016",,"Peptide","Topical","Stealth BioTherapeutics Inc.","MITO","Elamipretide (Ophthalmic Delivery)","Ophthalmology","Other Ophthalmological Indications (Ophthalmology)","Reactive Oxygen Species/Free Radicals",
"Suspended",,,,,,"Peptide","Topical","Mallinckrodt plc","MNK","DE-105","Ophthalmology","Persistent Corneal Epithelial Defects (Ophthalmology)","Unknown","08/03/2010"
"Preclinical",,,,,,"Peptide","Topical","Kv1.3 Therapeutics, Inc.",,"KPI-190","Ophthalmology","Uveitis (Ophthalmology)","Potassium channels",
"Development Outside U.S.",,,"05/28/2015",,,"Peptide","Topical","Maruho Co., Ltd.",,"CLS001","Allergy","Atopic Dermatitis (Eczema)","Unknown",
"Development Outside U.S.",,,,,,"Peptide","Topical","Transdermal Therapeutic Technologies LLC",,"DPK-060","Allergy","Atopic Dermatitis (Eczema)","Bacteria-miscellaneous,Candida,Staphylococcus",
"Development Outside U.S.",,,"09/11/2012",,,"Peptide","Topical","Promore Pharma AB","PROMO","LL-37","Hematology","Chronic Venous Ulcers",,
"Development Outside U.S.",,,,,"03/18/2019","Peptide","Topical","Cytovation AS",,"CyPep-1 (Topical)","Dermatology","Dermatology","Tumor Cells",
"Development Outside U.S.",,,,,,"Peptide","Topical","Shionogi & Co. Ltd.",4507,"SR-0379","Endocrine","Diabetic Foot and Other Ulcers","PI3K/AKT pathway",
"Development Outside U.S.",,,,,,"Peptide","Topical","Allegro Ophthalmics, LLC.",,"ALG-1007","Ophthalmology","Dry Eye (Ophthalmology)","Integrins",
"Development Outside U.S.",,,"01/16/2012",,,"Peptide","Topical","Transdermal Therapeutic Technologies LLC",,"DPK-060","Infectious Disease","Ear Infections (Antibacterial)","Bacteria-miscellaneous,Candida,Staphylococcus",
"Preclinical",,,,,,"Peptide","Transdermal","CLINUVEL PHARMACEUTICALS LIMITED","CLVLY","VLRX001","Dermatology","Vitiligo","Melanocortin (MC) receptors",
"Suspended",,,,,,"Peptide","Transdermal","Syneron Medical Ltd.",,"ViaDor-GLP1","Endocrine","Diabetes Mellitus, Type II","GLP-1 Receptor","09/14/2010"
"Suspended",,,,,,"Peptide","Transdermal","AstraZeneca PLC","AZN","Exenatide Patch","Endocrine","Diabetes Mellitus, Type II","GLP-1 Receptor","04/01/2009"
"Suspended",,,,,,"Peptide","Transdermal","Zosano Pharma Corporation","ZSAN","Semaglutide Transdermal Patch","Endocrine","Diabetes Mellitus, Type II","GLP-1 Receptor",
"Program Hold",,,,"01/31/2015",,"Peptide","Transdermal","Zosano Pharma Corporation","ZSAN","ZP-Glucagon Transdermal Patch","Endocrine","Hyperinsulinemia/Hypoglycemia","Glucagon Receptor",
"Program Hold",,,,"10/10/2011",,"Peptide","Transdermal","Zosano Pharma Corporation","ZSAN","ZP PTH (Weekly)","Endocrine","Osteoporosis / Osteopenia","Parathyroid Hormone Receptor (PTHR)","04/30/2014"
"Suspended",,,,"06/12/2008",,"Peptide","Transdermal","Syneron Medical Ltd.",,"ViaDor-hPTH (1-34)","Endocrine","Osteoporosis / Osteopenia","Parathyroid Hormone Receptor (PTHR)","07/09/2007"
"Suspended",,,,"06/19/2007",,"Peptide","Transdermal","Zosano Pharma Corporation","ZSAN","ZP PTH (Daily)","Endocrine","Osteoporosis / Osteopenia","Parathyroid Hormone Receptor (PTHR)",
"Suspended",,,"03/10/2009","03/10/2009",,"Peptide","Transdermal","Vyteris, Inc.","VYTRQ","Lutrepatch","Obstetrics/Gynecology","Reproductive Disorder","Unknown","08/10/2006"
"Suspended",,,,,,"Peptide","Transdermal","Syneron Medical Ltd.",,"ViaDor-Calcitonin","Rheumatology (Non Autoimmune)","Musculoskeletal Conditions","Calcitonin Receptor","01/11/2011"
"Development Outside U.S.",,,,,,"Peptide","Transdermal","Corium Inc.",,"MicroCor PTH","Endocrine","Osteoporosis / Osteopenia","Parathyroid Hormone Receptor (PTHR)",
